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BIOINFORMATIC ANALYSIS OF STREPTOMYCES TO ENABLE 
 IMPROVED DRUG DISCOVERY 
by 
Kaitlyn C. Belknap 
University of New Hampshire 
 
Biotransformation is the use of an organism’s metabolic system to process compounds of interest 
and induce chemical modifications. Natural products, including those that have antitumor 
properties, can be biotransformed in an effort to increase the potency of the synthesized bioactive 
chemicals. This study investigated the potential of a bacterial isolate of the Streptomyces genus 
to biotransform ursolic acid (UA). Ursolic acid (UA) is an antileukemic compound derived from 
the ethnobotanical Northern Labrador Tea. Streptomyces derived natural products have been 
developed into chemotherapeutics including Daunorubicin and Doxorubicin, among others. The 
collection, isolation, purification, sequencing, and identification of a Streptomyces species from a 
bear fecal sample, referred to as Streptomyces akac8, was successful. The biotransformation of 
UA did not yield. A bioinformatics approach was taken to investigate the diversity and 
phylogenetic distribution of biosynthetic gene clusters (BGCs) harbored in 1,110 Streptomyces 
genomes. A prioritization of the most prolific natural product producer strains was established 
and a strain specific analysis identified possible naturally occurring analogs of 38 existing 
chemotherapeutic gene clusters (CGCs). This was one of the largest BGC study of a single genus 
to date. Our results indicate a wide phylogenetic spread of CGCs beyond the established species 
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associated with the production of specific chemotherapeutics. We also found diverse BGC 
content in closely related strains. Finally, based upon our findings of variably distributed 




INTRODUCTION: THE ROLE OF THE MICROBIOME IN CANCER AND THE 
DEVELOPMENT OF IMPROVED CANCER THERAPEUTICS 
 
Kaitlyn C. Belknap, Andrea L. Cote, Colin M. McGill, Cheryl P. Andam, and Brian M. Barth 
 
Abstract 
Cancer is caused by a compilation of hereditary and environmental factors. In the past decade, 
Next Generation Sequencing (NGS) has revealed the extent to which the microbiome influences 
the maintenance of homeostasis and therefore the prevention of diseases such as cancer.  Current 
research efforts of today are exploring the interaction between cancer and the microbiome, and 
their results are expected to transform how clinicians approach cancer treatment. There is a 
plausible transition from the use of human genetic biomarkers to microbiomic biomarkers for 
genomic diagnostics. Considering the expanding knowledge of the ways in which the 
microbiome can affect the development of cancer, clinicians treating cancer patients should be 
considerate of how the microbiome can influence the host-drug or microbiome-cancer 
interactions. Soon, oncologists that do not consider the microbiome will be taking an allopathic 
approach. Recognition of the importance of the microbiome within the field of oncology is 
pertinent to understanding and furthering cancer development and treatment.  
 
Introduction 
An individual’s likelihood to develop cancer or respond to heterogeneous prescribed treatments 
for their cancer does not depend solely on the individual’s genome. The environment that a 
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person lives in does in fact play a very important role in the development and persistence of their 
cancer. Until recently, the environment within a patient was not considered when analyzing the 
longevity and treatment of cancer patients. The fields of cancer pharmacology and microbiology 
have become entangled within the last decade. Next generation sequencing has expedited this 
process by allowing researchers to identify the individual constituents and the overall complexity 
of the microbiome.  
 
The holobiont is a composite of all of the cells on and within our bodies. This concept is not 
restricted to human cells, but rather incorporates all present populations of bacteria, fungi, and 
viruses (Kutschera, 2018). Researchers are investigating the holobiont as a tool to monitor cancer 
development and treatment. Our bodies are ecosystems that support mutualistic relationships 
with the billions of other organisms that live on and within us. The holobiome is a term which 
refers to the combination of all of the genomes of the components that make up the holobiont 
(Guerrero et al, 2013). The human genome regulates the expression of the microbial genome, 
and vice versa. Additionally, bacterial metabolites produced on or within the human body 
influence both normal cells and cancer cells. The consequences of such interactions could 
determine how cancer cells respond to chemotherapy, while the microbiome itself has the ability 
to prevent or promote cancer development. Therefore, the composition of a patient’s microbiome 
may function as a useful biomarker in predicting how the patient will respond to different 
treatments, or combinations of treatments. This review covers the host-bacterial interaction in 





Dysbiosis, or the maladaptation and imbalance of bacteria present on or within the body, is 
correlated with decreasing levels of overall cancer survival and increased risk for infection 
Sheflin et al, 2014). There are differing perspectives regarding if dysbiosis causes cancer or if 
cancer causes dysbiosis, but nonetheless the two conditions are related to each other. This 
correlation is evident with leukemia and bacteremia. Leukemia is a hematological malignancy 
that causes a population of immature white blood cells to clonally expand in the bone marrow, 
thus inhibiting normal blood cell function. Bacteremia is a form of dysbiosis in which bacteria 
enter the blood stream (Samet et al, 2013). Necrosis Factor (TNF)-α mediated disruptions of the 
intestinal barrier can induce the translocation of macromolecules from the gastrointestinal system 
to the vascular bed in murine models (Costa-Lima, 2014). Induction chemotherapy can also 
break down the intestinal barrier, causing patients receiving hematopoietic stem cell transplants 
to have increased risk of bacteremia and acute graft-versus-host disease (Tuncer, 2012).  
The utilization of intestinal barrier protection to prevent the translocation of bacteria from the 
gastrointestinal tract to the blood stream has been contemplated but not investigated as a 
therapeutic for leukemia, to the author’s knowledge. However, Irritable Bowel Syndrome (IBS) 
has also been connected to leaky gut syndrome (Bron et al, 2017), but not to bacteremia. 
Although the findings are difficult to interpret due to the use of various strains of probiotics, 
supplementation of lactic acid bacteria has been found to improve the phenotype of IBS and 
reduce leakage (Bixquert, 2013, Bron, 2017, Zeng et al, 2008). Probiotics or prebiotics have been 
used as mechanisms to up-regulate lactic acid bacteria and repair the gastrointestinal barrier 
(Samet, 2013, Bixquert, 2017). The probiotics approach includes the administration of live 
bacteria, which, ironically, has been associated with a small percentage of bacteremia cases. 
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Prebiotics are polysaccharides that are non-digestible by humans (Zitvogel et al, 2018). The 
supplementation of these prebiotics modifies the microbiome by up-regulating the bacterium that 
are able to thrive on the polysaccharide substrate. Prebiotics have been utilized to up-regulate 
lactic acid bacteria and increase the production of butyrate (Distrutti et al, 2016, Vanhoutvin et 
al, 2009). Butyrate is a short chain fatty acid produced by the digestion of dietary fiber and 
complex carbohydrates. It can be an oncometabolite in mouse models of Lynch Syndrome, 
specifically of transgenic with mutations of the MMR gene family (MLH1, MSH2, or PMS2). In 
Lynch Syndrome model organisms, butyrate induces the proliferation of epithelial cells 
(Yurgelun, 2017). In MMR proficient models, butyrate can be utilized as an oncosuppressive 
metabolite. Therefore, in patients without MMR gene family mutations, butyrate should be 
considered as a potential cancer therapeutic. This alternating role of butyrate is termed the 
butyrate paradox. It is dependent upon the human host’s genetic background (Yurgelun, 2017), 
and must be considered if butyrate is utilized in leukemia drug development.  
Antibiotics can also cause dysbiosis, thus adding an additional variable to consider when 
analyzing the interconnections between leukemia and dysbiosis. Many leukemia patients are 
treated with chemotherapeutics in combination with antibiotics. This can cause 
immunosuppression and disruption of the mucosal epithelium (Samet, 2013). Disruption of an 
intestinal barrier’s microbiome, and therefore the alpha diversity of the microbiome, implies the 
absence of commensal microorganisms that typically defend mucosal sites from pathogenic 
species. This can in turn result in recurrent episodes of bacteremia. In the clinical setting, 
bacteremia is frequently correlated with intestinal barrier degradation and gut leakage (Samet, 
2013). Bacteria, and the toxins that the bacteria produce, can systemically spread throughout the 
body of a cancer patient if their gastrointestinal barrier is impaired. E. coli is responsible for the 
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majority of bacteremia cases in acute myeloid leukemia (AML) patients (Hakim et al., 2018). 
However, the so-called “leaky gut” of cancer patients has only recently been associated with 
AML patient bacteremia (Costa-Lima, 2014). Alternative portals of bacteremia in leukemia 
patients include vascular catheters (Karthaus, 2002), the respiratory tract (Hakim et al, 2016, 
Landgren et al, 2007) and skin abrasions (Sotman et al, 1980). However, at State Clinical 
Hospital in Gdańsk, Poland, an estimated 72% of all bacteremia cases in the Adult Hematology 
Clinic (AHC) came from previously unknown sources (Samet et al, 2013). Comparative 16S 
analysis of blood and bowel E. coli samples revealed that 24% of leukemia patient bacteremia 
cases of unknown origin were sourced from gastrointestinal leakage of E. coli. 19.1% of patients 
in the AHC developed bacteremia, compared to the 1.6% of the rest of the hospital (Samet et al, 
2013).  
The loss of heterozygosity (LOH) is associated with increased risk due to the inability of one 
chromosome to compensate for mutations on the other (Irving, 2005). Microbiome studies have 
noticed a similar loss of heterozygosity over time in cancer patient microbiomic profiles. This is 
otherwise referred to as decreased temporal variability or loss of diversity; it is associated with 
an increased risk of infection in cancer patients (Sheflin et al, 2014). LOH has been considered 
as a biomarker for leukemia patients to establish treatment plans. This form of dysbiosis does not 
stem from the absence of certain bacterium, but from the dysregulation of the native, commensal 
microbiota as a whole. Galloway-Pena et al established that AML patients have a higher 
likelihood to acquire an infection during induction chemotherapy (IC) if they have a low baseline 
gastrointestinal alpha diversity (Galloway-Peña et al, 2016). Comparatively, if the alpha diversity 
of both the oral and the gastrointestinal microbiome is low, the patient has a higher risk for 
infection within 90 days post-IC therapy (Galloway-Peña et al, 2016, Galloway-Peña et al, 
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2017). The fecal and buccal samples parallel each other in a trend of decreasing microbial 
diversity throughout a longitudinal analysis of patients undergoing IC therapy (Galloway-Peña et 
al, 2017). A pattern of increased pathogenic genera domination events was observed throughout 
a longitudinal analysis (Galloway-Peña et al, 2017). Not surprisingly, when pathogenic bacteria 
dominate a patient’s mucosal epithelium, the patient is more prone to infection (Taur et al, 2013). 
Although not nearly as common, cases of increased diversity throughout IC have also been 
reported (Galloway-Peña et al, 2017). Oral and gastrointestinal sites are common origins of 
infection in immunocompromised patients (Al Anazi, 2009, Li et al 2000). Therefore, the 
temporal variability of the microbiome at both of those sites is imperative to the understanding 
and identification of biomarkers of alpha diversity for high and low risk infection groups. 
Microbiome composition could be used as a biomarker to identify leukemia patients that are 
more likely to develop infections throughout IC-therapy and less likely to have positive 
outcomes. Therefore, preventative actions could be taken including alternations in 
chemotherapeutic intervention, antimicrobial therapeutics, and microbiomic modification.  
Breast Cancer 
Breast cancer is the second leading cause of death in the United States, yet its etiology remains 
relatively unknown (Fernández et al, 2018). An increased incidence of breast cancer has been 
observed within patients that move from an area with a low rate of breast cancer to an area with a 
high rate of breast cancer (Thomas, 2017). This higher risk of breast cancer development can be 
vertically transferred to the migrant’s offspring (Thomas, 2017). As previously discussed, cancer 
is sourced from a combination of genetic and environmental factors. Researchers have postulated 
that one of the possible environmental causes of this pattern could be a woman’s microbiome 
(Fernández et al, 2018).  A study investigated the breast microbial profiles of women effected by 
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breast cancer verses healthy women. The microbiomic profiles of women with breast cancer had 
higher abundances of Staphylococcus, Enterobacteriaceae, and Bacillus, compared to controls.  
Species of Staphylococcus epidermidis and Escherichia coli isolated from the skin of the 
cancerous breasts were able to cause genomic instability by inducing DNA double stranded 
breaks in HeLa cells (Urbaniak, 2016). Women with breast cancer also had decreased levels of 
lactic acid bacteria, as compared to women without breast cancer (Urbaniak, 2016).  
 
Oral administration of milk fermented by the lactic acid bacteria group member Lactobacillus 
helveticus R389, has been tested in mouse models and correlated with reduced growth of breast 
tumors and immunoregulation (de Moreno de LeBlanc, 2005). Further studies have established 
anti-metastatic and anti-angiogenic properties of Lactobacillus casei CRL 431 fermented milk 
(Aragón, 2015). Lactobacillus plantarum fermentation of the plant red ginseng (RG) has been 
used to increase the efficacy of bioactive compounds for the treatment of ulcerative colitis in 
mouse models (Jang et al, 2017). Comparably to breast cancer, there was an observed 
discrepancy between the microbiomes of ulcerative colitis patients and healthy patients (Shen et 
al, 2018), including a lack of lactic acid bacteria (Saez-Lara, 2015). It is predicted that non-
responder mouse models did not have the necessary microbiome constituents to actively 
biotransform the RG. A combination of probiotics, including Lactobacillus plantarum, was 
utilized to convert RG into an enhanced and activated form, thus reducing inflammation and the 
ulcerative colitis phenotype (Jang et al, 2017). The utilization of probiotic fermentation has 
successfully been implemented with RG treatments to induce an anti-diabetic effect as well (Jang 
et al, 2017). Our lab has postulated similar strategies of ethnobotanical biotransformation for the 
treatment of alternative cancers. Since dysbiosis is heavily correlated with cancer, we foresee the 
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utilization of biotransformation as a promising alternative approach to further cancer drug 
discovery efforts.  
 
An innate metabolic connection between the microbiome and breast cancer has been established, 
as well. The bacterial secondary bile acid lithocholic acid (LCA) was found to exhibit anti-
proliferative, anti-metastatic, and anti-angiogenic effects upon breast cancer in vivo and in vitro, 
without effecting primary cells (Mikó, 2018). The LCA mechanism of action has been implicated 
with TGR5 receptor activation (Luu, 2018). However, the origin of the metabolite is still under 
speculation. LCA can be produced both by the bacterium on the breast duct tissue and by the 
intestinal microflora (Mikó, 2018, Luu, 2018). This could imply a local, systemic, or combination 
effect. Finally, in the early stages of breast cancer, LCA levels and biosynthesis decrease which 




Gastric adenocarcinoma is a prime and well-studied example of the role of the microbiome in 
cancer. Gastric adenocarcinoma, or cancer of the stomach, is the second-leading cause of cancer-
related deaths worldwide. Infection of the Helicobacter pylori bacteria is the leading risk factor 
for gastric cancer and is considered a class 1 carcinogen by the International Agency for Research 
on Cancer (Vogtmann and Goedert, 2016). Humans hold a long history with the Helicobacter 
species, with studies indicating the co-evolutionary history to span between 2,500 to 11,000 years 
ago. The H. Pylori bacterium is endemic to Africa and other third-world countries where the 
incidence of gastric cancer has been historically higher than in Western countries where exposure 
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to the bacterium is less common (Brawner et al, 2014).  Exposure to H. Pylori typically occurs 
during childhood, but the bacterium will remain with the individual as an underlying component 
of the gastric microbiota for many years without the development of clinical symptoms. In fact, 
the large majority of H. Pylori-infected individuals will live their entire life without developing 
gastric carcinoma or its preceding traits (Crew and Neugut, 2006).  
 
Despite the need for further research to incorporate all the environmental factors which can cause 
H. Pylori-mediated gastric carcinogenesis, studies have explored the two main virulence factors 
of the bacterium. The two most well-known bacterial factors which play a role in gastric cancer 
development are VacA and CagA. The VacA gene is found in all strains of H. Pylori, but the levels 
of VacA protein production vary among individual strains. The VacA protein is excreted by the 
bacterium and causes pore formation in the host cells. This effect promotes many events such as 
intracellular vacuole formation and upregulation of apoptosis. Additionally, the VacA protein 
binds to DC4+ T cells, preventing dephosphorylation of nuclear factor of activated T cells (NFAT) 
to sequester NAFT in the cytoplasm from activating the genes for antigen-dependent T cell 
proliferation (Brawner et al, 2014, Cover et al, 2003). These immunosuppressive traits of H. Pylori 
can enhance the effects and/or development of gastric cancer. 
 
Additionally, more cytotoxic strains of H. Pylori possess the gene for production of the CagA 
protein, which is classified as a bacterial oncoprotein. This protein is produced by the bacterium, 
and when inserted into the host cell, causes morphological cell changes, loss of the gastric 
epithelial cell polarity, and resistance to apoptosis (Brawner et al, 2014). These bacteria may also 
inject a specific H. Pylori peptidoglycan into the gastric host cells which leads to stimulation and 
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activation of the PI3K/AKT signaling pathway. Activation of this pathway results in stimulation 
of metastasis by interrupting the E-cadherin receptor to β-catenin linkage at the cell membrane, 
which mediates the actin cytoskeleton and induces transcription of genes involved in gastric 
adenocarcinoma metaplasia (Brawner et al, 2014). Similarly, the introduction of CagA into host 
cells stimulates β-catenin activity through means of the Wnt signaling pathway. This over-
expression of the Wnt signaling pathway, or a mutation in one of its mediators like adenomatous 
polyposis coli (APC), can both result in increased activity of β-catenin and its target genes. Over 
50% of gastric adenocarcinoma cases are characterized by over-expression of the Wnt signaling 
pathway or mutation of APC. This demonstrates the role that metabolites of H. Pylori can have on 
gastric carcinogenesis (Brawner et al, 2014).  
 
Colorectal Cancer 
Continuing through the gastrointestinal tract to another type of foregut cancer, explorations have 
been made to uncover the role of the microbiome in colorectal carcinoma (CRC). CRC is the third 
most commonly diagnosed cancer to occur in both men and women. In CRC, polyps develop on 
the lining of the colon/rectum and begin to grow uncontrollably (Siegel et al, 2017). Marchesi et 
al (2011) used deep rRNA sequencing on human CRC-patient samples to analyze the difference 
in microbiota of “on-tumor” locations. They found overpopulation of the typically-probiotic 
subclass Coriobacteridae on the “on-tumor” samples, with a corresponding lack of strains of the 
potentially pathogenic Enterobacteriaceae. These findings promote two theories which aim to 
explain this observed difference in microbiota composition on and off tumor. One theory states 
that the microenvironment of CRC is colonized by anti-tumorigenic bacteria in order to prevent 
rapid carcinogenesis. A second theory explains that the bacteria found in “on-tumor” sites secrete 
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a compound called butyrate. This compound is often considered to be anti-CRC by stimulating 
cellular signaling pathways involved in upregulating apoptosis. However, it is possible that the 
anti-apoptotic characteristics of butyrate are only effective in early tumorigenesis. Thus, theory 
two suggests that butyrate is instead functioning as an energy source for later-stage tumors and 
suppressing the inflammatory response of the immune system (Marchesi et al, 2011). As with all 
cancer-microbiome studies, there exists many other outside factors which effect the microbiome 
and cancer development. The answer to these theories may be revealed with continued research 
and understanding of the many variables which play a role in the microbiome.  
 
The argument for the microbiota’s role in CRC is further supported in a second study by Newman 
et al (2001). In this study, researchers found that infection of the colon by Citrobacter rodentium 
promotes CRC carcinogenesis in APCmin murine models. C. rodentium is a commonly occurring 
bacterium in the gastrointestinal tracts of laboratory mice. In fact, the epithelial cell 
hyperproliferation that it can lead to has been compared to that of Chron’s disease and ulcerative 
colitis in humans. These diseases are linked to an increased risk of developing CRC. Although the 
mechanism of C. rodentium influence is not completely uncovered, it is known that C. rodentium 
causes attaching and effacing (AE) lesions in the colon.  
 
It is becoming more well-known to the general public that early detection and screening is an 
essential factor in beating CRC. Despite the ongoing push for supporting early screening and less 
invasive methods, it is reported that over 30% of Americans fail to seek/ receive proper and timely 
screening. Luckily, researchers are aware of this screening gap, and thus recent studies on the 
matter have provided hope for a future of improved CRC screening techniques. One study 
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compared the constituents of the microbiomes of healthy patients versus those with colorectal 
carcinomas or adenomas. This study demonstrated the clear difference in gut microbiome 
constituents between these three groups, indicating that the microbiome may be our next candidate 
for the improvement of CRC screening. The researchers used the data on the bacterial differences 
they collected from both healthy and cancerous patients to develop improved models for predicting 
the presence of an adenoma or carcinoma (Zackular et al, 2014). This shows the positive effect 
that the consideration of the microbiome can have on cancer screenings. As society works to urge 
people to receive proper screening, science is ensuring that those screening techniques can be the 
best possible at detecting the presence of cancer. 
 
Skin Cancer 
In 2014, the United States Surgeon General released a “Call-to-action to Prevent Skin Cancer” 
(US Department of Health and Human Services, 2014). Fervent efforts have been initiated using 
a preventative medicine approach to skin cancer. The integrity of the skin microbiome is well 
respected as a protective and preventative agent against opportunistic pathogens. However, the 
possibility of the microbiome protecting the host from skin cancer is a new prospective role. 
Individual constituents of the skin microbiome have been identified as possible biomarkers for 
melanoma due to studies that identified a discrepancy between the skin microbiomes of melanoma-
bearing Libechov mini-pigs, verses control pigs that did not develop cancer (Mrázek et al, 2018). 
Pigs with skin microbiomes that had higher percentages of Lactobacillus and Actinobacteria 
genera were less likely to develop melanoma than those with microbiomes that had lower 
Lactobacillus and Actinobacteria content (Mrázek et al, 2018). Comparatively, pigs with 
microbiome profiles containing Fusobacterium and Trueperella genera developed melanoma. 
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These pigs also had high abundances of Staphylococcus and Streptococcus (Mrázek, 2018). This 
is interesting due to the correlation between Fuscobacterium and other cancers, like colorectal 
cancer, in which it has been associated with the induction of inflammation, proliferation, and 
disease progression (Shang, 2018). Conversely, commensal strains of Staphylococcus epidermidis 
have been found to produce the anti-proliferative nucleobase analog 6-N-hydroxyaminopurine (6-
HAP) (Nakatsuji, 2018). 6-HAP can inhibit DNA polymerase in de novo UV light-induced 
neoplasia, thus preventing proliferation of multiple human tumor cell lines (Nakatsuji, 2018). From 
the author’s unique perspective, this could serve as possible evidence of the equivalent of a 
cytokine storm, in which the skin microbiome accumulated Staphylococcus to induce genomic 
stabilization.  
 
The prevalence of specific genera in a cancer patients’ microbiome could have a therapeutic effect. 
Having a high percentage of Actionobacteria in the oral microbiomes of squamous cell carcinoma 
patients has been associated with better outcomes (Wang et al, 2017). An inverse relationship was 
observed between the abundance of Actinomyces in the oral microflora of 121 patients and the T-
stage of head and neck squamous cell carcinoma (HNSC) (Wang et al, 2017). T-stage indicates 
the size and spread of the tumor into adjacent tissues. The increased abundance of Actinobacteria 
was correlated with decreased T-stage of the HNSC and better outcomes. This could be related to 
the fact that many species of the Actinobacteria phylum produce chemotherapeutic secondary 
metabolites that have been developed into drugs that are administered in a clinical setting.  
 
The role of the microbiome as a third immune system is still hypothetical. The stimulation of the 
immune system by the microbiome has demonstrated extreme success in the treatment of 
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melanoma with immunotherapy. Within 2018, multiple surveillance studies were performed to 
establish a correlation between melanoma patient’s progression of disease and the composition 
of the patient’s microbiomes. One study defined a correlation between increased diversity of oral 
and fecal samples and a higher response rate to anti-PD1 therapy (Gopalakrishnan, 2018). This 
trend was upheld through all subsequent studies. Indicator organisms of the Faecalibacterium 
genus and the Ruminococcacae family were found in higher abundance in sample from patients 
who responded well to anti-PD1 therapy. Comparatively, an increased abundance of organisms 
of the Bacteroidales order were found in non-responder fecal samples (Gopalakrishnan, 2018). 
Fecal microbiome transplant (FMT) is a prospective treatment for dysbiosis. To test this, 
genetically identical germ-free mice were given FMTs using malignant melanoma patient fecal 
samples to determine if the microbiome alone could influence effectiveness of the PD -1 based 
immunotherapy in the murine models (Matson et al, 2018). The samples came from both 
responder and non-responder melanoma patients undergoing anti-PD-1 therapy. The mice that 
received FMTs from responder patients had increased levels of cytotoxic CD8+ T cells; the mice 
that received an FMT from non-responders had increased levels of immunosuppressive 
regulatory CD4+ T cells (Matson et al, 2018). Equivalently, individual bacterial species were 
significantly correlated with responsiveness to anti-PD-1 therapy, including Bifidobacterium 
longum, as compared to Ruminococcus obeum and Roseburia intestinalis which were correlated 
with non-responsiveness to anti-PD-1 immunotherapy (Matson et al, 2018). These findings 
indicate the propensity for the microbiome to influence the host’s immune system. FMT is an 
emerging successful treatment of a variety of diseases, including Parkinson’s, Multiple Sclerosis, 
fibromyalgia, obesity, insulin resistance, and autism (Choi et al, 2016). The metabolic capacity 
of FMTs to both influence and treat cancer should be further explored. 
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Finally, in an alternative study of melanoma patient fecal samples, the presence of Akkermansia 
muciniphila was elevated in responder patient samples versus those of non-responders (Routy et 
al, 2018). The same study also explored the effect of antibiotics in combination with anti-PD1 
therapy on the responsiveness to therapy. Antibiotic use corresponded with decreased 
responsiveness, possibly due to the induction of dysbiosis (Routy, 2018). Compromising the 
diversity of the microbiome induced the inability of the immunotherapy treatment to function. 
These findings are supported by the correlation of intrinsic low-diversity and non-responsiveness 
to treatment described in previous studies (Matson et al, 2018, Gopalakrishnan, 2018).  
Therefore, future studies could elucidate the role of the indicator organisms in the mechanism of 
anti-PD1 responsiveness.  
 
Conclusions  
Dysbiosis is a common denominator between leukemia, breast, skin, foregut, and other cancers. 
Dysbiosis can systemically and locally effect the progression and treatment of cancer. Modifying 
and monitoring dysbiosis could increase the efficacy of treatment. Alternative approaches to 
cancer treatment include microbiomic profiling for risk stratification before antibiotic 
administration, probiotics, prebiotics, and fecal microbiome transplants. To the author’s 
knowledge, despite the overwhelming evidence for the correlation of dysbiosis with cancer, no 
clinical trails have progressed to enhance cancer treatment using microbiome modification. 
Algorithms have been designed to predictively model cancer risk based upon genomic mutations 
(Abelson et al, 2018). With the amount of data that is being accrued regarding dysbiosis and the 
role of microbiome in cancer, similar predictive modeling could be instantiated. Novel cancer 
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therapeutics are also being developed from the microbiome, including immunotherapy 
modulators and anti-tumor bacterial secondary metabolites. Together, these studies support the 
important role of the microbiome in the future of personalized medicine and cancer treatment.  
 
Table 1. Summary of bacterial strains and their role in the development and/or treatment of 
cancers. 
Cancer Bacterial Strains Associated with 
the disease 
Details of Role in Development/ Treatment 









Supplementation of prebiotics may foster 
increased growth of the bacteria, leading to 
increased production of the oncosupressive 
metabolite; butyrate. This metabolite may 
be used as treatment for Irritable Bowel 
Syndrome (IBS) to protect bacterial strains 
from entering the blood stream.  
 
Responsible for majority of bacteremia 
cases in AML  
      -gastrointestinal leakage to bloodstream  
Breast 
Cancer 




Lactic acid bacteria: 








- Lactobacillus plantarum 
Strains isolated from the skin of cancerous 
breasts induced DNA double-stranded 
breaks in HeLa cells 
 
Oral administration of milk fermented by 
this bacterium has been correlated with 
reduced immunoregulation and breast tumor 
growth in murine models  
 
Potential anti-metastatic and anti-
angiogenic properties of milk fermented by 
this bacterium 
 
Potential for use for biotransformation of 
bioactive plants (such as ginseng) for 
treatment of many cancers, including breast, 
as seen in studies with ulcerative colitis 
Gastric 
Cancer 
Helicobacter pylori -H. pylori is considered a class 1 carcinogen 
by the IARC 
-The VacA protein produced by the 
bacterium causes pore formation in host 
cells, promoting vacuole formation and 
upregulation of apoptosis 
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-VacA binds to DC4+ T cells, sequestering 
NAFT in the cytoplasm and preventing 
activation of genes for antigen-dependent T 
cell proliferation. Immunosuppression can 
moderate development / enhance effects of 
gastric cancer 
-CagA oncoprotein produced by H. pylori 
causes host morphological cell changes, 
loss of cell polarity, and resistance to 
apoptosis 
- H. pylori peptidoglycan leads to 
stimulation of PKT/AKT signaling pathway 
in host cells, effecting actin cytoskeleton 
arrangements and upregulating genes 
involved in adenocarcinoma metaplasia 
-CagA mediated over-stimulation of Wnt 
signaling pathway is seen in over 50% of 





























Overpopulation of this (typically probiotic) 
subclass found on “on-tumor” samples from 
CRC patients 
    -may produce butyrate, a potential anti-
CRC compound which may upregulate 
apoptosis 
    -conversely, butyrate may instead 
function as an energy source for later-stage 
tumors and suppress the immune system’s 
inflammatory response  
 
Lack of this (potentially pathogenic) 




Infection promotes CRC carcinogenesis in 
APCmin murine models 
    -results in epithelial cell 
hyperproliferation in Chron’s disease and 
ulcerative colitis in humans; both of which 
are linked to increased CRC risk 
    -causes attaching and effacing (AE) 
lesions in the colon 
 
Correlation between this bacterium and the 
induction of inflammation, proliferation, 



































Bacteroidales order, Ruminococcus 
obeum and Roseburia intestinalis 
 
Akkermansia muciniphila 
Pigs with microbiomes containing higher 
percentages of these bacteria were less 
likely to develop melanoma 
 
Pigs with microbiomes containing higher 
abundances of these bacteria were more 
likely to develop melanoma  
 
Found to produce the nucleobase analog 6-
HAP, which can inhibit DNA polymerase in 
de novo UV light-induced neoplasia to 
prevent proliferation of many human tumor 
cell lines  
 
High percentages of this bacterium in the 
oral microbiomes of squamous cell 
carcinoma patients is associated with 
improve outcomes 
     -produce chemotherapeutic secondary 
metabolites which have been developed into 
drugs  
 
Inverse relationship has been observed 
between abundance of the bacteria in the 
oral microflora and the T-stage of head and 
neck squamous cell carcinoma  
 
Found in higher abundance in patients who 
responded well to anti-PD1 therapy  
 
 
Found in higher abundance in patients who 
did not respond to anti-PD1 therapy  
 
Presence of this bacterium in fecal samples 
was elevated in patients who responded 






GENOME MINING OF BIOSYNTHETIC AND CHEMOTHERAPEUTIC GENE CLUSTERS 
IN STREPTOMYCES BACTERIA AND INSIGHTS TO POPULATION-LEVEL DRUG 
DISCOVERY STRATAGIES 
 




Streptomyces bacteria are known for their prolific production of secondary metabolites, many of 
which have been widely used in human medicine, agriculture and animal health. To guide the 
effective prioritization of specific biosynthetic gene clusters (BGCs) for drug development and 
targeting the most prolific producer strains, knowledge about phylogenetic relationships of 
Streptomyces species, genome-wide diversity and distribution patterns of BGCs is critical. 
 
Methods 
We used genomic and phylogenetic methods to elucidate the diversity of major classes of BGCs 
in 1,110 publicly available Streptomyces genomes. 
 
Results 
Genome mining of Streptomyces reveals high diversity of BGCs and variable distribution 
patterns in the Streptomyces phylogeny, even among strains of the same species. Of the 34 major 
classes of BGCs, Streptomyces harbor between 8-83 BGCs per genome (mean = 39.64, s.d. = 
 20 
11.40), with a weak but significant positive correlation between the total number of BGCs per 
genome and genome size (R2 = 0.29458, p-value = 0.0). The most common BGCs are  
non-ribosomal peptide synthetases (NRPS), type 1 polyketide synthases (t1PKS), terpenes, and 
lantipeptides. When hybrid BGCs are considered, the total number of unique BGCs increases to 
541. We found multiple species with a potential to produce a variety of antitumor compounds, 
including the anthracycline daunorubicin which is commonly used in chemotherapy of acute 
myeloid leukemia patients.  
 
Conclusions 
We present the largest BGC study of a single bacterial genus to date. There are two main 
conclusions from this study. First, we found high diversity and abundance of BGCs across the 
genus Streptomyces. We also found that numerous Streptomyces species harbor BGCs known to 
encode antitumor compounds, and hence, represent important but generally untapped sources of 
chemotherapeutic agents. Second, we also observed that members of the same species can vary 
tremendously in the BGCs they carry, suggesting that strain-level genome sequencing can 
uncover high levels of BGC diversity and potentially useful derivatives of any one compound. 
These findings suggest that a population-level strategy for exploring secondary metabolites for 
clinical use, instead of focusing on individual strains, provides an alternative or complementary 
approach to discovering novel pharmaceutical compounds from microbes. 
 
Keywords 




Members of the bacterial genus Streptomyces (phylum Actinobacteria) are best known for their 
prolific production of naturally derived antibiotics and many pharmaceutically relevant 
compounds such as antifungals, antitumors, antivirals, antihelminths, antiprotozoans and 
immunosuppressants (Bĕhal, 2000, Manivasagan et al, 2014). Beginning in the 1940s when 
microbiologist Selman Waksman discovered streptomycin (the first effective drug against 
tuberculosis) produced by the soil-dwelling Streptomyces griseus (Schatz et al, 1944), 
Streptomyces species have received enormous attention in microbial sampling efforts. Today, 
more than half of all clinically useful bioactive compounds are derived from Streptomyces 
(Procópio et al, 2014). However, the last few decades saw a steep decline in the development and 
introduction of new medically relevant drugs to the market. This decline is partly due to the 
repeated re-discovery of the same molecules in the same ecological niches (often soil) and the 
high costs associated with drug development (Fair et al, 2014). The increasing public health 
burden caused by multidrug resistance and the continuing need to find new treatments against 
non-communicable (chronic) diseases means that the search for bioactive compounds with novel 
mechanisms of action or with new cellular targets is greater than ever. 
 
Genome mining approaches, which often involve identifying the genes involved in secondary 
metabolite production, have revealed an unprecedented biosynthetic potential in many microbial 
species (Doroghazi et al, 2013, Donia  et al, 2014, Adamek et al, 2017, Pan et al, 2017). These 
genes encode for the enzymes involved in peptide assembly, regulation, resistance, and synthesis 
of a secondary metabolite, and are physically clustered into groups called biosynthetic gene 
clusters (BGCs) (Medema et al, 2015). A genome-wide study of representative Actinobacteria 
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showed that Streptomyces genomes possess 25-70 BGCs, much more than any other 
actinobacterial genera, but only a small fraction of these bioactive products are produced when 
strains are cultivated in the laboratory (Doroghazi et al, 2013). This suggests that the full 
inventory of the chemical weapons possessed by a single bacterial strain remains poorly studied. 
Today, with the continuously increasing number of bacterial genomes sequenced, we are 
confronted with the challenge to effectively prioritize those strains with the greatest ability to 
produce new compounds and understand the extent of biosynthetic potential that exists in nature. 
Hence, knowledge about BGC diversity, phylogenetic relationships and distribution patterns of 
BGCs is crucial. 
 
In this study, we aim to determine the diversity of BGCs and their phylogenetic distribution 
among 1,110 genomes of Streptomyces, the largest BGC study of a single genus to date. Genome 
mining reveals the presence of hybrid BGCs, variable distribution of antitumor BGCs and inter-
strain differences in BGC content that together expand the repertoire of secondary metabolites 
that are potentially encoded by individual Streptomyces strains. Genome mining of closely 
related taxa can therefore greatly facilitate the discovery of novel pharmaceuticals and untapped 
sources of chemotherapeutic agents. These findings also highlight the importance of population-
level drug discovery approaches, exploring multiple genomes and closely related strains, rather 








A total of 1,157 genomes of Streptomyces (as of September 2018) were downloaded from the 
National Center for Biotechnology Information (NCBI). Accession numbers and genomic 
information (genome size, % GC content, number of genes, number of protein-coding genes) are 
shown in Additional File 1: Table S1. To maintain consistency in gene annotations, the genomes 
were annotated using Prokka, a pipeline comprising several programs that include locating open 
reading frames (ORFs) and RNA regions on contigs, translating ORFs to protein sequences, 
searching for protein homologs and producing standard output files for downstream applications 
(Seemann, 2014). A total of 47 genomes were excluded from downstream analyses due to poor 
quality of assemblies, highly divergent rpoB sequences, and failed antiSMASH analyses (Blin et 
al, 2017). 
 
Phylogenetic tree reconstruction 
We extracted the rpoB sequences from the genome assemblies and aligned them using MAFFT 
(Katoh et al, 2002). The rpoB sequences were then used to build a maximum likelihood 
phylogeny using the program RAxML v.8.2.11 (Stamatakis et al, 2006) with a general time 
reversible (GTR) nucleotide substitution model (Tavaré et al, 1986), four gamma categories for 
rate heterogeneity, and 100 bootstrap replicates. We used the rpoB locus instead of the 16S 
ribosomal RNA (rRNA) for two reasons. First, Streptomyces are known to harbor multiple 
copies of the rRNA operon, with as many as six copies and some of which are divergent (van 
Wezel et al, 1991, Kim et al, 2007). Second, sequence variation in rpoB permits species 
differentiation and has been widely used for initial taxonomic identification of multiple 
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Streptomyces species in previous studies (Kim et al, 2004, Mun et al, 2007, Han et al, 2012). 
Phylogenetic trees were visualized using the Interactive Tree of Life [iToL] (Letunic et al, 2016). 
 
Identification of BGCs 
BGCs encoding secondary metabolites were predicted and annotated using the standalone 
version of antiSMASH 4.1, which identifies BGCs using a signature profile Hidden Markov 
Model based on multiple sequence alignments of experimentally characterized signature proteins 
or protein domains (Blin et al, 2017). Sequences of BGCs known to encode natural products 
with antitumor properties were obtained from DoBISCUIT (Database of BIoSynthesis cluster 
CUrated and InTegrated) (Ichikawa et al, 2013) (downloaded in March, 2019). We refer to these 
BGCs as chemotherapeutic gene clusters (CGCs) to differentiate them from BGCs that encode 
non-antitumor compounds. A total of 47 CGCs were listed in DoBISCUIT. However, we 
restricted our analyses to CGCs that were first isolated from Streptomyces bacteria. The 
compounds geldanamycin and salinomycin were listed twice in DoBISCUIT and each was 
reported to have been derived from two different Streptomyces strains. For clarity, we only used 
one copy of geldanamycin and salinomycin BGCs. At the end, we used a total of 38 CGCs in our 
analysis. We search for the presence of these 38 CGCs representing 17 major classes of 
antitumor drugs (Additional File 2: Table S2) in 1,110 Streptomyces genomes using BLASTX 







Widespread distribution and diversity of BGCs in Streptomyces 
We characterized the biosynthetic diversity in 1,110 Streptomyces genomes (Fig. 1). We detected 
a total of 34 major classes of BGCs, which is consistent with previous reports in other 
Actinobacteria genera such as Salinispora and Amycolatopsis (Doroghazi et al, 2013, Ziemert et 
al, 2014, Adamek et al, 2018). Streptomyces encode between 8-83 BGCs per genome (mean = 
39.64, s.d. = 11.40) (Fig. 2a), with Streptomyces rhizosphaericus NRRL B-24304 (n=83 BGCs), 
Streptomyces sp. NRRL B-1347 (n=82 BGCs), Streptomyces sp. PRh5 (n=82 BGCs), 
Streptomyces milbemycinicus NRRL 5739 (n=81 BGCs) and Streptomyces sp. NBS 14/10 (n=79 
BGCs) having the highest number of BGCs. Genomes with the least number of BGCs include 
Streptomyces gilvigriseus MUSC 26 (n=8 BGCs), Streptomyces thermoautotrophicus H1 (n=9 
BGCs) and S. thermoautotrophicus UBT1 (n=11 BGCs). We observed a weak but significant 
positive correlation between genome size and the number of BGCs per genome (R2 = 0.29458, p-
value = 0.0) (Fig. 2b). 
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Fig. 1. Phylogenetic distribution of the 34 major classes of BGCs in 1,110 Streptomyces 
genomes. The 35th group of BGCs are other those that contain a secondary metabolite-related 
protein but does not fit into any other category (labeled as “others”). BGCs were identified using 
antiSMASH. The midpoint-rooted maximum likelihood phylogenetic tree was calculated using 
sequence variation in the rpoB locus. Scale bar represents nucleotide substitutions per site. NRPS 
– non-ribosomal peptide synthetase, PKS – polyketide synthase, AT – acyltransferase. Members 
of each of two clusters labeled in blue and orange branches are those considered as belonging to 
the same species and are further examined in Fig. 4. 
 
The most common BGCs are non-ribosomal peptide synthetases (NRPS; present in 1,062 
genomes), type 1 polyketide synthases (t1PKS; 981 genomes), terpenes (697 genomes), other 
ketide synthases (KS; 650 genomes) and lantipeptides (540 genomes) (Fig. 2c). These five 
classes of BGCs comprise approximately half of the total BGCs found in any single genome. We 
also note that a strain may harbor multiple copies of a BGC class. For example, the maximum 
number of NRPS in a single genome is 60 (found in Streptomyces rimosus subsp. rimosus), 
while the average number of NRPS per genome is 17.66. Other BGCs that are commonly found 







































bacteriocin (419 genomes), and Type 3 PKS (366 genomes). Some BGCs are rarely found and 
are present in only a handful of genomes. These include bottromycin (17 genomes), furan (15 
genomes), phosphoglycolipid (12 genomes), homoserine lactone (8 genomes), cyanobactin (7 
genomes), acyl aminoacids (2 genomes), and resorcinol (1 genome). 
 
Some BGCs contain genes that code for more than one type of scaffold-synthesizing enzymes 
and are called hybrid BGCs (Zotchev et al, 2014, Cimermancic et al, 2014). The origins and 
specific roles of these hybrid BGCs are not fully known, but they provide additional structural 
and chemical modifications in major classes of BGCs and may produce medically beneficial 
derivatives of a compound (Gallagher et al, 2015, Khaldi et al, 2008). If we subdivide the 34 
BGCs into their hybrid types, we obtain a total of 541 unique BGCs. The most common 
hybrid BGCs are Type 1 PKS-NRPS (present in 753 genomes), Type 1 PKS-other types of KS 
(237 genomes), terpene-NRPS (189 genomes), bacteriocin-lantipeptide (143 genomes), and 
Type 3 PKS-NRPS (131 genomes) (Fig 2d). Of the 1,110 genomes, a total of 1,088 genomes, 
representing 98% of the dataset, carry at least one hybrid BGC (mean number of hybrid BGCs 
per genome = 5.58, s.d. = 2.92). Streptomyces griseochromogenes ATCC 14511 has the 
highest number of hybrid BGCs (n=19). However, it must be kept in mind that the draft nature 
of many of these genomes is likely to affect BGC prediction by antiSMASH. 
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Fig. 2. Frequency and diversity of BGCs. (a) Frequency distribution showing the number of total 
BGCs per genome. (b) Relationship between genome size and number of total BGCs per 
genome. (c) Frequency distribution showing the most common BGCs per genome. Because a 
genome can harbor multiple copies of the same BGC, we only show the total number of unique 
BGCs regardless of the number of copies there are in a single genome. (d) Frequency distribution 
showing the most common hybrid BGCs per genome. Only the total number of unique hybrid 
BGCs regardless of the number of copies there are of it present in a single genome. 
 
 
BGCs with known chemotherapeutic potential are found in multiple species 
Some Streptomyces species are known to harbor BGCs that encode for secondary metabolites 






































































































































































































































































































































































































































































































































































































































individual genes of each CGC obtained from DoBISCUIT (Additional File 1: Table S2) as query 
sequences, we searched all Streptomyces genomes for the presence of the 38 CGCs using 
BLASTX (Altschul et al, 1990). We noted the presence of a CGC if at least 90% of the 
individual genes that comprise a CGC have significant BLASTX hits. This minimum threshold 
value of 90% was selected to account for possible genome sequencing errors. We also searched 
NCBI for the genome sequences of strains listed in DoBISCUIT. Of all the strains encoding the 
38 CGCs, only three strains (Streptomyces globisporus C-1027 for the compound C-1027 
[synonym: lidamycin], Streptomyces neyagawaensis ATCC 27449 for concamycin, and 
Streptomyces avermitilis ATCC 31267 for oligomycin) have genome sequences available in 
NCBI and are included in our dataset. To ensure that our approach of CGC detection is accurate, 
we searched for the BGCs that encode for these three compounds in the genomes of the three 
Streptomyces species. We indeed retrieved the CGCs for C-1027, concamycin and oligomycin in 
these strains. 
 
We found that CGCs are widely but differentially distributed in the Streptomyces phylogeny 
(Fig. 3). The most common CGC are chromomycin, FD-891 and medermycin, which are present 
in all 1,110 Streptomyces genomes. Chromomycin, belonging to the class of antitumor 
compounds called aureolic acids (Lombó et al, 2006), was originally identified from 
Streptomyces griseus ATCC 13273 (=NBRC 3746) (Montanari  et al, 1990). Its antitumor 
properties are due to its ability to inhibit replication and transcription processes during 
macromolecular biosynthesis by intercalating with DNA (Lombó  et al, 2006). The macrolide 
FD-891 was initially isolated from Streptomyces graminofaciens A-8890 and has been shown to 
have strong cytocidal activities against human promyelocytic leukemia (HL-­‐60) and Jurkat cells 
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through its ability to induce apoptosis (Kudo et al, 2010). The benzoisochromanequinone 
medermycin (also known as lactoquinomycin) from Streptomyces sp. AM-7161 is an inhibitor of 
serine/threonine kinase AKT/PKB, which functions in signaling pathways in human 
malignancies (Ichinose et al, 2003, Toral-Barza et al, 2007).  
 
Induction chemotherapy based on anthracyclines remains a part of standard of care therapy for 
acute myeloid leukemia (AML) patients (Roboz et al, 2012, Choi et al, 2018). One of the most 
commonly used anthracycline for AML chemotherapy is daunorubicin (Gong et al, 2015, 
Pophali et al, 2017). It was first isolated from Streptomyces sp. C5 and acts mainly through 
intercalation with DNA and inhibition of macromolecular biosynthesis (Rajgarhia et al, 1997). 
We found 39 Streptomyces genomes that carry the BGC that encode for daunorubicin (Fig. 3). 
Other anthracyclines, such as aclacinomycin A from Streptomyces galilaeus ATCC 31615, 
doxorubicin from Streptomyces peucetius ATCC 29050 (=NBRC 100596), and nogalamycin 
from Streptomyces nogalater ATCC 27451 (=NBRC 13445) are also found in 37, 30, and 2 
genomes respectively. 
 
Of the 38 antitumor BGCs from DoBISCUIT, we did not find steffimycin (anthracycline), 
aureothin (unclassified BGC) and tautomycin (tetronic acid derivative) in any of the genomes. 
However, we speculated that these genomes are likely to carry some of the genes of these three 
CGCs but may not have the minimum 90% of the genes of a CGC, which we initially used as a 
cut-off to define the presence of a CGC. We found that all Streptomyces genomes harbor one or 
few of the genes of steffimycin, aureothin and tautomycin. We also found that sequence 
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similarity varies across the individual genes in each of the 38 CGCs (Additional File 3: Table 
S3). 
 
Fig. 3. Phylogenetic distribution of the CGCs that encode antitumor compounds. Presence of 
each CGC was determined by searching all the genomes for homologs of each of the genes 
comprising the CGCs using BLASTX (Altschul et al, 1990) with a minimum e-value of 10-10. 
Sequences of individual genes in a CGC were obtained from DoBISCUIT (Ichikawa et al, 2013) 
and were used as query sequences. Presence of the CGC was inferred if there were significant 
BLASTX hits for at least 90% of the individual genes within the CGC. The phylogenetic tree is 
identical to that used in Fig. 1. 
 
 
Strain-level variation in BGC distribution 
BGC analyses in Actinobacteria are often done using a single strain representative of a species. 
A few recent studies, however, have highlighted major differences in biosynthetic diversity even 
among very closely related strains (Antony-Babu et al, 2017, Seipke et al, 2015), which may 






































which members of the same species differ in the abundance and diversity of BGCs they carry. 
We selected two sub-clusters in the rpoB phylogeny that have identical or near identical rpoB 
sequences (labelled in orange and blue branches on the tree in Fig. 1). While strains in each 
cluster are likely to represent the same species, the long history of misclassification in 
Streptomyces taxonomy (Trejo et al, 1970) creates conflicting species groupings. Nevertheless, 
we observed highly variable BGC composition among members of a phylogenetic cluster. In the 
orange cluster, with majority of strains related to Streptomyces rimosus, each genome carries 
between 44-77 of BGCs from the 34 major classes of BGCs (Fig. 4a). We find the same pattern 
in the second cluster where majority of strains are named as Streptomyces albidoflavus, and 
genomes carry between 19-46 of BGCs from the 34 major BGC classes (Fig. 4b). We also found 
variation in the distribution of CGCs among closely related strains. Overall, strain-level 




Fig. 4. Inter-strain differences in the distribution of BGCs and CGCs. Two sub-clusters with 
nearly identical rpoB sequences were obtained from the phylogeny in Fig. 1 (branches labeled 
orange [a] and blue [b]). Colors of BGCs are identical to those in Fig. 1 and 3. Scale bars of 




In this study, we aim to explore the phylogenetic distribution and diversity of BGCs in 1,110 
Streptomyces genomes. We show that BGCs and CGCs in Streptomyces are highly diverse and 
exhibit variable patterns of phylogenetic distribution, with hybrid BGCs and inter-strain variation 
further expanding the BGC repertoire present in any one genome. These findings are consistent 







Number of BGCs CGCs
S. griseoflavus NRRL B-1830
S. rimosus subsp. rimosus ATCC 10970
S. rimosus subsp. rimosus NRRL B-8076
S. rimosus subsp. rimosus NRRL WC-3880
S. capuensis NRRL B-3501 
S. rimosus subsp. rimosus NRRL WC-3875 
S. capuensis NRRL B-12337
S. rimosus subsp. rimosus NRRL WC-3873 
S. rimosus subsp. rimosus NRRL WC-3909 
S. rimosus R6-500 
S. rimosus subsp. rimosus NRRL WC-3558 
S. rimosus R6-500MV9-R8 
S. rimosus subsp. rimosus NRRL B-2626 
S. rimosus subsp. rimosus NRRL WC-3899 
S. lavendulae subsp. lavendulae NRRL WC-3532 
S. rimosus subsp. rimosus NRRL WC-3876 
S. rimosus subsp. rimosus NRRL WC-3925 
S. rimosus subsp. rimosus NRRL WC-3882 
S. sp. NRRL WC-3702
S. rimosus subsp. rimosus NRRL WC-3897 
S. rimosus subsp. rimosus NRRL B-2661 
S. rimosus R6-500MV9 
S. rimosus subsp. rimosus NRRL WC-3927
S. rimosus subsp. rimosus NRRL WC-3924
S. rimosus subsp. rimosus NRRL WC-3877 
S. rimosus subsp. pseudoverticillatus NRRL WC-3896 
S. sp. NRRL WC-3703
S. rimosus subsp. rimosus NRRL ISP-5260 
S. rimosus subsp. rimosus NRRL WC-3874
S. sp. NRRL WC-3701  
S. rimosus subsp. rimosus NRRL WC-3898 
S. rimosus subsp. rimosus NRRL WC-3900  
S. lavendulae subsp. lavendulae NRRL B-2775 
S. rimosus subsp. rimosus NRRL WC-3560 
S. rimosus subsp. rimosus NRRL B-2660 
S. sp. NRRL B-11253  
S. peucetius NRRL WC-3868  
S. albus subsp. albus NRRL F-4371   
S. rimosus subsp. rimosus NRRL WC-3869 
S. rimosus subsp. rimosus NRRL B-16073 
S. albus O-9.4
S. sp. CNY228
S. albidoflavus J1074 (Broad)


















S. sp. NRRL F-6628
S. sp. NRRL B-3253









S. sampsonii KJ40 (Sichuan)
S. griseus subsp. griseus NRRL WC-3066
S. griseus subsp. griseus NRRL B-2307
S. sampsonii KJ40 (Sichuan)
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Adamek et al, 2018) and also highlight the power of mining the genomes of closely related 
strains. In a recent study, ten Streptomyces strains with 16S rRNA gene sequences identical to 
the type strain of Streptomyces cyaneofuscatus and hence are considered the same species, 
exhibit distinct secondary metabolomic profiles (Antony-Babu et al, 2017). In another example, 
Streptomyces albus, which is a promiscuous producer of numerous clinically relevant 
compounds, a total of 48 BGCs were identified in a mere seven strains (Seipke et al, 2015). Of 
these, 18 specify the core BGC of the species, 14 are auxiliary BGCs and 16 are strain-specific 
(Seipke et al, 2015).  
 
The highly variable phylogenetic distribution of BGCs, even among closely related Streptomyces 
genomes, is indicative of recent horizontal gene transfer (HGT) events (Doroghazi et al, 2010,  
Andam et al, 2016), which is prevalent in Streptomyces (Doroghazi et al, 2010,  Andam et al, 
2016, Egan et al, 2001, McDonald et al, 2017). Furthermore, the existence of hybrid BGCs, 
composed of different scaffold-synthesizing enzymes from the major BGC classes and joined 
in a variety of combinations (Gallagher et al, 2015, Khaldi et al, 2008), further reinforce the 
role of HGT in generating the remarkable BGC diversity in Streptomyces. That BGCs have 
undergone frequent HGT is not surprising. Genes encoding weakly selected functions are 
frequently lost from bacterial genomes when they do not provide an immediate selective 
advantage and are re-acquired through HGT when new conditions provide a benefit to carriers 
(Lawrence et al, 1996). Hence, inter-strain BGC variation should be taken into consideration 
when developing approaches to microbe-derived pharmacological compounds and that reliance 
on a single gene (e.g., 16S rRNA, rpoB) is likely to result to possible novel compounds with 
drug potential that are overlooked in sampling strategies. 
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The existence of strain-specific BGCs may also be a population-level strategy that prevents the 
permanent loss of a BGC from the population by maintaining them in one or few strains. When 
the necessity arises (e.g., environmental change, competition with other organisms, adaptation to 
a new host), these rare BGCs may be disseminated among other members of the population via 
HGT. As has been observed in the genus Salinispora, the different ways by which strains mix 
and match their BGCs to produce hybrid BGCs suggest that these bacteria are able to maximize 
its population-level diversity and production of secondary metabolites, while restricting the 
number of BGCs maintained within any individual genome which can be costly (Ziemert et al, 
2014). This likely holds true for Streptomyces as well. A previous study reported the production 
of multiple antibiotics by symbiotic Streptomyces harbored by beewolf digger wasps that the 
insect uses to protect their larvae and cocoons (Kroiss et al, 2010). Comparable to the 
combination prophylaxis used in human patients, this population-level strategy makes use of the 
synergistic action of eight different compounds, thereby providing an important long-term and 
more efficacious defense against multiple diseases (Kroiss et al, 2010). Hence, personalized 
medical strategies in the future can be developed towards using specific combinations of 
Streptomyces bacteria to produce drugs that will target multiple medical conditions.  
 
The observation that majority of the Streptomyces genomes carry some of the individual genes in 
a CGC while only a few harbor the nearly complete set of genes, may be explained by a 
population-level cooperative strategy conceptualized in the Black Queen hypothesis (Morris et 
al, 2012, Fullmer et al, 2015). Here, accessory genes, including BGCs, can be viewed as a shared 
resource in which members of a microbial population or community rely on the presence of other 
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cells to produce the functions that they lack (Morris et al, 2012, Fullmer et al, 2015). Hence, 
mutual sharing of common goods will lead to mutual dependencies and cooperation among 
members of a group (Morris et al, 2012, Fullmer et al, 2015). On the other hand, the differential 
distribution of individual genes of the 38 CGCs in Streptomyces suggests that there exists a 
common set of genes and pathways in the production of each CGC (Remali et al, 2017). The 
differences in the distribution of other components of the CGCs may suggest that each species or 
strain may produce different derivatives of each of the 38 chemotherapeutic natural products 
(Remali et al, 2017), which may prove useful in discovering more effective drugs for a variety of 
diseases. 
 
The major caveat of this study is that current methods of BGC identification, including methods 
used in this study, are largely dependent on the composition of the BGC database being used for 
comparison. This means that BGCs that encode for metabolites with previously unrecognized 
functions or cellular targets may be missed. Moreover, the draft nature of many of the genomes 
can have a significant impact on the ability of antiSMASH to accurately predict BGCs, 
particularly so in the identification of hybrid BGCs. Hence, improved sequencing quality is 
likely to alter some of our results. The use of a large genomic dataset, as in this study, coupled 
with phylogenetic and population genomics methods partially offsets these limitations and 







We present the largest BGC study of a single bacterial genus to date. There are two main 
conclusions from this study. First, we found high diversity and abundance of BGCs across the 
Streptomyces genus, with hybrid BGCs greatly expanding the repertoire of secondary 
metabolites and therefore can facilitate the discovery of novel pharmaceuticals. We also found 
that numerous Streptomyces species harbor BGCs known to encode antitumor compounds, and 
hence, represent important but generally untapped sources of chemotherapeutic agents. Second, 
we also observed that members of the same species can vary tremendously in the BGCs they 
carry, suggesting that strain-level genome sequencing can uncover high levels of BGC diversity 
and potentially useful derivatives of any one compound. These findings suggest that a 
population-level strategy for exploring secondary metabolites for clinical use, instead of focusing 
on individual strains, can provide an alternative or complementary approach to discovering novel 
compounds from microbes. 
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IDENTIFICATION OF STREPTOMYCES AKAC8 FOR THE MODIFICATION OF URSOLIC 
ACID 
 
Kaitlyn C. Belknap, Amy E. Michaud, Cheryl P. Andam, and Brian M. Barth 
 
Abstract 
Numerous therapies have been developed against leukemia however, an estimated 24,370 people 
died from the disease in 2018. In this study, we propose the generation of a novel antileukemic 
natural product using biotransformation. The pentacylic triterpenoid compound ursolic acid (UA) 
is derived from the Alaskan ethnobotanical Northern Labrador Tea (Rhododendron tomentosum 
Harmaja). UA was biotransformed by a strain of Streptomyces cultured from an Alaskan bear 
fecal sample. The collection, isolation, purification, and identification of a Streptomyces species 
from a bear fecal sample, referred to as Streptomyces akac8, was successful. A bioinformatic 
approach was taken to investigate the biosynthetic gene clusters (BGCs) harbored in the 
Streptomyces akac8 genome. Fifty percent of the BGC harbored in the Streptomyces akac8 
genome were terpenes. The prevalence of terpenes in the Streptomyces akac8 genome could 
indicate a compatibility for Streptomyces akac8 to effectively biotransform the pentacyclic 
triterpenoid UA. This BGC analysis was compared against an analysis of other previously 
published Streptomyces genomes. Other terpene rich Streptomyces species were identified as 






In 2018, leukemia killed an estimated 24,370 people and 60,300 people were diagnosed (Siegel, 
2018). Leukemia is a hematological malignancy in which a population of immature progenitor 
white blood cells clonally expands in the bone marrow. The differentiation of the hematopoietic 
stem cells is arrested before the cells are done developing, thus the immature blast cells 
proliferate and crowd out the developed, functional blood cells (Kumar, 2011). Many targeted 
therapies have been developed against leukemia, but due to the heterologous nature of the 
disease, the evolution of cancer surpasses the evolution of targeted therapeutics (Gillies, 2012, 
Rosenheim, 2018). Novel therapeutics are necessary to combat the cases that remain in the 
population when targeted therapeutics prove to be ineffective. Many of those cases are in the 
geriatric and pediatric populations and cannot withstand the repercussions of the trial and error 
methodology of targeted chemotherapies (Wang, 2016, Oran, 2012).  
 
Natural products are bioactive primary and secondary metabolites that are innately synthesized 
by an organism (Dias, 2012). Chemical libraries composed of natural products have an estimated 
100-fold higher rate of hits for drug discovery, compared to those comprised of human 
synthesized compounds (Floss, 2006). These findings are not surprising, as the generation of 
natural products is not limited to the extent of the human imagination. Even if the resulting hits 
are not immediately successful, the novel structures that are discovered through the screening 
process can be utilized as a starting point for drug discovery and development. Consequently, 
novel mechanisms of action and unknown signaling pathways could be detected. Natural 
products can be produced by prokaryotic or eukaryotic organisms (Kulka, 2013). Within this 
study, both were investigated. Our analysis was based on previous findings of the antileukemic 
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effects of natural products derived from the ethnobotanical Northern Labrador Tea (NLT) and 
ubiquitous soil bacterium Streptomyces. 
  
The medicinal properties of the Alaskan plant Northern Labrador Tea (NLT) (Rhododendron 
tomentosum Harmaja), have been used by the Inuit, Cree, and other First Nations peoples of the 
Pacific Northwest, and Greenland to treat a variety of ailments, including cancer (McGill et al, 
2018, Black et al, 2011). Today, despite having access to modern medicine, indigenous peoples 
prefer to utilize remedial effects of ethnobotanicals, like NLT. Extracts of NLT have displayed 
chemotherapeutic effects against lung, colon, and acute myeloid leukemia cell lines (McGill et 
al, 2018, Dampc, 2013). Although the cytotoxic properties of NLT had previously been 
attributed to quercetin and other alternative polyphenol components, McGill, et al 2018 found 
ursolic acid (UA) to be the primary anti-leukemia compound of NLT in vivo and in vitro 
(McGill, et al) (Figure 1). Therefore, UA was utilized to perform subsequent analysis of the 
potential anti-leukemia effects of NLT within this study. 
 
 
Figure 1. (a) Mass spectrometry results of acetone extract of NLT (b) MTS PMS viability assay 
after AML cell line exposure to quercetin or UA for 48 hours.   
McGill CM, Tomco PL, Ondrasik RM, Dwyer GK, Quinlan DJ, Kircher TA, Belknap KC, 
Andam CA, Brown TJ, Claxton DF, Barth BM. Therapeutic Effect of Northern Labrador Tea 




Streptomyces is a genus of bacteria, most notable for being an important ubiquitous soil 
microorganism, for its wide phylogenetic spread, and its production of bioactive natural products 
(Barka et al, 2016). Streptomyces is the most drug promiscuous genus within the Actinobacteria 
phyla, which produces two-thirds of the world’s naturally derived antibiotics in clinical use 
(Barka et al, 2016, Antorazet al, 2015). Streptomyces produces numerous other pharmacological 
agents, including immunosuppressives, antitumors, antifungals, antihemliths, antiprotozoans, and 
antivirals (Manivasagan et al, 2014). The success of Streptomyces metabolites used in 
chemotherapeutics, the anthracycline doxorubicin was originally derived from Streptomyces 
peucetius in 1969 (Lomovskaya et al, 1999) and rapamycin was derived from Streptomyces 
hygroscopicus in 1972 (Seto, 2012). Today, doxorubicin is one of the most commonly used 
adjuvant and neoadjuvant cytotoxic agents in the United States (Miller et al, 2014). It is a 
DNA/RNA synthesis inhibitor and has been utilized in the treatment of leukemia, lymphoma 
(Green, 2012), bladder (von der Maase, 2005), breast (Xing, 2015, Miller, 2014), stomach (Wu 
et al, 2017), uterine (Ricci et al, 2017), and ovarian (Pignata et al, 2017) cancers. Rapamycin is 
an mTOR inhibitor that is used to treat kidney (Afriansyah, 2016), breast, (Liu et al, 2017) and 
pancreatic (Morran et al, 2014) cancer, respectively.  
 
For this study, we collected bear fecal samples in Alaska due to the potential interaction between 
intestinal Streptomyces species and NLT in the bear gastrointestinal system. As a ubiquitous soil 
microorganism, Streptomyces are inadvertently digested and integrated into the microbiome of 
humans and other animals. Previous studies have identified Streptomyces species isolated from 
human and animal feces (Jiang, 2013, Zhou, 2017) that produce a variety of novel antitumor 
secondary metabolites. Although they were not tested for production of antitumor metabolites, 
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Streptomyces species have been identified in black bear (Ursus americanus) and grizzly bear 
(Ursus arctos) feces from Alberta Canada (Goatcher et al, 1987). Our study affirms the presence 
of Streptomyces species in Alaskan bear fecal samples, as well. Additionally, our samples were 
collected at the end of the salmon season (Cotton, 2017). Therefore, as bears are omnivores, they 
turn toward supplementary food sources including roots, berries, and plants as the salmon 
become sparse (McLellan, 2010). NLT has been found as a dominant species of low shrub 
communities in 73% of all sites sampled within the boreal forest of Alaska, which encompasses 
our sample site (Brown et al, 2016). Thus, there is the potential for Alaskan bears to eat NLT 
which would allow for interaction between it and the gastrointestinal Streptomyces. 
 
The aim of this study was to explore the biotransformation of the NLT derivative UA, by 
Streptomyces. The process of biotransformation allows for the potential development of 
modifications to the original chemical structure of UA, which could attribute novel mechanisms 
of action to the resulting natural products. Fundamentally, the concept relies on the fact that 
commensal gut microbiome metabolizes dietary components of the symbiotic host (Tremaroli et 
al, 2012). In this case, we tested if an Alaskan bear’s gut microbiota would be able to metabolize, 
thus biotransform, UA. Therefore, we hypothesized that the Streptomyces of the Alaskan bear 








Fecal Sample Collection and Streptomyces Isolation 
A total of 8 bear fecal samples were collected September 24th, 2017 from the Upper O’Malley 
trail in Anchorage, Alaska (Figure 2 a,b). For each sample, a total of 50mg of fecal matter were 
diluted 1:100 (wt/vol) in phosphate-buffered saline, then vortexed for two minutes. Then 50ul 
were spread plated on Actinobacteria Isolation Agar (AIA) with 300 mg/liter cycloheximide and 
30mg/liter Rose Bengal (both antifungals). Actinobacteria colonies developed after 
approximately a week of incubation at 37°C (Figure 2c). In total, 192 individual isolates were 
identified for DNA sequencing and further analysis.  
 
Figure 2. Fecal Sample Collection and Streptomyces Isolate Isolation, Purification, and 
Identification. (a) Bear fecal sample containing surplus seeds and other plant materials. (b) 
Researcher collecting bear fecal samples utilizing proper aseptic technique. (c) Isolation on AIA 
agar with antifungals (rose bengal and cycloheximide), purification on wheel plates, transfer to 
enrichment plates for confluent growth, and identification via DNA extraction from yeast-malt 
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Genetic Analysis of Streptomyces 
DNA extraction was performed from yeast-malt extract broth cultures using Qiagen DNeasy 
UltraClean Microbial Kit following manufacturer’s protocol and the resulting DNA was re-
suspended in 150 ul of Tris-EDTA buffer (Figure 2c). A paired-end library with sequences no 
longer than 250bp was constructed using Kapa Hyper Prep Plus DNA library preparation kit. 
The genome was sequenced using the Illumina HiSeq 2500 available at the Hubbard Genome 
Center for Genomic Studies, University of New Hampshire, New Hampshire, USA. The reads 
trimmed using Trimmomatic (Bolger et al, 2014) to eliminate the adaptors, assembled using 
SPAdes (Bankevich et al, 2012) and annotated using Prokka (Seemann et al, 2014). DNA 
isolation and genome sequencing was submitted twice for confirmatory results. 
 
The genome identification was confirmed using BLASTN (basic local alignment search tool: 
nucleotide) of the rpob and 16S sequence (Altschul, 1990). QIIME2 (Quantitative Insights Into 
Microbial Ecology) 2018.4, a pipeline designed to utilize raw reads to perform community 
analysis using rRNA subunit marker genes, was utilized to visualize the 16S analysis of the 
isolates (Bokulich, 2018). Of the 192 isolates that were sequenced, a single species has been 
confirmed as Streptomyces. Blobtools 1.0, software that visualizes quality and taxa-identification 
of individual contigs of a genome, was utilized to generate a blob plot as a secondary 
confirmatory test for the quality of the genome from the primary and secondary genome 
sequence submission (Laetsch et al, 2017).  This representative isolate will be referred to as 
Streptomyces akac8. A stand-alone version of Antismash 4.1 was used to identify the BGCs 
encoded in the Streptomyces akac8 genome. Antismash uses a Hidden Markov Modeling system 
to identify BGCs were associated with secondary metabolite production based on multiple 
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sequence alignments of experimentally characterized signature proteins or protein domains 
(Bolger et al, 2014). 1,110 Streptomyces genomes available on the NCBI REF Seq database were 
downloaded, assembled, and analyzed as previously described in the methods of chapter 2. 
 
 
Minimum Inhibitory Concentration Testing of Streptomyces akac8 and UA 
PBS with 6% dextrose (8mL) was inoculated with a single colony of Streptomyces akac8 from 
solid AIA and incubated for 24 hours or until the culture reached an OD of 0.5. A stock solution 
of 1mM UA dissolved in DMSO (UA+DMSO) was utilized to make 80 µM concentration of UA 
out of a total of 200 µl in the first well of a 96 well plate. All dilutions were performed using 
PBS media with 6% dextrose. The concentration of DMSO did not exceed 2% in any of the 
subsequent wells.  
 
The UA+DMSO 80 µM was serially diluted by 100 µL and 100 µL of PBS media with 6% 
dextrose + Streptomyces akac8 was added to each well, resulting in the UA concentrations of 40 
µM, 20 µM, 10 µM, 5 µM, 2.5 µM, 1.25 µM, 0.625 µM, 0.313 µM, 0.157 µM, 0.078 µM, 0.039 
µM, and 0.019 µM. This was repeated in triplicate. Controls of only PBS with 6% dextrose (n = 
12), only Streptomyces akac8 (n=12), and DMSO without UA serially diluted in the same 
mechanism as previously described (repeated in triplicate) were performed per 96 well plate. The 
96 well plate was incubated at 37 °C and results were read on a spectrophotometer at OD 595 





To investigate growth improvement of the Streptomyces akac8 a media optimization protocol 
was developed. The growth conditions were limited to dextrose, phosphate-buffered saline 
(PBS), water, and calcium carbonate (CaCO3) to prevent contamination of the natural products 
produced by the biotransformation of UA by Streptomyces akac8. The mediums contained 2%, 
to 10% dextrose dissolved in water or PBS. Replicates of PBS with dextrose and water with 
dextrose were performed with an additional 1% of CaCO3. An initial single colony of 
Streptomyces akac8 was added to a 5 mL tube of each medium. The mediums were incubated for 
5 days. A spectrophotometer was utilized to check the concentration of the mediums at the time 
of inoculation and 24-hour intervals.  
 
Results 
Confirmation of Streptomyces Genetic Analysis  
The most prevalent genus that was identified in the 16S analysis from the primary sequence 
submission was Proteobacteria, followed by Firmicutes, then Actinobacteria. The highest 
percentage of Streptomycetaceae 16S in a single genome was 9.122%, as compared to a 
maximum of 100% Enterobacteriales, 97.817% Lactobacillales, 11.576% Burkholderiales, 
2.540% Caulobacterales, 2.463% Pseudomonadales, 1.160% Micrococcales, 0.480% Bacillales, 
0.320% unassigned, 0.123% Corynebacteriales, and 0.021% Sphingobacteriales. (Figure 3). This 
was surprising, as the isolation techniques were designed to only facilitate the growth of 
Streptomyces. For this reason, the DNA isolation and sequencing was redone. The genome 
Streptomyces akac8 was confirmed as a Streptomyces using 16S, rpob sequence analysis, and 
blobtools. Blobtools was used to generate a blob plot of the resulting genome of Streptomyces 
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akac8 after the primary (BrAkc8) and secondary whole genome sequence submission. The 
primary sequence submission, termed BrAkc8, resulted in 56 contigs identified as Streptomyces, 
collectively the Streptomyces contigs constituted 0.2 Mb of the total genome, and were an 
average of 417 nucleotides long. Comparatively, after the second whole genome sequence 
submission, 162 contigs were identified as Streptomyces, collectively the Streptomyces contigs 
constituted of 32 Mb of the whole genome, and the average length of those contigs was 144,136 
nucleotides long (Figure 4). These results support our identification of Streptomyces akac8 as a 
species of Streptomyces because of the increased contig length and increased total percentage 
contigs of the genome that identify as Streptomyces. This test confirmed the identity of 
Streptomyces akac8 from previous BLASTN findings of the marker genes rpob and 16S.  
 
 
Figure 3. 16S Genomic Distribution of Primary Submission of Whole Genome Sequencing. 
Maximum percentages of 16S identifications Enterobacteriales (100%), Lactobacillales 
(97.817%), Burkholderiales (11.576%), Streptomyces (9.122%), Caulobacterales (2.540%), 
Pseudomonadales (2.463%), Micrococcales (1.160%), Bacillales (0.480%), unassigned 





Figure 4. Comparative Analysis of the Primary and Secondary Genome Sequencing of 
Streptomyces akac8. (a) Genome sequence analysis using blobtools to determine the content and 
quality of the primary genome sequence submission (BrAkc8) displays a majority of 
Enterobacteriaceae. (b) Genome sequence analysis using blobtools to determine the content and 
quality of the second genome sequence submission (Akac8) displays a majority of 
Streptomycetaceae. Therefore, thereafter that representative organism utilized for 
Streptomycetaceae analysis was referred to as Streptomyces akac8. 
 
 
Biotransformation of UA 
The media optimization protocol was instantiated in an attempt to promote the growth of 
Streptomyces akac8 to 0.5 OD. Without adequate confluence (above 0.5 OD), the products of 
biotransformation were undetectable. Figure 5 indicates the results of the media optimization 
protocol. Of all the mediums, the most promising medium was 4% dextrose dissolved in PBS 
with 1% calcium carbonate on day 6 which reached 0.372 OD. However, the turbidity of the 
calcium carbonate in that medium, as well as others, makes the results questionable. It may be 
possible that the spectrophotometer was reading the confluence of the bacteria. The erratic 
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increase and decrease of absorbance caused by calcium carbonate is exemplified in Figure 5c 
(OD of water with 1% calcium carbonate and 8% dextrose) and in Figure 3d (OD of PBS with 
1% calcium carbonate and 2%, 8%, and 10% dextrose). Additionally, the maximum OD reached 
was 0.372, however, significant bacterial growth is typically 0.5 OD or above. When yeast-malt 
extract broth was used in place of PBS with 6% dextrose, the concentration reached 0.67 OD 
(Figure 6). However, results were not consistently replicable to detect the maximum 
concentration of UA tolerated for significant growth. In the future, the next step would be to 
isolate metabolites produced by Streptomyces akac8. For Streptomyces akac8 grown in yeast-
malt extract broth, the metabolites produced could not be traced back as derivatives of UA 
biotransformation due to the contamination of chemically undefined components. 
 
 
Figure 5: Media Optimization Protocol Results. (a) Growth of Streptomyces akac8 in sterile 
water with dextrose supplementation. Maximum OD was 0.009 grown in water with 2% dextrose 
on day 5. (b) Growth of Streptomyces akac8 in sterile water with dextrose and 1% calcium 
carbonate (CaCO3) supplementation. Maximum OD was 0.223 grown in water with 2% dextrose 
on day 2. (c) Growth of Streptomyces akac8 in PBS with dextrose supplementation. Maximum 
OD was 0.008 grown in water with 2% dextrose on day 3. (d) Growth of Streptomyces akac8 in 
PBS with dextrose and 1% calcium carbonate (CaCO3) supplementation. Maximum OD was 
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Figure 6. Minimum Inhibitory Concentration Testing of Streptomyces Grown with UA. Three 
simultaneous replicates of MIC testing were done; this graph represents the average of these 
findings. Streptomyces akac8 grew at the highest concentration of 5 µM to 1.25µM of UA. 
However, this data is a single snapshot and needed further replication.   
 
 
Terpene BGC Analysis of Streptomyces akac8 
As we hypothesized, Streptomyces akac8 was able to grow in the presence of UA despite any 
potential toxicity of UA. This could potentially be due to the habitual exposure of Streptomyces 
akac8 to UA in the Alaskan bear’s gastrointestinal system. UA is a pentacylic terpenoid 
(Kashyap etal, 2016), therefore organisms that have a greater propensity to produce terpenes 
have a greater likelihood of survival due to the innate resistance that the organisms would have 
to the secondary metabolites that they produce. The mechanism of action of terpenes is not 
entirely understood, however, it is associated with membrane disruption by lipophilic 
compounds (Cowan, 1999). Half of the total BGCs of Streptomyces akac8 are terpenes (4 
individual terpene BGCs and 1 hybrid t1pks-terpene BGC) (Figure 7). Compared to alternative 
Streptomyces genomes, the maximum number of terpenes in a singular genome is 13 in the 
Streptomyces sp. TLI_053, Streptomyces clavuligerus ATCC 27064, and Streptomyces sp. NRRL 
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B-1347 (Figure 8a). The average number of terpenes per genome is 6.03. Therefore, 
Streptomyces is not the most prolific producer of terpenes. However, when examining the ratio 
of terpenes per genome verses all other BGCs within each genome, Streptomyces akac8 had one 
of the highest terpene to other BGC ratios (50%). The maximum ratio of terpene to other BGCs 
is 56% in Streptomyces sp. UNC401CLCol and the average is 18.8% (Figure 8b).  
 
 
Figure 7. Biosynthetic Gene Cluster Content of Streptomyces akac8. A total of 13 un-hybridized 
BGCs were identified in the Streptomyces akac8 genome and 1 hybridized genome was 





Figure 8. (a) Distribution of the number of terpene BGCs present in each genome. (b) 




The premise of this study was to investigate the metabolic products of the biotransformation of 
UA by Streptomyces akac8. We were unable to obtain the metabolic products due to the 
incompatibility of the necessary chemically defined media and the appropriate growth conditions 
for Streptomyces akac8. However, we believe that this study is the first to report the collection, 
isolation, purification, identification, and whole genome sequencing of a Streptomyces species 
from an Alaskan bear fecal sample. This contributes to the overall diversity and knowledge of 
the Streptomyces genus and understanding of the microbiome of Alaskan bears. Further analysis 
of Streptomyces akac8 in the broader context of the Streptomyces genus can be found in chapter 
2. A microbiomic profile of Alaskan bears was completed using QIIME 16S analysis, which was 
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with previous findings for grizzly bears (Ursus arctos) and black bears (Sommer, 2016, Song, 
2017). The least common, yet detectable, genera in the bear feces were Micrococcales, 
Bacillales, Corynebacteriales, and Sphingobacteriale. This is inconsistent with previous findings 
of Canadian (Goatcher, 1987), European grizzly bears and Chinese black bears (Song et al, 
2017), indicating a possible geographical distinction of bear intestinal microbiomic profiles. 
However, the derivative bacterial samples of bear feces were plated on selective media prior to 
sequencing, therefore the samples may not be a true representation of the native population 
within the bear fecal microbiome, despite the similarity of dominating genera to true 
representative samples. 
 
The caveat of this study was to maintain a chemically defined medium to be able to subsequently 
isolate the metabolic products of UA biotransformation from. The inability to satisfy the growth 
conditions of Streptomyces akac8 could have been caused by the absence of environmental 
factors provided by Streptomyces akac8’s natural ecological niche. Alternative approaches could 
include modification of pH, salt concentration, temperature, different nutritional sources, or 
aerobic conditions. Previous studies have identified other chemically defined media components 
that support Streptomyces growth, including 3-(N-morpholino)propanesulfonic acid (MOPS 
buffer), ammonium sulfate (Falzone et al 2013), peptone (Formica, 1983), monosodium 
glutamate (Ramirez-Malule, 2016), and L-asparagine (Demain, 1977). This study could have 
continued in that direction, however, a genomics approach was pursued instead.  
 
Nevertheless, the potential for products of novel drug discovery utilizing the biotransformation 
of UA by Streptomyces should not be neglected. The concept of utilizing the gut microbiome to 
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modify drugs and therefore increase their efficacy is not a novel concept. Probiotic fermentation 
of red ginseng by Lactobacillus plantarum increases the potency of red ginseng for the treatment 
of ulcerative colitis (Jang, 2017) and diabetes (Jang, 2017). A similar fermentation approach 
could be applied with NLT, however, there are some reports that NLT could contain some toxic 
components that may be of concern for broader consumption (Dampc, 2013). Therefore, by 
utilizing a microorganism that has habitually been exposed to, and thus has developed tolerance 
to, the toxic properties of NLT, there is a greater potential for the organism to survive and 
efficiently metabolize the NLT. The active anti-leukemia compound of NLT, UA, has been 
reported by some groups to have some toxicity (Jesus et al, 2017). Our study revealed the ability 
of Streptomyces akac8 to tolerate any toxicity of and grow in the presence of UA when cultured 
in a chemically undefined media. This is imperative to the continuation of this project. The 
biotransformation of medicinally relevant ethnobotanicals by a commensal intestinal bacterium 
from a host that regularly consumes the ethnobotanical could be a novel methodology of natural 
product drug discovery.  
 
In conclusion, based upon these findings, Streptomyces akac8 is a respectable candidate to 
biotransform UA in future studies. However, the prospect of using other Streptomyces strains 
that are more adept to surviving the toxicity of UA due to a higher concentration of terpenes or a 
higher terpene to other BGC ratio should be considered.  Also, further development of co-
cultivation conditions of UA and Streptomcyes akac8 is necessary. Biotransformation of 
medicinally relevant ethnobotanicals by a commensal intestinal bacterium from a host that 
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In these studies, multiple methods of drug discovery were explored and refined. Our first study 
was one of the largest single genus BGC studies to date. We found the BGCs encoded in 1,110 
Streptomyces genomes were highly diverse. This included inter-strain level diversity of BGCs. 
We were able to establish a prioritization of the most prolific natural product producing strains. 
Additionally, we identified possible analogs of 38 existing CGCs. Our results indicate a wide 
phylogenetic spread of CGCs beyond the established species associated with the production of 
specific chemotherapeutics. Finally, based upon our findings of variably distributed constituents 
of BGCs within the Streptomyces genus we promote the use of population-level drug discovery 
efforts.  
 
Our second study investigated the biotransformation of UA, a derivative of the ethnobotanical 
NLT, by a Streptomyces. Within this study, Streptomyces akac8 was isolated and purified from 
an Alaskan bear fecal sample. Subsequently, the Streptomyces akac8 whole genome was 
sequenced. This allowed for further analysis of the diversity of BGCs harbored within the 
Streptomyces akac8 genome, compared to the 1,110 other Streptomyces genome sequences from 
the first study. Given the high ratio of terpene BGCs to other BGCs in the Streptomyces akac8 
genome, we can say that this strain is a respectable candidate to biotransform UA. However, the 
prospect of using other Streptomyces strains that are more adept to surviving the toxicity of UA 
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due to a higher concentration of terpenes or a higher terpene to other BGC ratio could be 
considered.  
 
Finally, we were unable to further pursue a full biotransformation approach in this study due to 
the inability to replicate the obligatory conditions needed for Streptomyces growth.  Future 
studies should consider more complex media with alterations to pH, salt concentration, 
temperature, nutritional sources, or aerobic conditions. Biotransformation may not be possible 
with the given bacterium and compound that we are using. The exposure of Streptomyces akac8 
to UA could cause alterations in the genes and BGCs that are expressed by this strain. One of the 
largest faults with genome mining studies is the lack of expression of BGCs associated with 
secondary metabolite production in a laboratory setting, despite the presence of BGCs of interest 
in the genomes. Adding the compound UA (which is likely present in the bear gastrointestinal 
system that Streptomyces akac8 was isolated from) to the culture media could induce 
Streptomyces akac8 to express BGCs that it would express in its natural ecological niche. Lastly, 


















Genome Organism Biosample Bases CDS GC2content BGCs
GCF_000700005.1_ASM70000v1 Streptomyces2fradiae SAMN05722967 7670374 6444 0.728343494 25
GCF_003122345.1_ASM312234v1 Streptomyces2xinghaiensis SAMN02777962 7742003 6437 0.727280783 26
GCF_003048205.1_ASM304820v1 Streptomyces2chartreusis SAMN02471830 10404130 9382 0.706400343 48
GCF_001418505.1_ASM141850v1 Streptomyces2flocculus2 SAMN04003993 7425953 6306 0.724901168 33
GCF_000203835.1_ASM20383v1 Streptomyces2coelicolor2A3(2)2 SAMEA1705940 9054847 8128 0.711094876 35
GCF_000009765.2_ASM976v2 Streptomyces2avermitilis2MAO46802=2NBRC2148932 SAMD00061088 9119895 7896 0.698284852 49
GCF_000010605.1_ASM1060v1 Streptomyces2griseus2subsp.2griseus2NBRC2133502 SAMD00060929 8545929 7097 0.713357042 47
GCF_000091305.1_ASM9130v1 Streptomyces2scabiei287.222 SAMEA2272773 10148695 8771 0.705706962 41
GCF_000092385.1_ASM9238v1 Streptomyces2bingchenggensis2BCWO12 SAMN02603683 11936683 9950 0.698810729 71
GCF_000240165.1_ASM24016v1 Streptomyces2cattleya2NRRL280572=2DSM2464882 SAMN02603879 8095515 7133 0.721121035 49
GCF_000444875.1_ASM44487v1 Streptomyces2collinus2Tu23652 SAMN02603029 8377286 7212 0.716551065 48
GCF_000761215.1_ASM76121v1 Streptomyces2glaucescens2 SAMN03031338 7623774 6551 0.720145634 26
GCF_000802245.2_ASM80224v2 Streptomyces2pluripotens2 SAMN03070117 7346075 6397 0.690789781 32
GCF_000827005.1_ASM82700v1 Streptomyces2albus2 SAMN03283748 8384669 6736 0.717474738 50
GCF_000830005.1_ASM83000v1 Streptomyces2vietnamensis2 SAMN02730132 9153777 8158 0.711048316 39
GCF_000993785.2_ASM99378v2 Streptomyces2xiamenensis2 SAMN03332981 5961401 5356 0.71133443 30
GCF_001013905.1_sleC34 Streptomyces2leeuwenhoekii2 SAMEA3258058 8122491 6968 0.717796023 41
GCF_001278075.1_ASM127807v1 Streptomyces2pristinaespiralis2 SAMN03565307 8532592 7336 0.706581706 35
GCF_001443625.1_ASM144362v1 Streptomyces2venezuelae2 SAMN04230917 9054831 8033 0.708585292 39
GCF_001542625.1_ASM154262v2 Streptomyces2griseochromogenes2 SAMN04375936 10764674 9618 0.698827248 76
GCF_001685355.1_ASM168535v1 Streptomyces2lincolnensis2 SAMN05335414 10319054 9142 0.701337466 42
GCF_001693675.1_ASM169367v1 Streptomyces2clavuligerus2 SAMN05392246 7590758 6190 0.717082524 44
GCF_001704275.1_ASM170427v1 Streptomyces2noursei2ATCC2114552 SAMN03287657 9815884 8671 0.705708852 44
GCF_001729485.1_ASM172948v1 Streptomyces2lydicus2 SAMN05725998 8201357 7162 0.713270216 35
GCF_001735805.1_ASM173580v1 Streptomyces2puniciscabiei2 SAMN05520841 9698948 8585 0.70211162 50
GCF_001975025.1_ASM197502v1 Streptomyces2alfalfae2 SAMN04955000 8625867 7424 0.712036068 60
GCF_001983975.1_ASM198397v1 Streptomyces2autolyticus2 SAMN06209296 10184660 8105 0.703305411 59
GCF_002009175.1_ASM200917v1 Streptomyces2niveus2 SAMN05370045 7990492 6949 0.695910968 38
GCF_002189675.2_ASM218967v2 Streptomyces2alboflavus2 SAMN07173524 9967549 9009 0.711071135 36
GCF_002192455.1_ASM219245v1 Streptomyces2albireticuli2 SAMN06820531 8144417 6901 0.719239099 62
GCF_000349325.1_ASM34932v1 Streptomyces2davaonensis2JCM249132 SAMEA2272568 9555950 8581 0.69698183 46
GCF_000819545.1_ASM81954v1 Streptomyces2nodosus2 SAMN03020625 7714110 6807 0.699259987 28. tr t 9 9 .
GCF_002028425.1_ASM202842v1 Streptomyces9katrae9 SAMN06470724 8056450 7071 0.718307861 33
GCF_000156435.1_ASM15643v1 Streptomyces9viridosporus9ATCC9146729 SAMN02595233 8511919 7702 0.689070144 34
GCF_000158915.1_ASM15891v1 Streptomyces9himastatinicus9ATCC9536539 SAMN02595299 11030030 9859 0.667413748 48
GCF_000158955.1_ASM15895v1 Streptomyces9viridochromogenes9DSM9407369 SAMN02595301 8653262 7727 0.693920329 40
GCF_000280865.1_ASM28086v1 Streptomyces9auratus9AGR00019 SAMN02472162 7885420 6766 0.702175151 42
GCF_000372745.1_ASM37274v1 Streptomyces9scabrisporus9DSM9418559 SAMN02256465 11392659 9970 0.700456491 54
GCF_000380165.1_ASM38016v1 Streptomyces9vitaminophilus9DSM9416869 SAMN02256407 6429887 5432 0.711450193 26
GCF_000381025.1_ASM38102v1 Streptomyces9sulphureus9DSM9401049 SAMN02440478 7104952 6144 0.707829142 31
GCF_000384175.1_ASM38417v1 Streptomyces9purpureus9KA2819 SAMN02261248 7458334 6728 0.706173714 31
GCF_000429085.1_ASM42908v1 Streptomyces9flavidovirens9DSM9401509 SAMN02440879 7070406 6422 0.695081057 28
GCF_000715845.1_ASM71584v1 Streptomyces9monomycini9 SAMN02645312 9111622 7891 0.701361793 44
GCF_000725785.1_Doro.v1.0 Streptomyces9flavovariabilis9 SAMN02645208 8762262 7840 0.703636926 40
GCF_000745675.1_ASM74567v1 Streptomyces9atratus9 SAMN02787147 7308206 6625 0.688776471 18
GCF_001270025.1_Sazu_1.0 Streptomyces9azureus9 SAMD00031377 8790205 8044 0.700516412 26
GCF_001493375.1_Streptomyces_specialis Streptomyces9specialis9 SAMEA3696889 5884160 5446 0.715242757 27
GCF_001514045.1_ASM151404v1 Streptomyces9canus9 SAMN04193344 9844122 8808 0.691612929 28
GCF_001514115.1_ASM151411v1 Streptomyces9olivochromogenes9 SAMN04193347 11669312 10528 0.691186825 46
GCF_000204605.1_ASM20460v1 Streptomyces9griseoaurantiacus9M0459 SAMN02470039 7712377 6714 0.718330509 26
GCF_000225525.1_ASM22552v1 Streptomyces9zinciresistens9K429 SAMN02471576 8221694 7384 0.715609552 30
GCF_000242715.1_ASM24271v2 Streptomyces9acidiscabies984P1049 SAMN02471769 11005945 9740 0.697181235 59
GCF_000297155.2_ASM29715v2 Streptomyces9tsukubensis9NRRL184889 SAMN02470052 7672196 6666 0.706312548 61
GCF_000342125.1_S.mobaraensisn_1.0 Streptomyces9mobaraensis9NBRC9138199=9DSM9408479 SAMN02470112 7477811 6409 0.723639491 66
GCF_000376565.1_ASM37656v1 Streptomyces9hokutonensis9 SAMD00041833 11828360 10726 0.693911867 32
GCF_000478605.2_ASM47860v2 Streptomyces9thermolilacinus9SPC69 SAMN02116697 6448617 5579 0.72461706 22
GCF_000716805.1_ASM71680v1 Streptomyces9yerevanensis9 SAMN02645188 10925884 9896 0.687118179 29
GCF_000717025.1_ASM71702v1 Streptomyces9atroolivaceus9 SAMN02645281 8216207 7144 0.698535081 38
GCF_000717285.1_ASM71728v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02645319 9589920 8387 0.710522218 63CF_000717285.1_AS 71728v1 Strepto yces9ri osus9subsp.9ri osus9 SA 02645319 9589920 8387 0.710522218 63
GCF_000717745.1_ASM71774v1 Streptomyces9violens9 SAMN02645388 7941520 6923 0.705296797 36
GCF_000718015.1_ASM71801v1 Streptomyces9catenulae9 SAMN02645222 7046907 6023 0.720706743 34
GCF_000718095.1_ASM71809v1 Streptomyces9scopuliridis9RB729 SAMN02645233 8243500 7063 0.695184563 48
GCF_000718165.1_ASM71816v1 Streptomyces9fulvoviolaceus9 SAMN02645250 11584616 10426 0.693813239 32
GCF_000718315.1_ASM71831v1 Streptomyces9griseofuscus9 SAMN02645272 8945636 8014 0.70815968 67
GCF_000718635.1_ASM71863v1 Streptomyces9varsoviensis9 SAMN02645386 8588807 7174 0.715040459 46
GCF_000718985.1_ASM71898v1 Streptomyces9megasporus9 SAMN02645209 5850061 5247 0.713716484 21
GCF_000719265.1_ASM71926v1 Streptomyces9roseoverticillatus9 SAMN02645263 7205477 6177 0.715218527 56
GCF_000719865.1_ASM71986v1 Streptomyces9albus9subsp.9albus9 SAMN02645498 6938318 5726 0.722986244 30
GCF_000719955.1_ASM71995v1 Streptomyces9albidoflavus9 SAMN02645503 7084693 6049 0.725271559 35
GCF_000720455.1_ASM72045v1 Streptomyces9virginiae9 SAMN02645365 8318538 7450 0.715037927 44







GCF_000721235.1_ASM72123v1 Streptomyces9olivaceus9 SAMN02645259 8584392 7426 0.71520734 55
GCF_000725885.1_ASM72588v1 Streptomyces9albus9subsp.9albus9 SAMN02645215 7633340 6406 0.71836069 29
GCF_000745345.1_ASM74534v1 Streptomyces9yeochonensis9CN7329 SAMN02745173 7819394 6376 0.726482003 25
GCF_001187435.1_ASM118743v1 Streptomyces9caatingaensis9 SAMN03837863 7055077 6060 0.723516377 52
GCF_001543895.1_ASM154389v1 Streptomyces9thermoautotrophicus9 SAMN03328326 5134156 4797 0.700978832 11
GCF_001642995.1_ASM164299v1 Streptomyces9jeddahensis9 SAMN04325095 8449625 7371 0.694788661 20
GCF_001704635.1_ASM170463v1 Streptomyces9sparsogenes9 SAMN05366068 8907947 7781 0.714640092 53
GCF_001879105.1_ASM187910v1 Streptomyces9gilvigriseus9 SAMN05898137 5213277 4579 0.721295705 8
GCF_002007125.1_ASM200712v1 Streptomyces9tsukubensis9 SAMN06323803 8504127 6921 0.696231714 51
GCF_900105695.1_IMGKtaxon_2634166371_annotated_assembly Streptomyces9melanosporofaciens9 SAMN04490356 10769732 9233 0.70143229 51
GCF_001418335.1_ASM141833v1 Streptomyces9aurantiacus9 SAMN04002962 9255252 8105 0.693562827 38
GCF_001418475.1_ASM141847v1 Streptomyces9ossamyceticus9 SAMN04004085 9298634 8222 0.702659725 36
GCF_001418495.1_ASM141849v1 Streptomyces9pathocidini9 SAMN04004086 5542997 4895 0.704949469 28
GCF_001418575.1_ASM141857v1 Streptomyces9griseoplanus9 SAMN04003996 8245423 7225 0.716080903 26
GCF_001418585.1_ASM141858v1 Streptomyces9griseoruber9 SAMN04004079 9868987 8977 0.705586647 45
GCF_001418655.1_ASM141865v1 Streptomyces9phaeochromogenes9 SAMN04004087 10935515 9520 0.693111676 45
GCF_001419695.1_ASM141969v1 Streptomyces9prasinopilosus9 SAMN04004088 6416915 5857 0.716930667 23
GCF_001751245.1_ASM175124v1 Streptomyces9oceani9 SAMN04026263 6311054 5239 0.689539156 27
GCF_001751255.1_ASM175125v1 Streptomyces9nanshensis9 SAMN04026265 7724355 6670 0.705777052 38
GCF_001885705.1_ASM188570v1 Streptomyces9cinnamoneus9 SAMN05945585 11006533 10194 0.700252379 68
GCF_001905345.1_ASM190534v1 Streptomyces9uncialis9 SAMN03769207 8883497 7456 0.711755499 46
GCF_001906585.1_ASM190658v1 Streptomyces9kebangsaanensis9 SAMN03254380 8244886 7694 0.704796123 25
GCF_002154495.1_ASM215449v1 Streptomyces9cacaoi9subsp.9cacaoi9 SAMN06277326 8136809 6704 0.722299005 49
GCF_002155895.1_ASM215589v1 Streptomyces9rochei9 SAMN06291437 7682401 6762 0.715436347 36
GCF_002155915.1_ASM215591v1 Streptomyces9thermovulgaris9 SAMN06291438 6021617 5238 0.707926923 27
GCF_900100315.1_IMGKtaxon_2675903130_annotated_assembly Streptomyces9indicus9 SAMN05421806 8228196 7361 0.705485539 19
GCF_900103455.1_IMGKtaxon_2675903062_annotated_assembly Streptomyces9wuyuanensis9 SAMN05444921 8039558 7139 0.709619106 22
GCF_900103985.1_IMGKtaxon_2667527439_annotated_assembly Streptomyces9guanduensis9 SAMN05216259 8220839 6742 0.722394483 30
GCF_900110255.1_IMGKtaxon_2671180039_annotated_assembly Streptomyces9rubidus9 SAMN05216267 9005705 7647 0.720117184 27
GCF_900110735.1_IMGKtaxon_2663762755_annotated_assembly Streptomyces9radiopugnans9 SAMN05216481 6067124 5386 0.725188028 28
GCF_900111245.1_IMGKtaxon_2675903055_annotated_assembly Streptomyces9qinglanensis9 SAMN05421870 7175483 6138 0.7180549 31
GCF_900112355.1_IMGKtaxon_2675903061_annotated_assembly Streptomyces9aidingensis9 SAMN05421773 6482745 5589 0.721554393 30
GCF_900112845.1_IMGKtaxon_2667527403_annotated_assembly Streptomyces9alni9 SAMN05216251 8270097 7013 0.711685163 21
GCF_900142575.1_IMGKtaxon_2667527448_annotated_assembly Streptomyces9paucisporeus9 SAMN05216499 8164374 6990 0.713252348 36
GCF_900188405.1_IMGKtaxon_2671180020_annotated_assembly Streptomyces9glauciniger9 SAMN05216252 9808662 8632 0.713638785 28F . I .tax a tat ass ly Str t yc sBgla ci ig rB S .
GCF_000147815.2_ASM14781v3 StreptomycesBviolaceusnigerBTuB4113B SAMN00016986 11138313 9426 0.700013381 56
GCF_000176115.2_ASM17611v2 StreptomycesBpratensisBATCCB33331B SAMN00191232 7656104 6733 0.701169766 33
GCF_000177195.2_ASM17719v2 StreptomycesBsp.BSirexAA.EB SAMN02232054 7414440 6489 0.708623719 27
GCF_000220705.2_ASM22070v2 StreptomycesBxinghaiensisBS187B SAMN02469701 7137891 6035 0.722345777 23
GCF_000237305.1_ASM23730v1 StreptomycesBcattleyaBNRRLB8057B=BDSMB46488B SAMEA3138404 8092553 7130 0.721133196 50
GCF_000245355.1_ASM24535v1 StreptomycesBhygroscopicusBsubsp.BjinggangensisB5008B SAMN02603880 10383684 9212 0.709533721 46
GCF_000261345.2_ASM26134v2 StreptomycesBglobisporusBC.1027B SAMN02469977 7783599 6921 0.706588782 36
GCF_000340845.1_ASM34084v1 StreptomycesBhygroscopicusBsubsp.BjinggangensisBTL01B SAMN02603881 10077952 8903 0.71093517 46
GCF_000359525.1_ASM35952v1 StreptomycesBalbidoflavusB SAMN02603310 6841649 5847 0.72416066 27
GCF_000364805.1_ASM36480v1 StreptomycesBsp.BPAMCB26508B SAMN01821993 7630245 6610 0.701565984 35
GCF_000385945.1_ASM38594v1 StreptomycesBfulvissimusBDSMB40593B SAMN02603305 7905758 6919 0.705969083 39
GCF_000412265.2_ASM41226v2 StreptomycesBsp.BMg1B SAMN02471086 8716193 7729 0.712439464 42
GCF_000695235.1_ASM69523v1 StreptomycesBalbulusB SAMN02709029 9372401 8179 0.714260845 48
GCF_000739105.1_ASM73910v1 StreptomycesBlividansBTK24B SAMN02947304 8345283 7423 0.713523954 31
GCF_000772045.1_ASM77204v1 StreptomycesBsp.BCCM_MD2014B SAMN03106103 8274043 7389 0.71234725 27
GCF_000816025.1_ASM81602v1 StreptomycesBsp.B769B SAMN03275450 10338286 8980 0.707147972 54
GCF_000816465.3_ASM81646v4 StreptomycesBpluripotensB SAMN03070122 7586568 6609 0.690572983 33
GCF_000931445.1_ASM93144v1 StreptomycesBcyaneogriseusBsubsp.BnoncyanogenusB SAMN03329629 7762396 6497 0.719595935 44
GCF_000935185.3_ASM93518v3 StreptomycesBalbulusB SAMN03276531 9336218 8051 0.714563996 46
GCF_000952035.2_ASM95203v2 StreptomycesBlydicusB SAMN02864172 9307519 8299 0.698055245 44
GCF_000963515.1_ASM96351v1 StreptomycesBalbulusBZPMB SAMN03445854 9784577 8501 0.712402132 48
GCF_001011035.1_ASM101103v1 StreptomycesBsp.BCNQ.509B SAMN03699827 8039333 6874 0.72165495 36
GCF_001267885.1_ASM126788v1 StreptomycesBambofaciensBATCCB23877B SAMN03921868 8393598 7391 0.712966342 33
GCF_001278095.1_ASM127809v1 StreptomycesBsp.BCFMRB7B SAMN03463183 8307279 7008 0.711423602 48
GCF_001406115.1_Streptomyces_venezuelae_ATCC_15439 StreptomycesBvenezuelaeB SAMEA3516846 9034396 8052 0.708596151 39
GCF_001431765.1_ASM143176v1 StreptomycesBsp.BFR.008B SAMN03120580 7258031 6277 0.724184685 26
GCF_001447075.1_ASM144707v1 StreptomycesBhygroscopicusBsubsp.BlimoneusB SAMN04277307 10537932 9257 0.710720223 42
GCF_001484565.1_ASM148456v1 StreptomycesBsp.BCdTB01B SAMN04235813 10191567 9253 0.706482134 39CF_001484565.1_AS 148456v1 Strepto yces9sp.9CdTB019 SA 04235813 10191567 9253 0.706482134 39
GCF_001484705.1_ASM148470v1 Streptomyces9sp.94F9 SAMN04245816 8047771 7124 0.713925327 25
GCF_001511815.1_TUE45 Streptomyces9reticuli9 SAMEA3707210 9336224 8090 0.718183644 52
GCF_001577385.1_ASM157738v1 Streptomyces9albidoflavus9 SAMN04053756 7170504 6182 0.724346211 26
GCF_001611795.1_ASM161179v1 Streptomyces9qaidamensis9 SAMN04592628 9083372 8072 0.703781757 32
GCF_001632865.1_ASM163286v1 Streptomyces9ambofaciens9 SAMN04160834 8137876 7071 0.714336376 33
GCF_001650215.1_ASM165021v1 Streptomyces9sp.9RTd229 SAMN04901306 11142275 9615 0.70399211 51
GCF_001654495.1_ASM165449v1 Streptomyces9sp.9SAT19 SAMN05161780 7472530 6331 0.722473766 34
GCF_001660045.1_ASM166004v1 Streptomyces9parvulus9 SAMN04924834 7766531 6859 0.71835965 25
GCF_001704195.1_ASM170419v1 Streptomyces9sampsonii9 SAMN04338613 7070328 6057 0.724823669 29
GCF_001750785.1_ASM175078v1 Streptomyces9rubrolavendulae9 SAMN04595356 6543262 5427 0.738610695 26
GCF_001753425.1_ASM175342v1 Streptomyces9albus9 SAMN04577683 8308430 6690 0.717479767 48
GCF_001767375.1_ASM176737v1 Streptomyces9olivaceus9 SAMN05436714 8180260 7229 0.715116087 45
GCF_001886595.1_ASM188659v1 Streptomyces9venezuelae9 SAMN06014621 8380320 7473 0.715262505 36
GCF_001931635.1_ASM193163v1 Streptomyces9sp.9Tue960759 SAMN03295241 7931832 6830 0.706854332 40
GCF_001941845.1_ASM194184v1 Streptomyces9sp.9TN589 SAMN06167403 7585034 6797 0.714032714 37
GCF_001984445.1_ASM198444v1 Streptomyces9lydicus9 SAMN06251699 8243179 7190 0.711257517 349l i 9
GCF_002005225.1_ASM200522v1 Streptomyces9pactum9 SAMN04002534 8550793 7151 0.711662873 42
GCF_002007685.1_ASM200768v1 Streptomyces9sp.9fd1Exmd9 SAMN06329945 7929999 7045 0.716125819 33





GCF_002021875.1_ASM202187v1 Streptomyces9hygroscopicus9 SAMN05935554 12012215 10016 0.698766803 60
GCF_002028385.1_ASM202838v1 Streptomyces9sp.932119 SAMN06464033 8991292 8086 0.706211573 49
GCF_002080455.1_ASM208045v1 Streptomyces9sp.9Sge129 SAMN06647473 8110698 7201 0.712819756 44
GCF_002082175.1_ASM208217v1 Streptomyces9violaceoruber9 SAMN06323808 7916045 6781 0.717536104 38
GCF_002082195.1_ASM208219v1 Streptomyces9gilvosporeus9 SAMN06323804 8482298 7483 0.700759647 34
GCF_002090335.1_ASM209033v1 Streptomyces9sp.9MOE79 SAMN06271910 8399509 7381 0.71104108 34
GCF_002094995.1_ASM209499v1 Streptomyces9sp.9S89 SAMN04870419 7601864 6458 0.713955302 44
GCF_002128305.1_ASM212830v1 Streptomyces9sp.9SCSIO9030329 SAMN06883772 6287975 5384 0.726111606 34
GCF_002288075.1_ASM228807v1 Streptomyces9sp.9CLI25099 SAMN06855397 7232701 6173 0.723908732 23
GCF_002556545.1_ASM255654v1 Streptomyces9formicae9 SAMN07444202 9611874 8149 0.705018679 50
GCF_002591335.1_ASM259133v1 Streptomyces9malaysiensis9 SAMN07427119 10744231 8551 0.702154104 62
GCF_002777535.1_ASM277753v1 Streptomyces9peucetius9subsp.9caesius9ATCC9279529 SAMN07357090 8023114 7164 0.697215317 29
GCF_002803845.1_ASM280384v1 Streptomyces9lavendulae9subsp.9lavendulae9 SAMN07663065 8932792 7951 0.717215734 37
GCF_002812405.1_ASM281240v1 Streptomyces9sp.9M569 SAMN07312782 11742376 9398 0.701126135 65
GCF_002847285.1_ASM284728v1 Streptomyces9sp.9CMBOStM04239 SAMN08161523 8029398 6751 0.722385122 35
GCF_002910725.2_ASM291072v2 Streptomyces9sp.9SM179 SAMN06828995 7179914 6181 0.724472173 25
GCF_002910775.2_ASM291077v2 Streptomyces9sp.9SM189 SAMN06828993 7703166 6670 0.709510894 33
GCF_002943895.1_ASM294389v1 Streptomyces9sp.9WAC002889 SAMN08559993 7852859 6983 0.71834291 30
GCF_002946835.1_ASM294683v1 Streptomyces9dengpaensis9 SAMN08469739 8710171 7945 0.690563348 28
GCF_003032475.1_ASM303247v1 Streptomyces9sp.9P39 SAMN08660902 9851971 8535 0.70484739 44
GCF_003054555.1_ASM305455v1 Streptomyces9lunaelactis9 SAMN08367447 8570191 7714 0.688930914 33
GCF_003074055.1_ASM307405v1 Streptomyces9nigra9 SAMN08957528 7641029 6881 0.710244965 24
GCF_003097515.1_ASM309751v1 Streptomyces9sp.9HNM00399 SAMN08996718 7289495 6167 0.715689779 38
GCF_003122365.1_ASM312236v1 Streptomyces9spongiicola9 SAMN08984914 7180417 5948 0.715546934 35
GCF_003147545.1_ASM314754v1 Streptomyces9globisporus9 SAMN09104458 7666521 6836 0.706567621 35
GCF_003173275.1_ASM317327v1 Streptomyces9sp.9NEAUOS7GS29 SAMN09217500 9687439 8345 0.699091393 47
GCF_003208035.1_ASM320803v1 Streptomyces9actuosus9 SAMN09296291 8145579 7309 0.716372156 33
GCF_003261055.1_ASM326105v1 Streptomyces9sp.9ZFG479 SAMN09388963 10239272 8788 0.698860857 38
GCF_003268675.1_ASM326867v1 Streptomyces9bacillaris9 SAMN09197286 7888441 6788 0.710657268 41
GCF_003325375.1_ASM332537v1 Streptomyces9globosus9 SAMN08286884 7535750 6544 0.727386084 44
GCF_003330845.1_ASM333084v1 Streptomyces9sp.9GoO4759 SAMN08364892 8570609 7571 0.710685453 42
GCF_003330865.1_ASM333086v1 Streptomyces9atratus9 SAMN08612569 9641288 8412 0.687320122 38
GCF_003344445.1_ASM334444v1 Streptomyces9lincolnensis9 SAMN05466746 9513637 8442 0.701858634 36
GCF_003344965.1_ASM334496v1 Streptomyces9sp.9GSSDO129 SAMN09699158 8454852 7085 0.703086068 42
GCF_003352445.1_ASM335244v1 Streptomyces9cavourensis9 SAMN09642110 7613757 6433 0.712340975 41
GCF_003369795.1_ASM336979v1 Streptomyces9sp.9CB090019 SAMN08474659 7787608 6932 0.710587024 31CF_003369795.1_AS 336979v1 Strepto yces:sp.:CB09001: SA 08474659 7787608 6932 0.710587024 31
GCF_003391135.1_ASM339113v1 Streptomyces:olivoreticuli:subsp.:olivoreticuli: SAMN09769444 8809793 7449 0.702309641 68
GCF_003428925.1_ASM342892v1 Streptomyces:koyangensis: SAMN09842183 7220839 6245 0.7212533 29
GCF_003443735.1_ASM344373v1 Streptomyces:sp.:CC0208: SAMN09925543 9320089 8334 0.697137981 32
GCF_003454755.1_ASM345475v1 Streptomyces:clavuligerus: SAMN09930682 8059125 6619 0.716336238 48
GCF_003573485.1_ASM357348v1 Streptomyces:fradiae: SAMN10024168 8081458 7007 0.712418623 53
GCF_900236475.1_NRRL3882 Streptomyces:chartreusis:NRRL:3882: SAMEA104372011 8983317 7941 0.703464056 37
GCF_900236505.1_NRRL3882 Streptomyces:chartreusis:NRRL:3882: SAMEA104372071 8983317 7941 0.703464056 37
GCF_000253235.1_ASM25323v1 Streptomyces:venezuelae:ATCC:10712: SAMEA3138410 8226158 7327 0.715064921 36
GCF_003287915.1_ASM328791v1 Streptomyces:sp.:ICC4: SAMN08559943 9010404 8294 0.711376861 37
GCF_003287935.1_ASM328793v1 Streptomyces:sp.:ICC1: SAMN08559942 9034319 8312 0.711204835 40
GCF_003352805.1_ASM335280v1 Streptomyces:sp.:ETH9427: SAMN09209490 7978031 7240 0.690304252 29
GCF_900104935.1_IMGRtaxon_2690315611_annotated_assembly Streptomyces:sp.:2114.2: SAMN05428941 8620263 7662 0.712240134 30
GCF_900105395.1_IMGRtaxon_2671180173_annotated_assembly Streptomyces:sp.:TLI_053: SAMN05216371 9900053 8131 0.727170344 66
GCF_900129855.1_IMGRtaxon_2695421014_annotated_assembly Streptomyces:sp.:3214.6: SAMN05444521 9375551 8327 0.697957788 34
GCF_900221035.1_IMGRtaxon_2738543001_annotated_assembly Streptomyces:sp.:2323.1: SAMN06272775 8212455 6981 0.703067223 42
GCF_000148465.1_Scla_1.0 Streptomyces:clavuligerus:ATCC:27064: SAMN02470183 9143376 7586 0.714294201 59
GCF_000154945.1_ASM15494v1 Streptomyces:pristinaespiralis:ATCC:25486: SAMN02595222 8133379 7347 0.659658166 26
GCF_000154965.1_ASM15496v1 Streptomyces:sviceus:ATCC:29083: SAMN02595223 9313494 8537 0.676684928 27
GCF_000163875.1_Strep_clav_ATCC27064 Streptomyces:clavuligerus:ATCC:27064: SAMN02471788 8556892 6986 0.713637026 57
GCF_000213055.1_ASM21305v1 Streptomyces:sp.:Tu6071: SAMN02470040 7506727 6433 0.721733867 25
GCF_000403665.1_Streptomyces_lividans_1326 Streptomyces:lividans:1326: SAMN02469606 8496762 7656 0.705436098 31
GCF_000495635.1_GBA94R10.20 Streptomyces:sp.:GBA:94R10: SAMN02469388 7224475 6155 0.720629815 37
GCF_000495755.1_PVA94R07.23 Streptomyces:sp.:PVA:94R07: SAMN02469391 7106149 6009 0.721481111 38
GCF_000497425.1_S.niveus_v1 Streptomyces:niveus:NCIMB:11891: SAMN02469390 8726876 7822 0.685797462 34
GCF_000497445.1_S.roseochromogenes_v1 Streptomyces:roseochromogenus:subsp.:oscitans:DS:12.976: SAMN02469393 9782257 8962 0.679545715 56
GCF_001434355.1_ASM143435v1 Streptomyces:anulatus: SAMN02951406 8847108 7634 0.708388919 47
GCF_002019855.1_ASM201985v1 Streptomyces:antibioticus: SAMN03941256 8506622 7537 0.707856397 34
GCF_000154885.1_ASM15488v1 Streptomyces:sp.:Mg1: SAMN02595219 7260368 6670 0.6879641 29
GCF_000154905.1_ASM15490v1 Streptomyces:sp.:SPB074: SAMN02595220 6970553 6372 0.672894912 17
GCF_000154925.1_ASM15492v1 Streptomyces:clavuligerus:ATCC:27064: SAMN02595221 6941735 6121 0.680301415 41
GCF_000156455.1_ASM15645v1 Streptomyces:filamentosus:NRRL:15998: SAMN02595234 7817295 6880 0.681559295 33
GCF_000156475.1_ASM15647v1 Streptomyces:albidoflavus: SAMN02595235 6823670 5855 0.700816302 26
GCF_000158855.1_ASM15885v1 Streptomyces:sp.:SPB78: SAMN02595296 7557384 6718 0.657180077 19. tr t 7 .7 7 .
GCF_000158935.1_ASM15893v1 Streptomyces7lividans7TK247 SAMN02595300 8318010 7466 0.701949279 29
GCF_000158975.1_ASM15897v1 Streptomyces7griseoflavus7Tu40007 SAMN02595302 8047042 7503 0.647780686 23
GCF_000162775.1_ASM16277v1 Streptomyces7sp.7e147 SAMN02595349 7928946 6985 0.646836398 19
GCF_000177175.2_ASM17717v2 Streptomyces7sp.7ACTK17 SAMN00713595 8731683 7361 0.712193538 45
GCF_000226455.1_ASM22645v1 Streptomyces7chartreusis7NRRL7123387 SAMN02471828 8893692 7913 0.701472197 36
GCF_000316095.1_ASM31609v1 Streptomyces7viridosporus7T7A7 SAMN02261266 8293298 7402 0.714840881 36
GCF_000340335.1_ASM34033v2 Streptomyces7bottropensis7ATCC7254357 SAMN02471210 8914727 7726 0.703495088 36
GCF_000365385.1_ASM36538v1 Streptomyces7sp.7CNS6157 SAMN02441407 7349627 6179 0.717374863 39
GCF_000373225.1_ASM37322v1 Streptomyces7sp.7LaPpAHK2027 SAMN02441710 7004837 6002 0.725892841 35
GCF_000373305.1_ASM37330v1 Streptomyces7sp.7CcalMPK8W7 SAMN02441713 7805445 6505 0.715828178 54
GCF_000373405.1_ASM37340v1 Streptomyces7sp.7ScaeMPKe107 SAMN02441715 8075580 7067 0.70704702 42
GCF_000373465.1_ASM37346v1 Streptomyces7sp.7FxanaD57 SAMN02441716 7586126 6870 0.712378078 15
GCF_000373525.1_ASM37352v1 Streptomyces7sp.7LaPpAHK1657 SAMN02440428 7564905 6660 0.70995575 34






GCF_000373565.1_ASM37356v1 Streptomyces9sp.9HmicA129 SAMN02440430 9161949 8271 0.702506517 23
GCF_000373585.1_ASM37358v1 Streptomyces9sp.9MspMPBM59 SAMN02440431 8596663 7567 0.709721584 56
GCF_000373625.1_ASM37362v1 Streptomyces9sp.9LaPpAHB1089 SAMN02441702 6850887 6128 0.709450319 24
GCF_000373645.1_ASM37364v1 Streptomyces9sp.9ATexABBD239 SAMN02441037 7948485 6876 0.708388244 42
GCF_000373665.1_ASM37366v1 Streptomyces9sp.9BoleA59 SAMN02441703 8646873 7919 0.713972962 26
GCF_000373685.1_ASM37368v1 Streptomyces9sp.9PsTaAHB1249 SAMN02441038 8808859 7531 0.7203869 46
GCF_000377105.1_ASM37710v1 Streptomyces9sp.9CNQ7669 SAMN02440453 8474577 7134 0.727270545 49
GCF_000377125.1_ASM37712v1 Streptomyces9sp.9CNS3359 SAMN02440454 8591972 7245 0.726862648 45
GCF_000377145.1_ASM37714v1 Streptomyces9sp.9CNT3729 SAMN02441678 6456450 5560 0.723775289 31
GCF_000377165.1_ASM37716v1 Streptomyces9sp.9CNY2439 SAMN02441361 8481985 7117 0.726756227 40
GCF_000377525.1_ASM37752v1 Streptomyces9sp.9CNT3029 SAMN02441002 7174271 6114 0.716295986 36
GCF_000377545.1_ASM37754v1 Streptomyces9sp.9CNY2289 SAMN02441350 6959154 5962 0.726057483 34
GCF_000377965.1_ASM37796v1 Streptomyces9sp.9CNB0919 SAMN02441673 8228950 7150 0.70714296 47
GCF_000383595.1_ASM38359v1 Streptomyces9bottropensis9ATCC9254359 SAMN02261243 8955726 7749 0.703103431 36
GCF_000383615.1_ASM38361v1 Streptomyces9canus9299MFChir4.19 SAMN02440519 10479972 9518 0.694552383 38
GCF_000383635.1_ASM38363v1 Streptomyces9sp.9303MFCol5.29 SAMN02441630 9550898 8341 0.705226745 34
GCF_000383655.1_ASM38365v1 Streptomyces9sp.9351MFTsu5.19 SAMN02441631 9330122 8350 0.701023662 25
GCF_000383935.1_ASM38393v1 Streptomyces9sp.9Amel2xE99 SAMN02441313 8252435 7091 0.72016434 36
GCF_000411315.1_Stre_sp_HGB0020_V1 Streptomyces9sp.9HGB00209 SAMN02596734 9361238 8458 0.696837509 27
GCF_000411495.1_Stre_sp_HPH0547_V1 Streptomyces9sp.9HPH05479 SAMN02596979 7887973 6619 0.711951513 29
GCF_000415505.1_STAFG Streptomyces9afghaniensis97729 SAMN01893930 9848774 9014 0.700885143 51
GCF_000424765.1_ASM42476v1 Streptomyces9sp.9CNT3189 SAMN02440809 7284201 6186 0.718784177 35
GCF_000424785.1_ASM42478v1 Streptomyces9sp.9CNT3609 SAMN02440677 7720660 6575 0.71321633 25
GCF_000424805.1_ASM42480v1 Streptomyces9sp.9CNQ8659 SAMN02441151 8612798 7321 0.726776843 44
GCF_000424825.1_ASM42482v1 Streptomyces9sp.9CNH2879 SAMN02441484 6788521 6106 0.717877321 29
GCF_000424845.1_ASM42484v1 Streptomyces9sp.9TAA0409 SAMN02440678 5311812 4696 0.716196135 23
GCF_000424945.1_ASM42494v1 Streptomyces9sp.9142MFCol3.19 SAMN02440811 9726042 8587 0.702024246 30
GCF_000424965.1_ASM42496v1 Streptomyces9sp.9TAA2049 SAMN02441152 6582155 5492 0.703262174 34
GCF_000426165.1_ASM42616v1 Streptomyces9sp.9TAA4869 SAMN02440637 7069448 6147 0.691894643 25
GCF_000426325.1_ASM42632v1 Streptomyces9sp.9CNS6069 SAMN02441534 5932917 5110 0.721505535 37
GCF_000482585.1_ASM48258v1 Streptomyces9sp.9CNQ3299 SAMN02441102 7185226 6056 0.721616886 34
GCF_000514055.1_ASM51405v1 Streptomyces9griseolus9 SAMN02597209 7295516 6223 0.712452252 33
GCF_000514715.1_ASM51471v1 Streptomyces9sp.9CNH0999 SAMN02597242 8138922 7031 0.728665249 39
GCF_000514995.1_ASM51499v1 Streptomyces9sp.9CNT3719 SAMN02597256 8597758 7380 0.725016174 42
GCF_000515055.1_ASM51505v1 Streptomyces9sp.9CNR6989 SAMN02597259 7496553 6316 0.716413864 41
GCF_000611795.1_Tu61761.0 Streptomyces9sp.9Tu961769 SAMN02666786 8820073 7913 0.674748744 37
GCF_000647875.1_ASM64787v1 Streptomyces9sp.9SolWspMPBsol2th9 SAMN02951871 7654598 6370 0.71596084 47
GCF_000686765.1_ASM68676v1 Streptomyces9sp.9UNC401CLCol9 SAMN02743369 7336835 6580 0.71372133 14
GCF_000701285.1_ASM70128v1 Streptomyces9sp.9CNQB5259 SAMN02841146 8645224 7217 0.72468135 43
GCF_000701325.1_ASM70132v1 Streptomyces9sp.9URHA00419 SAMN02841147 8015544 7033 0.713940637 43
GCF_000702365.1_ASM70236v1 Streptomyces9sp.9CNS6549 SAMN02841233 8340747 7198 0.707714899 52
GCF_000709915.1_JSD Streptomyces9griseorubens9 SAMN02715572 7668630 6842 0.708859269 24
GCF_000716025.1_ASM71602v1 Streptomyces9baarnensis9 SAMN02645350 8227069 7191 0.704005573 46
GCF_000716215.1_ASM71621v1 Streptomyces9resistomycificus9 SAMN02645381 9462133 9440 0.673110186 26
GCF_000721935.1_ASM72193v1 Streptomyces9sp.9NRRL9WCB35499 SAMN02645425 7312232 7490 0.674280474 24
GCF_000721945.1_ASM72194v1 Streptomyces9sp.9NRRL9WCB37749 SAMN02645406 9604196 8723 0.69734443 38
GCF_000721955.1_ASM72195v1 Streptomyces9sp.9NRRL9SB4819 SAMN02645428 8360088 8249 0.679080382 33
GCF_000722015.1_ASM72201v1 Streptomyces9sp.9NRRL9SB4749 SAMN02645436 8102445 7216 0.698475345 36
GCF_000722185.1_ASM72218v1 Streptomyces9sp.9NRRL9SB159 SAMN02645461 7756758 7547 0.670178097 32
GCF_000725465.1_Doro.v1.0 Streptomyces9bicolor9 SAMN02645269 9624527 8585 0.696207378 38
GCF_000725475.1_Doro.v1.0 Streptomyces9durhamensis9 SAMN02645292 9312374 8434 0.708006558 53CF_000725475.1_Doro.v1.0 Strepto yces8durha ensis8 SA 02645292 9312374 8434 0.708006558 53
GCF_000725495.1_Doro.v1.0 Streptomyces8aureus8 SAMN02645331 9928053 8591 0.706651238 30
GCF_000725545.1_Doro.v1.0 Streptomyces8exfoliatus8 SAMN02645344 7874957 6992 0.710409976 35
GCF_000725555.1_Doro.v1.0 Streptomyces8erythrochromogenes8 SAMN02645335 7507524 6788 0.712971487 30
GCF_000725565.1_Doro.v1.0 Streptomyces8peucetius8 SAMN02645417 9528656 8208 0.710140352 61
GCF_000725575.1_Doro.v1.0 Streptomyces8ruber8 SAMN02645371 9657428 8090 0.712995513 44
GCF_000725625.1_Doro.v1.0 Streptomyces8sp.8NRRL8FM66768 SAMN02645487 8120997 7057 0.714547085 26
GCF_000725635.1_Doro.v1.0 Streptomyces8sp.8NRRL8BM32538 SAMN02645459 6992994 5998 0.725481924 30
GCF_000725645.1_Doro.v1.0 Streptomyces8sp.8NRRL8FM56358 SAMN02645452 7879835 6886 0.717233013 34
GCF_000725655.1_Doro.v1.0 Streptomyces8sp.8NRRL8SM18968 SAMN02645516 10771060 9649 0.707975966 46
GCF_000725705.1_Doro.v1.0 Streptomyces8sp.8NRRL8SM6238 SAMN02645523 7717870 6703 0.707406858 45
GCF_000725715.1_Doro.v1.0 Streptomyces8sp.8NRRL8WCM37198 SAMN02645410 6572375 5692 0.737249946 27
GCF_000725725.1_Doro.v1.0 Streptomyces8xanthophaeus8 SAMN02645336 8568408 7693 0.713471393 38
GCF_000725745.1_Doro.v1.0 Streptomyces8aureocirculatus8 SAMN02645372 9315748 8063 0.703230094 49
GCF_000725795.1_Doro.v1.0 Streptomyces8seoulensis8 SAMN02645290 6383407 5772 0.710258917 29
GCF_000725805.1_Doro.v1.0 Streptomyces8xanthophaeus8 SAMN02645271 8621934 7735 0.713398081 38
GCF_000738695.1_ASM73869v1 Streptomyces8scabiei8 SAMN02927997 10476708 9006 0.696932248 47
GCF_000738715.1_ASM73871v1 Streptomyces8scabiei8 SAMN02927996 10010251 8670 0.705815557 44
GCF_000739045.1_ASM73904v1 Streptomyces8luteus8 SAMN02803977 7829169 7088 0.70744062 33
GCF_000745715.1_ASM74571v1 Streptomyces8mirabilis8 SAMN02787133 10042643 9023 0.699089309 37
GCF_000746395.1_ASM74639v1 Streptomyces8mirabilis8 SAMN02787054 11452267 10473 0.694126098 34
GCF_000800535.1_ASM80053v1 Streptomyces8sp.8M108 SAMN02781121 7207169 6157 0.721071575 40
GCF_000805335.1_ASM80533v1 Streptomyces8sp.8CT348 SAMN03144576 8066430 7140 0.704216269 32
GCF_000938975.1_Siranensis Streptomyces8iranensis8 SAMEA2519540 12130542 9791 0.699812501 67i i :i i :
GCF_000958545.1_ASM95854v1 Streptomyces:sp.:FxanaA7: SAMN02745829 10443568 8923 0.704623986 50
GCF_000964305.1_ASM96430v1 Streptomyces:sp.:WMMB:714: SAMN02745759 6594919 5547 0.708131133 32
GCF_000968255.1_ASM96825v1 Streptomyces:avermitilis:MAG4680:=:NBRC:14893: SAMN03390037 10468295 9164 0.6968204 64
GCF_001189015.1_ASM118901v1 Streptomyces:acidiscabies: SAMN02927998 9978361 8850 0.697783574 57
GCF_001189025.1_ASM118902v1 Streptomyces:europaeiscabiei: SAMN02927995 8624932 7477 0.707349175 46
GCF_001189035.1_ASM118903v1 Streptomyces:stelliscabiei: SAMN02927999 10419108 9155 0.701662963 39
GCF_001513955.1_ASM151395v1 Streptomyces:pseudovenezuelae: SAMN04193342 9639743 8548 0.69955204 38. 8 l 8 .
GCF_001513965.1_ASM151396v1 Streptomyces8cellostaticus8 SAMN04193341 9835283 8639 0.697934041 60
GCF_001513975.1_ASM151397v1 Streptomyces8curacoi8 SAMN04193339 8412249 7434 0.700249595 33
GCF_001513985.1_ASM151398v1 Streptomyces8griseorubiginosus8 SAMN04193340 9555958 8418 0.700112036 28
 63 
 
GCF_001513985.1_ASM151398v1 Streptomyces9griseorubiginosus9 SAMN04193340 9555958 8418 0.700112036 28
GCF_001514035.1_ASM151403v1 Streptomyces9yokosukanensis9 SAMN04193343 10159272 9001 0.700192362 57
GCF_001514055.1_ASM151405v1 Streptomyces9corchorusii9 SAMN04193345 10309547 9099 0.709716632 45
GCF_001514065.1_ASM151406v1 Streptomyces9antibioticus9 SAMN04193346 10145887 9121 0.698086243 33
GCF_001514125.1_ASM151412v1 Streptomyces9longwoodensis9 SAMN04193348 8363623 7296 0.719957247 41
GCF_001514135.1_ASM151413v1 Streptomyces9avermitilis9 SAMN04193349 8950231 7831 0.696530337 47
GCF_001514145.1_ASM151414v1 Streptomyces9canus9 SAMN04193350 11570753 10424 0.692119059 35
GCF_001514195.1_ASM151419v1 Streptomyces9griseorubiginosus9 SAMN04193351 9866755 8652 0.699059599 26
GCF_001514205.1_ASM151420v1 Streptomyces9griseoruber9 SAMN04193353 10217879 9089 0.704601928 44
GCF_001514215.1_ASM151421v1 Streptomyces9bungoensis9 SAMN04193354 8408982 7356 0.713962957 42
GCF_001514235.1_ASM151423v1 Streptomyces9caeruleatus9 SAMN04193355 10290495 9010 0.697617111 50
GCF_001514265.1_ASM151426v1 Streptomyces9resistomycificus9 SAMN04193356 9179735 8130 0.700657055 32
GCF_001514285.1_ASM151428v1 Streptomyces9sp.9DSM9153249 SAMN04193352 9379038 8111 0.708084579 45
GCF_001514305.1_ASM151430v1 Streptomyces9sp.9RV159 SAMN04193357 10773767 9955 0.690497921 36
GCF_001543925.1_ASM154392v1 Streptomyces9thermoautotrophicus9 SAMN02911631 5014930 4446 0.640457805 9
GCF_001705785.1_ASM170578v1 Streptomyces9hygroscopicus9subsp.9hygroscopicus9 SAMN04870507 10242506 8362 0.711740345 58
GCF_001865315.1_ASM186531v1 Streptomyces9sampsonii9 SAMN04338613 7261502 6313 0.722447504 28
GCF_001865795.1_ASM186579v1 Streptomyces9albidoflavus9 SAMN05712738 6952079 5996 0.725227745 31
GCF_001888885.1_ASM188888v1 Streptomyces9viridifaciens9 SAMN06016489 9560682 8657 0.709034387 50
GCF_002114065.1_ASM211406v1 Streptomyces9griseofuscus9 SAMN06236792 8577566 7512 0.70755664 48
GCF_002188335.1_ASM218833v1 Streptomyces9sp.9CS1599 SAMN06837585 8406443 7419 0.712786789 30
GCF_002188345.1_ASM218834v1 Streptomyces9sp.9CS0579 SAMN06835239 8351125 7015 0.708515448 47
GCF_002188355.1_ASM218835v1 Streptomyces9sp.9CS2279 SAMN06837627 7059316 5878 0.724296722 29
GCF_002188365.1_ASM218836v1 Streptomyces9sp.9CS1139 SAMN06835261 8728089 7658 0.712841671 36
GCF_002217715.1_ASM221771v1 Streptomyces9sp.9SS079 SAMN07275199 7603850 6787 0.707704737 34
GCF_002705665.1_ASM270566v1 Streptomyces9sp.9SceaMPOe969 SAMN02746030 9563454 8263 0.699472656 50
GCF_002705685.1_ASM270568v1 Streptomyces9sp.9NcostOT6TO19 SAMN02746059 8099030 7069 0.704337158 44
GCF_002705695.1_ASM270569v1 Streptomyces9sp.9OspMPOM459 SAMN02746034 7407922 6419 0.711882175 33
GCF_002705725.1_ASM270572v1 Streptomyces9sp.9AmelKGOD39 SAMN05005151 7969495 6853 0.71231047 51
GCF_002705975.1_ASM270597v1 Streptomyces9sp.9AmelKGOE11A9 SAMN05005153 8386301 7074 0.712818288 41
GCF_002711365.1_ASM271136v1 Streptomyces9sp.9LamerLSO3169 SAMN05005155 7866187 6956 0.706744005 31
GCF_002911015.1_ASM291101v1 Streptomyces9populi9 SAMN08166457 9587301 8338 0.70778248 42
GCF_002940705.1_ASM294070v1 Streptomyces9sp.9469 SAMN06211538 8996216 7960 0.703506217 38
GCF_002954775.1_ASM295477v1 Streptomyces9geranii9 SAMN08162815 10196536 8793 0.696376119 35
GCF_003024195.1_ASM302419v1 Streptomyces9sp.9A2179 SAMN08730466 10239468 8571 0.69829054 48
GCF_003024215.1_ASM302421v1 Streptomyces9sp.9CS1499 SAMN08637882 7775341 6799 0.706496028 41
GCF_003116675.1_ASM311667v1 Streptomyces9sp.9CS090A9 SAMN08896244 8298873 7274 0.705747213 43
GCF_003116685.1_ASM311668v1 Streptomyces9sp.9CS0149 SAMN08895276 8460409 7328 0.704934074 40
GCF_003116715.1_ASM311671v1 Streptomyces9sp.9CS081A9 SAMN08896069 7213245 6438 0.721857241 30
GCF_003116725.1_ASM311672v1 Streptomyces9sp.9CS065A9 SAMN08895617 7190709 6213 0.707475654 34
GCF_003116755.1_ASM311675v1 Streptomyces9sp.9CS1319 SAMN08896432 8010476 6887 0.706527746 47
GCF_003116775.1_ASM311677v1 Streptomyces9sp.9CS1479 SAMN08896652 7877244 6932 0.706544245 39
GCF_003116795.1_ASM311679v1 Streptomyces9sp.9CS2079 SAMN08896841 6664327 5835 0.716349528 22
GCF_003265665.1_ASM326566v1 Streptomyces9qinglanensis9 SAMN02841245 7185643 6164 0.716829973 29
GCF_003574445.1_ASM357444v1 Streptomyces9sp.9YIM91300019 SAMN09558212 8039857 7009 0.697547598 25
GCF_000179195.1_ASM17919v1 Streptomyces9sp.9SA3_actG9 SAMN02441809 7443083 6500 0.724157565 26
GCF_000179215.1_ASM17921v1 Streptomyces9sp.9SA3_actF9 SAMN02441794 7217762 6662 0.721773458 20
GCF_000239075.1_ASM23907v2 Streptomyces9sp.9W0079 SAMN02472142 9057348 8056 0.704739648 56
GCF_000241835.1_ASM24183v2 Streptomyces9coelicoflavus9ZG06569 SAMN02471212 8478314 7564 0.708876872 35
GCF_000258595.1_Ssomaliensis1 Streptomyces9somaliensis9DSM9407389 SAMN02471954 5176903 4614 0.73206715 25
GCF_000259895.1_ASM25989v1 Streptomyces9sp.9TOR32099 SAMN02469879 8013370 7213 0.717209783 38
GCF_000262345.1_Streptomyces_sulphureus_L180_version_1.0 Streptomyces9xiaopingdaonensis9 SAMN02469700 6466982 5588 0.71326848 31
GCF_000280905.1_ASM28090v1 Streptomyces9sp.9AA15299 SAMN02470041 7285977 6225 0.71848167 35
GCF_000297635.1_ASM29763v1 Streptomyces9sp.9AA05399 SAMN02470042 5768564 5138 0.72020903 26
GCF_000317595.1_Sipom9103v1.0 Streptomyces9ipomoeae991O039 SAMN02436560 10403856 9070 0.69298278 54
GCF_000331185.1_ASM33118v1 Streptomyces9rimosus9subsp.9rimosus9ATCC9109709 SAMN02471950 9501372 8420 0.709900803 70
GCF_000332625.1_STVIR_1.0 Streptomyces9viridochromogenes9Tue579 SAMN00811239 9687428 8627 0.700876303 44
GCF_000342345.1_Whole_genome_assembly Streptomyces9gancidicus9BKS913O159 SAMN02469981 7300479 6559 0.717266792 25
GCF_000367365.1_ASM36736v1 Streptomyces9prunicolor9NBRC9130759 SAMD00041815 11760649 10786 0.688713914 35
GCF_000375625.1_ASM37562v1 Streptomyces9sp.9FxanaC19 SAMN02440408 7846427 6840 0.702423779 32
GCF_000375725.1_ASM37572v1 Streptomyces9sp.9LaPpAHO959 SAMN02441060 7564593 6657 0.710105252 33
GCF_000382745.1_ASM38274v1 Streptomyces9sp.9DvalAAO839 SAMN02441645 7452860 6545 0.708919756 27
GCF_000403765.2_SAlb2 Streptomyces9albulus9CCRC9118149 SAMN02471960 9304371 8150 0.713567425 53
GCF_000404005.1_Streptomyces_sp._FXJ7.023 Streptomyces9sp.9FXJ7.0239 SAMN02470037 8215649 7167 0.715887863 44
GCF_000414115.1_STRAU Streptomyces9aurantiacus9JA945709 SAMN01893928 8762126 7606 0.710792113 57
GCF_000470535.1_STREPTOMYCES1 Streptomyces9sp.9AW19M429 SAMEA2272178 8008792 7169 0.696985366 39
GCF_000498935.1_HCCB10043 Streptomyces9sp.9HCCB100439 SAMN02470969 6687533 6425 0.700643576 29
GCF_000504065.1_Velvet_for_version_02_of_Streptomyces_albulus_PDO1 Streptomyces9albulus9PDO19 SAMN02470570 9427044 8269 0.714044302 55
GCF_000518045.1_StrExf1.0 Streptomyces9exfoliatus9DSM9416939 SAMN02597357 8847593 8028 0.709363501 36
GCF_000590515.1_Streptomyces_sp._PRh5_version1.0 Streptomyces9sp.9PRh59 SAMN02951919 11084188 9255 0.702123946 82
GCF_000698495.1_NTK937 Streptomyces9sp.9NTK99379 SAMN02725841 7444861 6445 0.710175109 31
GCF_000716435.1_ASM71643v1 Streptomyces9xylophagus9 SAMN02645193 11386825 10217 0.689378644 40
GCF_000716445.1_ASM71644v1 Streptomyces9wedmorensis9 SAMN02645189 9380839 8193 0.711758142 38
GCF_000716455.1_ASM71645v1 Streptomyces9sp.9NRRL9BO112539 SAMN02645192 8864755 7585 0.71160108 55
GCF_000716515.1_ASM71651v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02645202 9386539 8062 0.710686169 60
GCF_000716525.1_ASM71652v1 Streptomyces9graminis9 SAMN02645198 7867602 6599 0.717746431 37
GCF_000716535.1_ASM71653v1 Streptomyces9flaveolus9 SAMN02645200 10347389 9210 0.709478489 45
GCF_000716605.1_ASM71660v1 Streptomyces9sp.9NRRL9FO5259 SAMN02645279 10943254 9702 0.693643664 38
GCF_000716615.1_ASM71661v1 Streptomyces9sp.9NRRL9FO66749 SAMN02645280 8220191 7138 0.714217437 26
GCF_000716625.1_ASM71662v1 Streptomyces9bikiniensis9 SAMN02645284 7391008 6559 0.721691156 32
GCF_000716675.1_ASM71667v1 Streptomyces9alboflavus9 SAMN02645294 9717375 8193 0.712842264 43
GCF_000716685.1_ASM71668v1 Streptomyces9virginiae9 SAMN02645303 9185056 8381 0.708205286 45
GCF_000716745.1_ASM71674v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02645311 8415612 7379 0.710862944 55
GCF_000716815.1_ASM71681v1 Streptomyces9olivaceus9 SAMN02645191 7397654 6475 0.702530588 33
GCF_000716845.1_ASM71684v1 Streptomyces9capuensis9 SAMN02645194 9329832 8178 0.710751748 58
GCF_000716875.1_ASM71687v1 Streptomyces9novaecaesareae9 SAMN02645195 7427993 6451 0.720786192 48
GCF_000716935.1_ASM71693v1 Streptomyces9alboviridis9 SAMN02645199 8571085 7646 0.703699231 46
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GCF_000716935.1_ASM71693v1 Streptomyces:alboviridis: SAMN02645199 8571085 7646 0.703699231 46
GCF_000716945.1_ASM71694v1 Streptomyces:albus:subsp.:albus: SAMN02645201 7978071 7002 0.70826082 38
GCF_000717015.1_ASM71701v1 Streptomyces:brasiliensis: SAMN02645206 7781346 6730 0.71796006 35
GCF_000717055.1_ASM71705v1 Streptomyces:iakyrus: SAMN02645283 9127873 8360 0.703311716 35
GCF_000717065.1_ASM71706v1 Streptomyces:fulvoviridis: SAMN02645282 7398515 6474 0.702540227 34
GCF_000717105.1_ASM71710v1 Streptomyces:anulatus: SAMN02645293 8402693 7589 0.703791679 42
GCF_000717215.1_ASM71721v1 Streptomyces:vinaceus: SAMN02645316 8062003 7041 0.715238432 38
GCF_000717245.1_ASM71724v1 [Kitasatospora]:papulosa: SAMN02645317 7568795 6612 0.700854184 33
GCF_000717345.1_ASM71734v1 Streptomyces:lydicus: SAMN02645328 8181439 7246 0.711630142 38
GCF_000717375.1_ASM71737v1 Streptomyces:griseus:subsp.:griseus: SAMN02645337 7202597 6295 0.724219434 35
GCF_000717595.1_ASM71759v1 Streptomyces:flavochromogenes: SAMN02645343 8884918 7884 0.709255543 39
GCF_000717635.1_ASM71763v1 Streptomyces:sp.:NRRL:BP12105: SAMN02645351 8119530 7063 0.714504211 26
GCF_000717645.1_ASM71764v1 Streptomyces:californicus: SAMN02645354 7785545 6738 0.7179122 36
GCF_000717655.1_ASM71765v1 Streptomyces:katrae: SAMN02645353 8582897 7697 0.708687969 44
GCF_000717665.1_ASM71766v1 Streptomyces:floridae: SAMN02645357 7896344 6734 0.717576579 37
GCF_000717715.1_ASM71771v1 Streptomyces:sp.:NRRL:BP24484: SAMN02645363 8863434 8042 0.728968659 33
GCF_000717725.1_ASM71772v1 Streptomyces:pyridomyceticus: SAMN02645379 6312990 5480 0.72024104 32
GCF_000717735.1_ASM71773v1 Streptomyces:griseoluteus: SAMN02645385 8103281 7368 0.709653507 37
GCF_000717795.1_ASM71779v1 Streptomyces:griseus:subsp.:griseus: SAMN02645398 8329687 7103 0.713408675 49
GCF_000717805.1_ASM71780v1 Streptomyces:sp.:NRRL:WCP3702: SAMN02645409 9519524 8317 0.71062849 63
GCF_000717815.1_ASM71781v1 Streptomyces:rimosus:subsp.:rimosus: SAMN02645403 9593305 8242 0.710352967 64
GCF_000717845.1_ASM71784v1 Streptomyces:violaceoruber: SAMN02645411 8489968 7553 0.713606143 32
GCF_000717875.1_ASM71787v1 Streptomyces:sp.:NRRL:SP455: SAMN02645426 8232740 7390 0.700645656 38
GCF_000717895.1_ASM71789v1 Streptomyces:sp.:NRRL:WCP3744: SAMN02645416 9962335 8800 0.710449847 41
GCF_000717915.1_ASM71791v1 Streptomyces:sp.:NRRL:SP244: SAMN02645430 7096454 6266 0.714405266 28
GCF_000717925.1_ASM71792v1 Streptomyces:sp.:NRRL:SP241: SAMN02645431 8768483 7870 0.711801275 48
GCF_000717945.1_ASM71794v1 Streptomyces:sp.:NRRL:SP920: SAMN02645438 8247846 7292 0.702509327 49
GCF_000717965.1_ASM71796v1 Streptomyces:purpeochromogenes: SAMN02645443 7887122 6844 0.717495386 38
GCF_000717995.1_ASM71799v1 Streptomyces:violaceorubidus: SAMN02645210 7651467 6711 0.713364005 32
GCF_000718135.1_ASM71813v1 Streptomyces:cyaneofuscatus: SAMN02645238 7899007 7012 0.7066959 39
GCF_000718155.1_ASM71815v1 Streptomyces:lavendulae:subsp.:lavendulae: SAMN02645248 8466185 7634 0.718136577 39
GCF_000718175.1_ASM71817v1 Streptomyces:exfoliatus: SAMN02645253 8618209 7590 0.708300093 35
GCF_000718205.1_ASM71820v1 Streptomyces:griseus:subsp.:rhodochrous: SAMN02645256 8030720 6972 0.717502589 37
GCF_000718235.1_ASM71823v1 Streptomyces:griseus:subsp.:rhodochrous: SAMN02645257 7836951 6670 0.717866922 37
GCF_000718245.1_ASM71824v1 Streptomyces:californicus: SAMN02645258 7783343 6730 0.71796499 35
GCF_000718295.1_ASM71829v1 Streptomyces:capuensis: SAMN02645264 9439884 8297 0.710379159 58
GCF_000718305.1_ASM71830v1 Streptomyces:niger: SAMN02645268 8485418 7435 0.708248929 34
GCF_000718375.1_ASM71837v1 Streptomyces:sp.:NRRL:FP2305: SAMN02645274 8604831 7526 0.714786686 45
GCF_000718455.1_ASM71845v1 Streptomyces:globisporus:subsp.:globisporus: SAMN02645339 7454528 6625 0.707665618 38
GCF_000718525.1_ASM71852v1 Streptomyces:griseus:subsp.:griseus: SAMN02645348 7429044 6559 0.729783051 27
GCF_000718595.1_ASM71859v1 Streptomyces:bikiniensis: SAMN02645375 7389938 6562 0.721734424 32
GCF_000718615.1_ASM71861v1 Streptomyces:purpeochromogenes: SAMN02645387 7996821 6946 0.717107664 38
GCF_000718625.1_ASM71862v1 Streptomyces:lavenduligriseus: SAMN02645384 8716851 7744 0.713958156 52
GCF_000718675.1_ASM71867v1 Streptomyces:rimosus:subsp.:rimosus: SAMN02645396 9520128 8251 0.709676318 58
GCF_000718695.1_ASM71869v1 Streptomyces:puniceus: SAMN02645397 8179821 7087 0.716211139 39
GCF_000718705.1_ASM71870v1 Streptomyces:lavendulae:subsp.:lavendulae: SAMN02645401 8354185 7490 0.715234935 44
GCF_000718715.1_ASM71871v1 Streptomyces:rimosus:subsp.:rimosus: SAMN02645400 9551326 8460 0.710610966 77
GCF_000718755.1_ASM71875v1 Streptomyces:rimosus:subsp.:rimosus: SAMN02645402 8603240 7316 0.711991602 55
GCF_000718775.1_ASM71877v1 Streptomyces:sp.:NRRL:SP31: SAMN02645408 8737340 7396 0.719207023 57
GCF_000718815.1_ASM71881v1 Streptomyces:sp.:NRRL:WCP3703: SAMN02645414 9588181 8390 0.710517235 62
GCF_000718835.1_ASM71883v1 Streptomyces:rimosus:subsp.:rimosus: SAMN02645419 8413065 7372 0.710400596 48
GCF_000718855.1_ASM71885v1 Streptomyces:lavendulae:subsp.:lavendulae: SAMN02645420 8948005 7841 0.710628399 61
GCF_000718865.1_ASM71886v1 Streptomyces:rimosus:subsp.:rimosus: SAMN02645421 8273726 7281 0.710825062 44
GCF_000718895.1_ASM71889v1 Streptomyces:rimosus:subsp.:rimosus: SAMN02645422 8734407 7603 0.711217121 60
GCF_000718915.1_ASM71891v1 Streptomyces:sp.:NRRL:WCP3540: SAMN02645429 8031299 6968 0.717468936 37
GCF_000718935.1_ASM71893v1 Streptomyces:sp.:NRRL:SP237: SAMN02645433 8825688 8014 0.707827445 37
GCF_000718945.1_ASM71894v1 Streptomyces:sp.:NRRL:SP813: SAMN02645439 10480439 9494 0.701246739 29
GCF_000718955.1_ASM71895v1 Streptomyces:sp.:NRRL:SP575: SAMN02645442 8686896 7807 0.709120961 35
GCF_000719015.1_ASM71901v1 Streptomyces:ruber: SAMN02645211 9594095 8151 0.712633043 46
GCF_000719035.1_ASM71903v1 Streptomyces:griseus:subsp.:rhodochrous: SAMN02645212 8086515 7013 0.71722667 37
GCF_000719105.1_ASM71910v1 Streptomyces:sclerotialus: SAMN02645221 7022382 6219 0.70633236 23
GCF_000719135.1_ASM71913v1 Streptomyces:avicenniae: SAMN02645236 6480326 5934 0.725463124 23
GCF_000719185.1_ASM71918v1 Streptomyces:rimosus:subsp.:rimosus: SAMN02645244 9085517 7734 0.711923507 62
GCF_000719195.1_ASM71919v1 Streptomyces:puniceus: SAMN02645252 8175879 7079 0.716217503 39
GCF_000719255.1_ASM71925v1 Streptomyces:varsoviensis: SAMN02645265 8595093 7198 0.715012902 50
GCF_000719285.1_ASM71928v1 Streptomyces:bicolor: SAMN02645270 9481884 8435 0.696535316 38
GCF_000719335.1_ASM71933v1 Streptomyces:sp.:NRRL:SP87: SAMN02645444 8150698 6899 0.726012964 41
GCF_000719345.1_ASM71934v1 Streptomyces:sp.:NRRL:FP2664: SAMN02645275 7984681 7056 0.71241692 39
GCF_000719355.1_ASM71935v1 Streptomyces:griseus:subsp.:griseus: SAMN02645278 7849817 6965 0.706517956 41
GCF_000719365.1_ASM71936v1 Streptomyces:sp.:NRRL:SP1448: SAMN02645447 8960230 7797 0.707033454 40
GCF_000719415.1_ASM71941v1 Streptomyces:sp.:NRRL:BP5680: SAMN02645449 8022182 7076 0.719977682 40
GCF_000719425.1_ASM71942v1 Streptomyces:sp.:NRRL:FP5639: SAMN02645453 7940770 6723 0.716740957 36
GCF_000719435.1_ASM71943v1 Streptomyces:griseus:subsp.:griseus: SAMN02645456 7102828 6143 0.725320311 32
GCF_000719475.1_ASM71947v1 Streptomyces:sp.:NRRL:FP5630: SAMN02645457 7063039 5926 0.720027139 29
GCF_000719495.1_ASM71949v1 Streptomyces:griseus:subsp.:griseus: SAMN02645463 7341200 6262 0.724653502 46
GCF_000719505.1_ASM71950v1 Streptomyces:sp.:NRRL:BP3229: SAMN02645458 8694115 7641 0.701999858 31
GCF_000719555.1_ASM71955v1 Streptomyces:sp.:NRRL:FP5727: SAMN02645466 7945813 7165 0.722885203 27
GCF_000719575.1_ASM71957v1 Streptomyces:sp.:NRRL:SP1824: SAMN02645468 8826443 7944 0.686892818 21
GCF_000719585.1_ASM71958v1 Streptomyces:sp.:NRRL:FP5681: SAMN02645469 7821598 6659 0.718085548 37
GCF_000719605.1_ASM71960v1 Streptomyces:sp.:NRRL:SP1813: SAMN02645470 8474751 7576 0.699941252 38
GCF_000719625.1_ASM71962v1 Streptomyces:sp.:NRRL:BP1322: SAMN02645474 8351943 7506 0.715224562 44
GCF_000719655.1_ASM71965v1 Streptomyces:sp.:NRRL:BP1381: SAMN02645475 8054921 6895 0.716379208 37
GCF_000719665.1_ASM71966v1 Streptomyces:sp.:NRRL:FP5555: SAMN02645478 7943020 6941 0.715864809 33
GCF_000719695.1_ASM71969v1 Streptomyces:sp.:NRRL:FP6131: SAMN02645482 9138054 7698 0.72867222 62
GCF_000719705.1_ASM71970v1 Streptomyces:sp.:NRRL:SP350: SAMN02645483 8783146 7800 0.721442537 36
GCF_000719735.1_ASM71973v1 Streptomyces:sp.:NRRL:FP5917: SAMN02645485 8011469 6847 0.716772847 36
GCF_000719745.1_ASM71974v1 Streptomyces:sp.:NRRL:FP6677: SAMN02645484 8117720 7052 0.714515818 26
 65 
 
GCF_000719745.1_ASM71974v1 Streptomyces9sp.9NRRL9F=66779 SAMN02645484 8117720 7052 0.714515818 26
GCF_000719775.1_ASM71977v1 Streptomyces9sp.9NRRL9F=51359 SAMN02645486 8023791 6930 0.708565342 26
GCF_000719785.1_ASM71978v1 Streptomyces9sp.9NRRL9S=13149 SAMN02645489 7489829 6674 0.71694727 26
GCF_000719815.1_ASM71981v1 Streptomyces9sp.9NRRL9F=50659 SAMN02645490 7062954 6156 0.725899064 29
GCF_000719855.1_ASM71985v1 Streptomyces9sp.9NRRL9F=44749 SAMN02645496 7882256 7084 0.716526454 32
GCF_000719895.1_ASM71989v1 Streptomyces9sp.9NRRL9F=27999 SAMN02645500 6114646 5584 0.707706628 21
GCF_000719915.1_ASM71991v1 Streptomyces9sp.9NRRL9F=28909 SAMN02645501 5942201 5377 0.712008668 28
GCF_000719925.1_ASM71992v1 Streptomyces9sp.9NRRL9F=22029 SAMN02645502 7806945 6651 0.718094518 37
GCF_000720055.1_ASM72005v1 Streptomyces9sp.9NRRL9F=32189 SAMN02645510 8078043 6940 0.716638428 40
GCF_000720065.1_ASM72006v1 Streptomyces9sp.9NRRL9F=32739 SAMN02645509 8249819 7067 0.715961524 40
GCF_000720115.1_ASM72011v1 Streptomyces9sp.9NRRL9F=25809 SAMN02645512 8445760 7743 0.709185133 39
GCF_000720135.1_ASM72013v1 Streptomyces9sp.9NRRL9S=10229 SAMN02645515 8915148 7966 0.71427242 52
GCF_000720145.1_ASM72014v1 Streptomyces9sp.9NRRL9F=27479 SAMN02645513 8726004 7834 0.713927762 42
GCF_000720175.1_ASM72017v1 Streptomyces9sp.9NRRL9S=3379 SAMN02645518 9059583 8089 0.706120348 41
GCF_000720185.1_ASM72018v1 Streptomyces9sp.9NRRL9S=3409 SAMN02645519 8641367 7430 0.71932106 33
GCF_000720215.1_ASM72021v1 Streptomyces9sp.9NRRL9S=4759 SAMN02645522 8540499 7555 0.705672339 34
GCF_000720235.1_ASM72023v1 Streptomyces9sp.9NRRL9S=989 SAMN02645524 8203792 7345 0.715704208 43
GCF_000720255.1_ASM72025v1 Streptomyces9griseus9subsp.9griseus9 SAMN02645525 9889723 8821 0.698282365 47
GCF_000720295.1_ASM72029v1 Streptomyces9sp.9NRRL9WC=37259 SAMN02645528 10009878 8799 0.70943447 42
GCF_000720325.1_ASM72032v1 Streptomyces9sp.9NRRL9B=13479 SAMN02645333 10230785 8764 0.714756409 82
GCF_000720395.1_ASM72039v1 Streptomyces9flavovirens9 SAMN02645356 7670646 6752 0.701744835 34
GCF_000720405.1_ASM72040v1 Streptomyces9sp.9NRRL9B=240519 SAMN02645359 7539096 6566 0.702443581 40
GCF_000720475.1_ASM72047v1 Streptomyces9aureocirculatus9 SAMN02645370 9321142 8075 0.703201807 48
GCF_000720485.1_ASM72048v1 Streptomyces9ochraceiscleroticus9 SAMN02645378 8408570 7309 0.704833724 45
GCF_000720505.1_ASM72050v1 Streptomyces9sp.9NRRL9S=1469 SAMN02645377 8864045 8333 0.702756723 30
GCF_000720535.1_ASM72053v1 Streptomyces9halstedii9 SAMN02645380 7740838 6696 0.710310361 34
GCF_000720555.1_ASM72055v1 Streptomyces9sclerotialus9 SAMN02645383 8229908 7125 0.709942383 43
GCF_000720565.1_ASM72056v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02645394 9356233 8196 0.710707368 62
GCF_000720595.1_ASM72059v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02645395 8139309 6953 0.710244474 49
GCF_000720605.1_ASM72060v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02645399 9590596 8383 0.710499327 62
GCF_000720635.1_ASM72063v1 Streptomyces9sp.9NRRL9WC=37429 SAMN02645412 8744700 7718 0.719011051 50
GCF_000720645.1_ASM72064v1 Streptomyces9sp.9NRRL9S=3789 SAMN02645404 8160967 7513 0.712326697 38
GCF_000720675.1_ASM72067v1 Streptomyces9sp.9NRRL9WC=37959 SAMN02645413 7612017 6724 0.716845667 32
GCF_000720685.1_ASM72068v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02645418 8724291 7604 0.711193991 61
GCF_000720715.1_ASM72071v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02645424 9375207 8212 0.710825449 57
GCF_000720725.1_ASM72072v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02645423 9639708 8333 0.710933479 69
GCF_000720755.1_ASM72075v1 Streptomyces9flaveus9 SAMN02645427 10035419 8965 0.709920417 42
GCF_000720765.1_ASM72076v1 Streptomyces9sp.9NRRL9S=6469 SAMN02645435 10697161 9585 0.693800713 56
GCF_000720795.1_ASM72079v1 Streptomyces9sp.9NRRL9S=5159 SAMN02645437 8682129 7800 0.709133477 36
GCF_000720805.1_ASM72080v1 Streptomyces9violaceoruber9 SAMN02645441 10530441 9429 0.695889815 27
GCF_000720835.1_ASM72083v1 Streptomyces9achromogenes9subsp.9achromogenes9 SAMN02645217 8112410 7186 0.716476375 41
GCF_000720875.1_ASM72087v1 Streptomyces9globisporus9subsp.9globisporus9 SAMN02645220 8632737 7690 0.715156591 41
GCF_000720885.1_ASM72088v1 Streptomyces9albus9subsp.9albus9 SAMN02645223 7845903 6630 0.718327151 35
GCF_000720915.1_ASM72091v1 Streptomyces9albus9subsp.9albus9 SAMN02645227 8322459 7338 0.709001777 48
GCF_000720995.1_ASM72099v1 Streptomyces9celluloflavus9 SAMN02645237 8676521 7349 0.707979641 45
GCF_000721035.1_ASM72103v1 Streptomyces9griseus9subsp.9griseus9 SAMN02645239 7428938 6545 0.729850092 27
GCF_000721045.1_ASM72104v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02645240 9663214 8490 0.709723076 63
GCF_000721085.1_ASM72108v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02645245 10022470 8724 0.707735534 63
GCF_000721105.1_ASM72110v1 Streptomyces9cellulosae9 SAMN02645247 10063079 9004 0.697632015 31
GCF_000721155.1_ASM72115v1 Streptomyces9lavendulae9subsp.9lavendulae9 SAMN02645249 9588559 8384 0.710506138 63
GCF_000721175.1_ASM72117v1 Streptomyces9anulatus9 SAMN02645251 8402354 7596 0.703785432 43
GCF_000721185.1_ASM72118v1 Streptomyces9griseolus9 SAMN02645254 7537539 6497 0.710975311 32
GCF_000721205.1_ASM72120v1 Streptomyces9griseus9subsp.9rhodochrous9 SAMN02645255 8029964 6974 0.717491153 37
GCF_000721255.1_ASM72125v1 Streptomyces9avellaneus9 SAMN02645262 7409201 6464 0.718472431 42
GCF_000721265.1_ASM72126v1 Streptomyces9sp.9NRRL9F=51269 SAMN02645277 7186016 6342 0.711279792 25
GCF_000721305.1_ASM72130v1 Streptomyces9sp.9NRRL9S=18689 SAMN02645446 8745418 7171 0.723682401 54
GCF_000721335.1_ASM72133v1 Streptomyces9sp.9NRRL9S=18319 SAMN02645462 7716098 6692 0.717633554 33
GCF_000721365.1_ASM72136v1 Streptomyces9sp.9NRRL9F=56509 SAMN02645464 8346799 7378 0.715536165 36
GCF_000721415.1_ASM72141v1 Streptomyces9sp.9NRRL9F=57029 SAMN02645472 8032142 6933 0.716770998 39
GCF_000721435.1_ASM72143v1 Streptomyces9sp.9NRRL9F=55279 SAMN02645480 7787448 7004 0.716207273 25
GCF_000721445.1_ASM72144v1 Streptomyces9sp.9NRRL9F=50539 SAMN02645488 8825667 7200 0.721108434 47
GCF_000721455.1_ASM72145v1 Streptomyces9sp.9NRRL9F=66289 SAMN02645492 6714743 5882 0.72325189 19
GCF_000721495.1_ASM72149v1 Streptomyces9sp.9NRRL9F=51239 SAMN02645493 8804763 7514 0.723324241 45
GCF_000721515.1_ASM72151v1 Streptomyces9sp.9NRRL9F=51939 SAMN02645494 8903396 7929 0.724305636 32
GCF_000721525.1_ASM72152v1 Streptomyces9sp.9NRRL9F=33079 SAMN02645497 10353103 9218 0.709422931 44
GCF_000721535.1_ASM72153v1 Streptomyces9hygroscopicus9subsp.9hygroscopicus9 SAMN02645505 9919231 8197 0.711766631 64
GCF_000721575.1_ASM72157v1 Streptomyces9griseus9subsp.9griseus9 SAMN02645514 8042224 6902 0.71693447 39
GCF_000721595.1_ASM72159v1 Streptomyces9sp.9NRRL9S=3259 SAMN02645517 7558826 6632 0.702243871 37
GCF_000721605.1_ASM72160v1 Streptomyces9sp.9NRRL9S=379 SAMN02645520 8229831 7178 0.711166539 41
GCF_000721625.1_ASM72162v1 Streptomyces9sp.9NRRL9S=3849 SAMN02645521 8129609 7216 0.731633154 40
GCF_000721665.1_ASM72166v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02645530 9738851 8457 0.709629399 58
GCF_000721685.1_ASM72168v1 Streptomyces9mediolani9 SAMN02645531 8120903 7285 0.705623228 38
GCF_000721715.1_ASM72171v1 Streptomyces9sp.9NRRL9B=247209 SAMN02645235 9426194 8409 0.687762695 24
GCF_000725125.1_ASM72512v1 Streptomyces9toyocaensis9 SAMN02649413 7341014 6558 0.711509013 31
GCF_000743295.1_ASM74329v1 Streptomyces9sp.9JS019 SAMN02935386 7799375 7016 0.707343882 34
GCF_000772895.1_ASM77289v1 Streptomyces9galbus9 SAMN03031363 10053065 8797 0.701622591 39
GCF_000797385.1_ASM79738v1 Streptomyces9sp.9CNQ4319 SAMN03173244 7037644 6129 0.721761866 46
GCF_000816485.1_ASM81648v1 Streptomyces9sp.9MUSC91259 SAMN03070123 7656461 6782 0.691582057 40
GCF_000932225.2_ASM93222v2 Streptomyces9griseus9 SAMN03320103 7691616 6804 0.706480282 35
GCF_000935125.1_SNA_1.0 Streptomyces9natalensis9ATCC9274489 SAMN03074232 8651730 7817 0.697625284 38
GCF_000935135.2_ASM93513v2 Streptomyces9sp.9MNU779 SAMN03200165 8868350 7590 0.708167436 49
GCF_000955965.1_ASM95596v1 Streptomyces9variegatus9 SAMN03323307 8775595 7846 0.703608625 39
GCF_000956015.1_ASM95601v1 Streptomyces9sp.9NRRL9F=44289 SAMN03323306 7081441 6380 0.715855669 38
GCF_000961885.1_ASM96188v1 Streptomyces9rubellomurinus9 SAMN03323311 8610816 7461 0.727390479 60
GCF_000966955.1_ASM96695v1 Streptomyces9sp.9NRRL9S=4959 SAMN03323301 9063795 7922 0.726028439 63
GCF_000966965.1_ASM96696v1 Streptomyces9sp.9NRRL9S=1049 SAMN03323303 8171095 7346 0.715707664 50
GCF_000966975.1_ASM96697v1 Streptomyces9katrae9 SAMN03323304 8049424 7657 0.718975875 42
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GCF_000966975.1_ASM96697v1 Streptomyces9katrae9 SAMN03323304 8049424 7657 0.718975875 42
GCF_000967025.1_ASM96702v1 Streptomyces9sp.9NRRL9BD15689 SAMN03327474 3384006 2903 0.702443001 32
GCF_000968685.2_ASM96868v2 Streptomyces9antioxidans9 SAMN03445834 9118065 7491 0.705884417 64
GCF_000974985.2_ASM97498v2 Streptomyces9mangrovisoli9 SAMN03451686 9165825 7854 0.715660718 32
GCF_000980885.2_ASM98088v2 Streptomyces9malaysiense9 SAMN03445833 7963326 7013 0.713117538 46
GCF_000981895.1_ASM98189v1 Streptomyces9odonnellii9 SAMN03444664 8280224 7176 0.695182446 31
GCF_000988945.1_ASM98894v1 Streptomyces9europaeiscabiei9 SAMN03581172 9982072 8789 0.696424745 33
GCF_001005085.2_ASM100508v2 Streptomyces9humi9 SAMN03465092 10014215 8605 0.709086543 44
GCF_001005405.1_ASM100540v1 Streptomyces9scabiei9 SAMN03573919 9839340 8588 0.706133314 45
GCF_001014595.1_ASM101459v1 Streptomyces9sp.9KE19 SAMN03454257 6830045 5937 0.725249704 28
GCF_001044185.1_ASM104418v1 Streptomyces9sp.9HNS0549 SAMN03757723 7452852 6646 0.714753489 28
GCF_001047315.1_ASM104731v1 Streptomyces9leeuwenhoekii9 SAMN03769433 6876961 6033 0.719348618 28
GCF_001047325.1_ASM104732v1 Streptomyces9viridochromogenes9 SAMN02900581 10626331 9425 0.695157343 47
GCF_001049855.1_Wb2nD11_upgraded Streptomyces9sp.9Wb2nD119 SAMEA3373827 8228099 7600 0.701497692 44
GCF_001190165.1_ASM119016v1 Streptomyces9fradiae9 SAMN03890301 7667096 6442 0.719179435 26
GCF_001270485.1_P006IDBA Streptomyces9viridochromogenes9 SAMN02900583 10281308 9031 0.695489951 49
GCF_001270495.1_P009IDBA Streptomyces9viridochromogenes9 SAMN02900584 10292007 9133 0.695584587 47
GCF_001270505.1_ASM127050v1 Streptomyces9resistomycificus9 SAMN02900586 9182736 8155 0.701500681 34
GCF_001270515.1_P002IDBA1 Streptomyces9viridochromogenes9 SAMN02900582 9393980 8225 0.711695634 37
GCF_001270565.1_ASM127056v1 Streptomyces9virginiae9 SAMN02900589 8614071 7620 0.707340353 51
GCF_001270575.1_ASM127057v1 Streptomyces9decoyicus9 SAMN02900588 8586029 7612 0.700887974 35
GCF_001270585.1_ASM127058v1 Streptomyces9griseoflavus9 SAMN02900591 9068791 7725 0.711936435 64
GCF_001270635.1_ASM127063v1 Streptomyces9antibioticus9 SAMN02900593 9978861 8893 0.710145137 41
GCF_001270675.1_ASM127067v1 Streptomyces9griseus9subsp.9rhodochrous9 SAMN02900579 8029206 6974 0.717476251 37
GCF_001279005.1_ASM127900v1 Streptomyces9caelestis9 SAMN02900596 8622162 7544 0.71474642 43
GCF_001279015.1_ASM127901v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02900601 9222548 8073 0.71109862 58
GCF_001279025.1_ASM127902v1 Streptomyces9sp.9NRRL9WCD37019 SAMN02900602 9600052 8394 0.710480973 63
GCF_001279065.1_ASM127906v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02900603 9485098 8153 0.710174934 64
GCF_001279075.1_ASM127907v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02900604 9527802 8310 0.710630092 65
GCF_001279095.1_ASM127909v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02900607 9511651 8330 0.710402195 60
GCF_001279105.1_ASM127910v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02900605 9588334 8385 0.710493124 61
GCF_001279345.1_ASM127934v1 Streptomyces9rimosus9subsp.9pseudoverticillatus9 SAMN02900609 9518353 8267 0.709736094 63
GCF_001279355.1_ASM127935v1 Streptomyces9sp.9NRRL9FD47119 SAMN02900612 7956271 6944 0.715796877 33
GCF_001279365.1_ASM127936v1 Streptomyces9sp.9NRRL9FD57559 SAMN02900611 9273907 8026 0.710804695 60
GCF_001279375.1_ASM127937v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02900608 9592778 8392 0.710471833 61
GCF_001279425.1_ASM127942v1 Streptomyces9sp.9NRRL9FD22959 SAMN02900613 7844330 6650 0.718096066 38
GCF_001279445.1_ASM127944v1 Streptomyces9sp.9WM63499 SAMN02900614 7608527 6833 0.714264482 36
GCF_001279455.1_ASM127945v1 Streptomyces9sp.9XY1529 SAMN02900623 8224003 7225 0.71537898 39
GCF_001279485.1_ASM127948v1 Streptomyces9sp.9XY5119 SAMN02900628 8052035 7201 0.714927313 40
GCF_001279495.1_ASM127949v1 Streptomyces9sp.9H0219 SAMN02900637 8062295 7178 0.715679266 45
GCF_001279545.1_ASM127954v1 Streptomyces9sp.9NRRL9BD36489 SAMN02900645 8587870 7657 0.715314852 45
GCF_001279605.1_ASM127960v1 Streptomyces9sp.9NRRL9FD47079 SAMN02900651 7836363 6881 0.716944478 33
GCF_001279615.1_ASM127961v1 Streptomyces9sp.9NRRL9FD74429 SAMN02900653 7598939 6605 0.718140055 33
GCF_001279625.1_ASM127962v1 Streptomyces9sp.9WM63689 SAMN02900616 8212860 7283 0.713324071 46
GCF_001279655.1_ASM127965v1 Streptomyces9sp.9WM63729 SAMN02900617 8763196 7818 0.712310413 52
GCF_001279685.1_ASM127968v1 Streptomyces9sp.9WM63739 SAMN02900618 8269391 7446 0.714938962 44
GCF_001279695.1_ASM127969v1 Streptomyces9sp.9WM63789 SAMN02900619 9486712 8623 0.697802764 63
GCF_001279725.1_ASM127972v1 Streptomyces9sp.9WM42359 SAMN02900620 7812079 7034 0.706276286 36
GCF_001279735.1_ASM127973v1 Streptomyces9sp.9MMG15229 SAMN02900621 7953758 6823 0.71712793 38
GCF_001279765.1_ASM127976v1 Streptomyces9sp.9XY4139 SAMN02900626 8565282 7674 0.713861251 46
GCF_001279775.1_ASM127977v1 Streptomyces9sp.9MMG15339 SAMN02900622 10362086 9313 0.696788247 33
GCF_001279805.1_ASM127980v1 Streptomyces9sp.9XY4319 SAMN02900627 9490701 8008 0.725205891 68
GCF_001279815.1_ASM127981v1 Streptomyces9sp.9XY379 SAMN02900625 8149060 7273 0.715475766 43
GCF_001279845.1_ASM127984v1 Streptomyces9sp.9XY5339 SAMN02900629 8278192 7433 0.715320031 44
GCF_001279855.1_ASM127985v1 Streptomyces9sp.9XY589 SAMN02900630 8142216 7270 0.715457773 45
GCF_001279885.1_ASM127988v1 Streptomyces9sp.9XY5939 SAMN02900631 8330448 7442 0.715465673 45
GCF_001279905.1_ASM127990v1 Streptomyces9sp.9XY669 SAMN02900632 8531037 7646 0.714324812 45
GCF_001279925.1_ASM127992v1 Streptomyces9sp.9H0369 SAMN02900638 8621977 7729 0.714388367 47
GCF_001279935.1_ASM127993v1 Streptomyces9sp.9IGB1249 SAMN02900636 8431584 7560 0.71442862 48
GCF_001279965.1_ASM127996v1 Streptomyces9sp.9MMG10649 SAMN02900639 8128098 7254 0.715574253 44
GCF_001279985.1_ASM127998v1 Streptomyces9sp.9AS589 SAMN02900640 10576888 9191 0.700392089 43
GCF_001280005.1_ASM128000v1 Streptomyces9sp.9NRRL9WCD36189 SAMN02900642 9338462 8194 0.691979529 37
GCF_001280015.1_ASM128001v1 Streptomyces9sp.9MMG11219 SAMN02900641 9453902 8459 0.703710409 55
GCF_001280045.1_ASM128004v1 Streptomyces9sp.9NRRL9WCD37239 SAMN02900643 10369869 9277 0.708830941 48
GCF_001280065.1_ASM128006v1 Streptomyces9sp.9NRRL9BD11409 SAMN02900646 8206934 7262 0.704637224 39
GCF_001280095.1_ASM128009v1 Streptomyces9sp.9NRRL9FD64919 SAMN02900650 7754592 6819 0.722164117 35
GCF_001280125.1_ASM128012v1 Streptomyces9sp.9NRRL9FD64929 SAMN02900652 7753113 6822 0.722162945 35
GCF_001280885.1_ASM128088v1 Streptomyces9sp.9XY3329 SAMN02900624 8612030 7774 0.70861535 41
GCF_001282115.1_ASM128211v1 Streptomyces9sp.9NRRL9BD240859 SAMN04026160 8963402 8099 0.704282717 33
GCF_001294335.1_ASM129433v1 Streptomyces9chattanoogensis9 SAMN03327492 9129105 8101 0.700182045 53
GCF_001294345.1_ASM129434v1 Streptomyces9sp.9NRRL9SD49 SAMN02900599 7384559 6348 0.697664805 44
GCF_001417695.1_ASM141769v1 Streptomyces9sp.9JHA199 SAMD00023446 7708767 6938 0.71060363 24
GCF_001445835.1_ASM144583v1 Streptomyces9vitaminophilus9 SAMN04201512 6549812 5514 0.71121443 27
GCF_001484625.1_ASM148462v1 Streptomyces9kanasensis9 SAMN04285690 7026257 6207 0.729669329 27
GCF_001507395.1_ASM150739v1 Streptomyces9rimosus9subsp.9rimosus9 SAMN02900606 9592983 8388 0.710463199 62
GCF_001507435.1_ASM150743v1 Streptomyces9sp.9NRRL9FD51229 SAMN03327488 10162813 9198 0.691466891 21
GCF_001509475.1_ASM150947v1 Streptomyces9regalis9 SAMN03327473 10954269 9981 0.692861635 41
GCF_001509485.1_ASM150948v1 Streptomyces9sp.9NRRL9FD44899 SAMN03327485 7524057 6624 0.723916539 29
GCF_001509505.1_ASM150950v1 Streptomyces9sp.9NRRL9SD15219 SAMN03327493 8541802 7309 0.712833491 61
GCF_001509565.1_ASM150956v1 Streptomyces9griseus9subsp.9griseus9 SAMN03327495 7151148 6179 0.725042575 34
GCF_001509775.1_ASM150977v1 Streptomyces9violaceusniger9 SAMN03327491 10460168 8937 0.700908996 63
GCF_001509785.1_ASM150978v1 Streptomyces9sp.9NRRL9WCD36049 SAMN03327496 7585455 6855 0.712761637 25
GCF_001509795.1_ASM150979v1 Streptomyces9sp.9NRRL9WCD36059 SAMN03327497 7584593 6863 0.712749707 25
GCF_001517125.1_ASM151712v1 Streptomyces9canus9 SAMN04365298 7795072 6990 0.711168814 31
GCF_001541145.1_ASM154114v1 Streptomyces9albus9subsp.9albus9 SAMN03327484 9246299 7950 0.712166011 68
GCF_001543915.1_ASM154391v1 Streptomyces9thermoautotrophicus9 SAMN03328325 4726535 4718 0.696537408 11
GCF_001550215.1_ASM155021v1 Streptomyces9scabiei9 SAMN04437011 9978746 8932 0.704080303 39
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GCF_001550215.1_ASM155021v1 Streptomyces7scabiei7 SAMN04437011 9978746 8932 0.704080303 39
GCF_001550225.1_ASM155022v1 Streptomyces7scabiei7 SAMN04437012 10489082 9609 0.703031447 34
GCF_001550235.1_ASM155023v1 Streptomyces7scabiei7 SAMN04439349 11200310 10306 0.697771566 35
GCF_001550245.1_ASM155024v1 Streptomyces7scabiei7 SAMN04440839 9992374 8991 0.703502246 35
GCF_001550295.1_ASM155029v1 Streptomyces7scabiei7 SAMN04441030 9219556 8242 0.703280931 32
GCF_001550305.1_ASM155030v1 Streptomyces7diastatochromogenes7 SAMN04440795 12331773 11463 0.692417386 35
GCF_001550315.1_ASM155031v1 Streptomyces7sp.796F127 SAMN04441028 10080713 9179 0.700601529 37
GCF_001550325.1_ASM155032v1 Streptomyces7europaeiscabiei7 SAMN04441019 10515639 9427 0.696197043 25
GCF_001550375.1_ASM155037v1 Streptomyces7europaeiscabiei7 SAMN04441027 10499951 9287 0.697469522 31
GCF_001553455.1_ASM155345v1 Streptomyces7hygroscopicus7subsp.7hygroscopicus7 SAMD00022817 9464604 8026 0.710978025 54
GCF_001553475.1_ASM155347v1 Streptomyces7hygroscopicus7subsp.7hygroscopicus7 SAMD00022818 9781661 8264 0.710380227 58
GCF_001572115.1_ASM157211v1 Streptomyces7scabiei7 SAMN04432926 9832255 8761 0.703915256 32
GCF_001579685.1_ASM157968v1 Streptomyces7scabiei7 SAMN04438373 9023059 8114 0.700603814 29
GCF_001592685.1_ASM159268v1 Streptomyces7sp.7WAC046577 SAMN04397504 7761583 6946 0.718698675 32
GCF_001625365.1_ASM162536v1 Streptomyces7sp.7MJM86457 SAMN04044472 9234445 7787 0.719207061 65
GCF_001636945.1_ASM163694v1 Streptomyces7sp.7FXJ1.1727 SAMN04892703 9185177 8251 0.703323202 39
GCF_001653115.1_ASM165311v1 Streptomyces7sp.7FF37 SAMD00051289 6190739 5395 0.709731929 27
GCF_001653515.1_ASM165351v1 Streptomyces7sp.7ERV77 SAMN05163630 7105287 6358 0.705019627 41
GCF_001672315.1_ASM167231v1 Streptomyces7sp.7HFKF87 SAMN04606695 7684888 6623 0.71182063 33
GCF_001746305.1_ASM174630v1 Streptomyces7sp.7EN237 SAMN05717680 7438109 6652 0.707026964 38
GCF_001746415.1_ASM174641v1 Streptomyces7agglomeratus7 SAMN04277419 9128732 8331 0.695583199 39
GCF_001746425.1_ASM174642v1 Streptomyces7subrutilus7 SAMN05631079 8093975 7214 0.712190329 37
GCF_001746455.1_ASM174645v1 Streptomyces7agglomeratus7 SAMN05631103 8962368 8046 0.696241107 41
GCF_001746465.1_ASM174646v1 Streptomyces7agglomeratus7 SAMN04216912 9514325 8715 0.695247372 43
GCF_001746475.1_ASM174647v1 Streptomyces7agglomeratus7 SAMN05687608 9018469 8113 0.695688914 43
GCF_001746485.1_ASM174648v1 Streptomyces7agglomeratus7 SAMN05631093 7087990 6336 0.699369143 32
GCF_001756925.1_ASM175692v1 Streptomyces7fradiae7 SAMN05366695 7632932 6464 0.718835071 26
GCF_001865255.1_ASM186525v1 Streptomyces7sp.7CC777 SAMN05861225 6812024 6027 0.725698046 27
GCF_001866645.1_ASM186664v1 Streptomyces7sp.7MUSC7937 SAMN05915828 7015076 6367 0.690353805 27
GCF_001866665.1_ASM186666v1 Streptomyces7sp.7MUSC717 SAMN05915827 10254857 9218 0.706213257 58
GCF_001866675.1_ASM186667v1 Streptomyces7sp.7MUSC7147 SAMN05915731 10274825 9412 0.704176685 57
GCF_001905595.1_ASM190559v1 Streptomyces7sp.7CB003167 SAMN03999381 7414887 6576 0.704237075 38
GCF_001941265.1_ASM194126v1 Streptomyces7acidiscabies7 SAMN05102460 10199530 9339 0.69579859 64
GCF_001941275.1_ASM194127v1 Streptomyces7acidiscabies7 SAMN05094139 10550187 9542 0.697637612 60
GCF_001941285.1_ASM194128v1 Streptomyces7acidiscabies7 SAMN05107165 10978399 9975 0.696290282 61
GCF_001941325.1_ASM194132v1 Streptomyces7acidiscabies7 SAMN05111124 10556215 9512 0.696785925 59
GCF_001949645.1_ASM194964v1 Streptomyces7acidiscabies7 SAMD00034893 10582418 9295 0.697715642 57
GCF_001969965.1_Sparso1.0 Streptomyces7sparsogenes7DSM7403567 SAMN06251500 9699678 8611 0.71302969 60
GCF_002005565.1_ASM200556v1 Streptomyces7sp.7JHA267 SAMD00066058 7342837 6516 0.716377294 37
GCF_002017835.1_ASM201783v1 Streptomyces7avermitilis7 SAMN06209693 9446868 8440 0.698425603 56
GCF_002024165.1_SSNF3.0 Streptomyces7scabrisporus7 SAMN06459519 10958352 9630 0.707243927 58
GCF_002027195.1_ASM202719v1 Streptomyces7sp.7GKU78957 SAMN06335520 8296413 8155 0.698545526 35
GCF_002078175.1_ASM207817v1 Streptomyces7sp.7M41(2017)7 SAMN06311458 9023708 7987 0.704963582 29
GCF_002081495.1_ASM208149v1 Streptomyces7sp.7B91737 SAMN06626863 8773824 7640 0.709163302 33
GCF_002119195.1_ASM211919v1 Streptomyces7platensis7 SAMN05722965 8400476 7302 0.70289377 44
GCF_002128465.1_ASM212846v1 Streptomyces7pharetrae7CZA147 SAMN06140980 8426663 7612 0.713388187 40
GCF_002237655.1_ASM223765v1 Streptomyces7sp.7XY0067 SAMN07357003 8251847 7255 0.714412686 38
GCF_002242735.1_ASM224273v1 Streptomyces7sp.72R7 SAMN05449203 8486085 7471 0.704347881 47
GCF_002251155.1_ASM225115v1 Streptomyces7sp.7FBKL.40057 SAMN07276277 9441858 8228 0.718199016 56
GCF_002276245.1_ASM227624v1 Streptomyces7sp.7alainF8387 SAMN07488462 8390376 7955 0.709928746 43
GCF_002277855.1_ASM227785v1 Streptomyces7sp.7AlainFF2R57 SAMN07488463 8083365 7438 0.710414988 30
GCF_002286695.1_ASM228669v1 Streptomyces7albireticuli7 SAMN07502174 8454574 7164 0.715266053 72
GCF_002289335.1_CMBFCS132 Streptomyces7albidoflavus7 SAMN07505022 6797439 6057 0.721071459 31
GCF_002300315.1_ASM230031v1 Streptomyces7sp.72321.67 SAMN06272754 8186214 7281 0.701155559 42
GCF_002300355.1_ASM230035v1 Streptomyces7sp.7TLI_2357 SAMN06272720 9254774 8437 0.72143677 34
GCF_002300485.1_ASM230048v1 Streptomyces7sp.7Ag82_O1F157 SAMN06272791 11733994 10554 0.692651761 42
GCF_002317005.1_CMBFCS038 Streptomyces7albidoflavus7 SAMN07505020 6985550 6230 0.720829636 35
GCF_002317025.1_CMBFCS138 Streptomyces7albidoflavus7 SAMN07505024 6978043 6205 0.720928159 40
GCF_002317035.1_CMBFCS143 Streptomyces7albidoflavus7 SAMN07505023 7029244 6263 0.721200448 34
GCF_002335465.1_Solivochromogenes3561_assembly01 Streptomyces7olivochromogenes7 SAMD00078848 11639641 10515 0.693550489 45
GCF_002382885.1_WZ.A104 Streptomyces7sp.7WZ.A1047 SAMN07430084 8116078 7224 0.703082901 55
GCF_002551015.1_ASM255101v1 Streptomyces7sp.7wa10717 SAMN07606166 8738241 7858 0.7050418 47
GCF_002551045.1_ASM255104v1 Streptomyces7sp.7wa10637 SAMN07606165 8841778 7978 0.705009805 42
GCF_002551055.1_ASM255105v1 Streptomyces7sp.7wa10027 SAMN07606164 8626931 7628 0.705887599 46
GCF_002551065.1_ASM255106v1 Streptomyces7sp.7t997 SAMN07606163 7778589 7015 0.707809066 38
GCF_002551105.1_ASM255110v1 Streptomyces7sp.7st1707 SAMN07606162 8080444 7338 0.705383119 39
GCF_002551135.1_ASM255113v1 Streptomyces7sp.7st1407 SAMN07606161 7964327 7163 0.706187779 37
GCF_002551145.1_ASM255114v1 Streptomyces7sp.7st1157 SAMN07606160 8345486 7449 0.708630372 42
GCF_002551175.1_ASM255117v1 Streptomyces7sp.7st777 SAMN07606159 8145921 7274 0.706588413 38
GCF_002551185.1_ASM255118v1 Streptomyces7sp.7sk2267 SAMN07606158 7964739 6911 0.716100146 43
GCF_002551215.1_ASM255121v1 Streptomyces7sp.7rh2077 SAMN07606157 8624918 7815 0.705943405 42
GCF_002551225.1_ASM255122v1 Streptomyces7sp.7rh2067 SAMN07606156 8623355 7800 0.70597692 37
GCF_002551235.1_ASM255123v1 Streptomyces7sp.7rh1957 SAMN07606155 8626399 7772 0.706041188 42
GCF_002551245.1_ASM255124v1 Streptomyces7sp.7rh347 SAMN07606154 8221365 7324 0.706493714 40
GCF_002551295.1_ASM255129v1 Streptomyces7sp.7or37 SAMN07606152 8929626 7821 0.708144825 48
GCF_002551305.1_ASM255130v1 Streptomyces7sp.7or207 SAMN07606153 9079700 7961 0.706581563 52
GCF_002551335.1_ASM255133v1 Streptomyces7sp.7ms1847 SAMN07606151 7855502 7013 0.707905261 43
GCF_002551345.1_ASM255134v1 Streptomyces7sp.7ms1157 SAMN07606150 7498588 6687 0.708539949 37
GCF_002551375.1_ASM255137v1 Streptomyces7sp.7gb147 SAMN07606148 7877341 6885 0.707825856 44
GCF_002551415.1_ASM255141v1 Streptomyces7sp.7f517 SAMN07606146 7715130 6835 0.708795834 38
GCF_002551425.1_ASM255142v1 Streptomyces7sp.7b947 SAMN07606145 8028544 7009 0.716570946 39
GCF_002551435.1_ASM255143v1 Streptomyces7sp.7f1507 SAMN07606147 8056508 7196 0.707156594 41
GCF_002551465.1_ASM255146v1 Streptomyces7sp.7b847 SAMN07606144 8714623 7525 0.706061857 45
GCF_002551475.1_ASM255147v1 Streptomyces7sp.7b627 SAMN07606143 7818569 6988 0.707492769 37
GCF_002573955.1_ASM257395v1 Streptomyces7sp.7Ru877 SAMN07765385 7675182 6329 0.722122162 24
GCF_002633395.1_ASM263339v1 Streptomyces7sp.7ScaeMPFe487 SAMN05005154 8325244 7340 0.70422972 38
GCF_002727115.1_ASM272711v1 Streptomyces7cinnamoneus7 SAMN05939257 7548962 6566 0.713029786 42
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GCF_002727115.1_ASM272711v1 Streptomyces8cinnamoneus8 SAMN05939257 7548962 6566 0.713029786 42
GCF_002754435.1_ASM275443v1 Streptomyces8sp.8768 SAMN07626130 8227126 7205 0.710902782 34
GCF_002754455.1_ASM275445v1 Streptomyces8sp.82233.58 SAMN06272782 8060305 7241 0.701522878 41
GCF_002754515.1_ASM275451v1 Streptomyces8sp.81121.28 SAMN06272753 10155046 9137 0.696912085 35
GCF_002754535.1_ASM275453v1 Streptomyces8sp.8618 SAMN07626131 8424735 7607 0.714012763 36
GCF_002754555.1_ASM275455v1 Streptomyces8sp.8948 SAMN07626128 11368563 10205 0.693393721 42
GCF_002754595.1_ASM275459v1 Streptomyces8sp.8938 SAMN07626129 11991619 10753 0.69239753 41
GCF_002754615.1_ASM275461v1 Streptomyces8sp.818 SAMN07621066 8399087 7474 0.723317096 36
GCF_002754675.1_ASM275467v1 Streptomyces8sp.8CNZ2798 SAMN07626378 7971722 7160 0.702713753 40
GCF_002754715.1_ASM275471v1 Streptomyces8sp.8708 SAMN07621052 10926041 9832 0.693444716 48
GCF_002797655.1_ASM279765v1 Streptomyces8sp.8CNZ3068 SAMN07626381 8549577 7193 0.725662073 39
GCF_002797835.1_ASM279783v1 Streptomyces8sp.82333.58 SAMN06272758 8230569 6907 0.703083788 44
GCF_002813165.1_ASM281316v1 Streptomyces8sp.84121.58 SAMN06272776 8326181 7162 0.73129773 46
GCF_002813225.1_ASM281322v1 Streptomyces8sp.8Ag109_G2E18 SAMN06272725 8325873 7422 0.717762061 33
GCF_002813405.1_ASM281340v1 Streptomyces8sp.8698 SAMN07621241 8720845 7941 0.701300893 32
GCF_002844215.1_ASM284421v1 Streptomyces8sp.8EAG28 SAMN08102828 7174282 6172 0.723237603 38
GCF_002846295.1_ASM284629v1 Streptomyces8sp.8598 SAMN07621645 10420965 9248 0.700889697 45
GCF_002846315.1_ASM284631v1 Streptomyces8sp.8738 SAMN07626138 10396874 9334 0.701112443 43
GCF_002846355.1_ASM284635v1 Streptomyces8sp.8GP558 SAMN04515641 8962713 7929 0.706580062 47
GCF_002846415.1_ASM284641v1 Streptomyces8sp.8TLI_1468 SAMN06272790 8949889 7882 0.705204196 47
GCF_002846455.1_ASM284645v1 Streptomyces8sp.85112.28 SAMN06272726 8852242 7933 0.710365154 45
GCF_002879675.2_ASM287967v2 Streptomyces8sp.8SMS_SU218 SAMN08295422 7449420 6569 0.714286188 27
GCF_002891295.1_ASM289129v1 Streptomyces8eurocidicus8 SAMN03941210 7931574 6642 0.717218254 61
GCF_002891435.1_ASM289143v1 Streptomyces8sp.813K3018 SAMN08329200 9035421 8314 0.69949832 30
GCF_002899455.1_ASM289945v1 Streptomyces8sp.8DHE128 SAMN08365448 7604612 6503 0.719000088 30
GCF_002907485.1_ASM290748v1 Streptomyces8sp.8ZLE248 SAMN06211535 7817762 6767 0.711409888 45
GCF_002920535.1_ASM292053v1 Streptomyces8sp.8Ru718 SAMN08428758 8229423 7399 0.712068703 27
GCF_002920575.1_ASM292057v1 Streptomyces8sp.8Ru738 SAMN08428760 8211620 7191 0.716206928 31
GCF_002920615.1_ASM292061v1 Streptomyces8sp.8Ru628 SAMN08428756 9536025 8477 0.710815416 43
GCF_002920635.1_ASM292063v1 Streptomyces8sp.8Ru728 SAMN08428759 8512543 7700 0.699864846 26
GCF_002939475.1_ASM293947v1 Streptomyces8cinnamoneus8 SAMN08203848 6662690 5676 0.715054787 36
GCF_002966105.1_ASM296610v1 Streptomyces8xinghaiensis8 SAMN08114311 7731821 6425 0.71856577 27
GCF_003041235.1_ASM304123v1 Streptomyces8sp.8A2448 SAMN08794443 8648123 7712 0.70570275 33
GCF_003073355.1_ASM307335v1 Streptomyces8scopuliridis8RB728 SAMN02472441 7939832 6829 0.69575194 41
GCF_003096915.1_ASM309691v1 Streptomyces8sp.83212.28 SAMN08777534 11985328 10745 0.692396284 40
GCF_003112515.1_ASM311251v1 Streptomyces8fragilis8 SAMD00090286 6847990 5864 0.722957691 30
GCF_003112555.1_ASM311255v1 Streptomyces8coelicoflavus8 SAMD00090288 8727276 7717 0.712793847 31
GCF_003112575.1_ASM311257v1 Streptomyces8diastaticus8subsp.8ardesiacus8 SAMD00090289 7851547 6869 0.717574371 34
GCF_003121295.1_ASM312129v1 Streptomyces8orinoci8 SAMN08092869 7502208 6645 0.699116865 39
GCF_003129505.1_ASM312950v1 Streptomyces8sp.8V28 SAMN09083361 10249899 8916 0.704727349 67
GCF_003143855.1_ASM314385v1 Streptomyces8sp.8NWU3398 SAMN09197742 9425309 8775 0.699508541 36
GCF_003146615.1_ASM314661v1 Streptomyces8sp.8NWU498 SAMN09207752 8905076 8021 0.713792425 41
GCF_003148825.1_ASM314882v1 Streptomyces8sp.8CG89268 SAMN05445056 8513506 7524 0.709432073 42
GCF_003173635.1_ASM317363v1 Streptomyces8sp.8ZEA17I8 SAMN09228098 7515197 6741 0.711145627 44
GCF_003173645.1_ASM317364v1 Streptomyces8sp.8FT05W8 SAMN09228097 7692712 7286 0.698519574 40
GCF_003236365.1_ASM323636v1 Streptomyces8sp.8NTH338 SAMN08329152 7858487 7196 0.705506088 35
GCF_003248335.1_ASM324833v1 Streptomyces8sp.8AC1E42T8 SAMN09377738 7273138 6546 0.706328606 38
GCF_003248355.1_ASM324835v1 Streptomyces8sp.8AC1E42W8 SAMN09378330 7648131 6787 0.706718141 40
GCF_003254205.1_ASM325420v1 Streptomyces8sp.8DvalAAE218 SAMN02745827 7426643 6529 0.709056011 28
GCF_003263885.1_ASM326388v1 Streptomyces8badius8 SAMN04589202 7682334 6854 0.706525691 35
GCF_003263925.1_ASM326392v1 Streptomyces8badius8 SAMN04589131 7624848 6785 0.7067417 34
GCF_003268535.1_ASM326853v1 Streptomyces8sp.8ST10158 SAMN04967901 9838554 9049 0.704081889 60
GCF_003268555.1_ASM326855v1 Streptomyces8sp.8ST10208 SAMN04977949 9893137 8972 0.704384785 54
GCF_003270085.1_ASM327008v1 Streptomyces8triticisoli8 SAMN09043984 6844226 6332 0.705117181 20
GCF_003311645.1_ASM331164v1 Streptomyces8sp.8PT128 SAMN09009764 6922703 5966 0.72007111 54
GCF_003324565.1_ASM332456v1 Streptomyces8sp.8SDrE068 SAMN09623796 8583590 7772 0.705537632 48
GCF_003344905.1_ASM334490v1 Streptomyces8parvulus8 SAMN09708212 8348559 7527 0.71390578 37
GCF_003363195.1_ASM336319v1 Streptomyces8sp.8M78 SAMN09724918 7774362 6980 0.710325105 25
GCF_003367645.1_ASM336764v1 Streptomyces8sp.8IB20148011E128 SAMN08995759 8153082 7282 0.706298805 35
GCF_003384795.1_ASM338479v1 Streptomyces8sp.8758 SAMN07626153 10065237 9101 0.695224685 47
GCF_003384865.1_ASM338486v1 Streptomyces8sp.83212.38 SAMN06272730 9891705 9012 0.692885981 20
GCF_003386135.1_ASM338613v1 Streptomyces8sp.8628 SAMN07621086 9263311 8327 0.711739202 36
GCF_003386245.1_ASM338624v1 Streptomyces8sp.8678 SAMN07621053 10386477 9010 0.70099243 59
GCF_003386845.1_ASM338684v1 Streptomyces8sp.8Ag82_O1E98 SAMN06272786 10201402 8983 0.701744035 44
GCF_003387455.1_ASM338745v1 Streptomyces8sp.82221.18 SAMN06272750 8614390 7693 0.712269679 30
GCF_003402595.1_ASM340259v1 Streptomyces8spongiicola8 SAMD00129508 6912677 5712 0.717134213 33
GCF_003403055.1_ASM340305v1 Streptomyces8sp.8AcE2108 SAMN09765673 10567477 9527 0.69517491 29
GCF_003435025.1_ASM343502v1 Streptomyces8xanthocidicus8 SAMN09536585 9686058 8281 0.725676107 61
GCF_003501885.1_ASM350188v1 Streptomyces8globisporus8 SAMN09521591 7365300 6586 0.706506722 38
GCF_003550115.1_ASM355011v1 Streptomyces8sp.82233.28 SAMN06272767 8182917 7312 0.701181685 42
GCF_003550155.1_ASM355015v1 Streptomyces8sp.83212.58 SAMN08778378 10397447 9020 0.700983983 59
GCF_003550235.1_ASM355023v1 Streptomyces8sp.83211.18 SAMN06272733 8850976 7906 0.711716997 46
GCF_003568675.1_ASM356867v1 Streptomyces8sp.8NEAUESSA818 SAMN09949855 10364544 9192 0.69050863 43
GCF_900091315.1_IMGEtaxon_2657245700_annotated_assembly Streptomyces8sp.8DI1668 SAMN04883196 8871383 7890 0.703848753 50
GCF_900091485.1_IMGEtaxon_2657245724_annotated_assembly Streptomyces8sp.8LcepLS8 SAMN04883135 7154322 6218 0.725260248 25
GCF_900091715.1_IMGEtaxon_2657245702_annotated_assembly Streptomyces8sp.8DpondAAEF4a8 SAMN04883148 7327645 6620 0.708754832 29
GCF_900091725.1_IMGEtaxon_2657245701_annotated_assembly Streptomyces8sp.8DvalAAE438 SAMN04883096 9324761 8123 0.701002821 45
GCF_900091735.1_IMGEtaxon_2657245705_annotated_assembly Streptomyces8sp.8di50b8 SAMN04883094 6468676 5907 0.713046577 23
GCF_900091745.1_IMGEtaxon_2657245708_annotated_assembly Streptomyces8sp.8DpondAAED48 SAMN04883146 7273112 6254 0.712492767 32
GCF_900091755.1_IMGEtaxon_2657245718_annotated_assembly Streptomyces8sp.8TverLSE9158 SAMN04883130 7048370 6097 0.724893753 24
GCF_900091765.1_IMGEtaxon_2657245714_annotated_assembly Streptomyces8sp.8PalvLSE9848 SAMN04883180 7098159 6214 0.712453188 35
GCF_900091775.1_IMGEtaxon_2657245710_annotated_assembly Streptomyces8sp.8ScaeMPEe838 SAMN04883097 7833966 6921 0.706604889 39
GCF_900091785.1_IMGEtaxon_2657245717_annotated_assembly Streptomyces8sp.8BvitLSE9838 SAMN04876000 7282735 6431 0.723139046 30
GCF_900091805.1_IMGEtaxon_2657245712_annotated_assembly Streptomyces8sp.8di1888 SAMN04881429 6614685 6085 0.7121719 23
GCF_900091815.1_IMGEtaxon_2657245719_annotated_assembly Streptomyces8sp.8DfronAAE1718 SAMN04883159 7294527 6628 0.7231952 23
GCF_900091825.1_IMGEtaxon_2657245713_annotated_assembly Streptomyces8sp.8SolWspMPEsol7th8 SAMN04883158 6504426 6009 0.720938989 18
GCF_900091835.1_IMGEtaxon_2657245716_annotated_assembly Streptomyces8sp.8PpalLSE9218 SAMN04883149 7371288 6438 0.71094053 34
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GCF_900091835.1_IMG.taxon_2657245716_annotated_assembly StreptomycesCsp.CPpalLS.921C SAMN04883149 7371288 6438 0.71094053 34
GCF_900091845.1_IMG.taxon_2657245709_annotated_assembly StreptomycesCsp.CSolWspMP.5a.2C SAMN04875601 8956613 7703 0.720913054 53
GCF_900091855.1_IMG.taxon_2657245707_annotated_assembly StreptomycesCsp.CDvalAA.14C SAMN04883092 7944178 6953 0.709892788 31
GCF_900091865.1_IMG.taxon_2657245711_annotated_assembly StreptomycesCsp.CDvalAA.19C SAMN04883095 8061879 6886 0.711643599 53
GCF_900091875.1_IMG.taxon_2657245706_annotated_assembly StreptomycesCsp.CBpilaLS.43C SAMN04883160 7385971 6659 0.707659024 28
GCF_900091885.1_IMG.taxon_2657245704_annotated_assembly StreptomycesCsp.CScaeMP.6WC SAMN04883166 7163425 6160 0.724032006 32
GCF_900091955.1_IMG.taxon_2657245721_annotated_assembly StreptomycesCsp.CNcost.T10.10dC SAMN04883155 9361102 8437 0.687333065 30
GCF_900091975.1_IMG.taxon_2657245725_annotated_assembly StreptomycesCsp.CLamerLS.31bC SAMN04883142 8516683 7555 0.706944767 60
GCF_900091985.1_IMG.taxon_2657245723_annotated_assembly StreptomycesCsp.CDconLSC SAMN04883143 8568595 7837 0.705960256 61
GCF_900091995.1_IMG.taxon_2657245726_annotated_assembly StreptomycesCsp.CMnatMP.M17C SAMN04883173 8137273 7449 0.685829918 33
GCF_900092005.1_IMG.taxon_2657245729_annotated_assembly StreptomycesCsp.CCmuel.A718bC SAMN04883156 8143336 7131 0.707242863 50
GCF_900095575.1_IMG.taxon_2657245715_annotated_assembly StreptomycesCsp.CDpondAA.F4C SAMN04883147 7354500 6514 0.709081247 27
GCF_900102245.1_IMG.taxon_2671180083_annotated_assembly StreptomycesCsp.CKS_16C SAMN05216511 8068758 7158 0.701514196 42
GCF_900104815.1_IMG.taxon_2634166373_annotated_assembly StreptomycesCmisionensisC SAMN04490357 8473721 7530 0.714841049 41
GCF_900104865.1_IMG.taxon_2684623024_annotated_assembly StreptomycesCsp.C2112.2C SAMN05428942 8377187 7095 0.70251196 45
GCF_900105235.1_IMG.taxon_2687453697_annotated_assembly StreptomycesCsp.C2133.1C SAMN05428940 8130510 7207 0.701184212 42
GCF_900105245.1_IMG.taxon_2690315622_annotated_assembly StreptomycesCsp.C1222.5C SAMN05428944 8852362 7927 0.710365861 45
GCF_900105265.1_IMG.taxon_2675903008_annotated_assembly StreptomycesCsp.C3213.3C SAMN05216489 10923892 9827 0.692685699 32
GCF_900105275.1_IMG.taxon_2690315621_annotated_assembly StreptomycesCsp.CKS_5C SAMN05428938 10344370 8947 0.699999981 44
GCF_900105415.1_IMG.taxon_2687453810_annotated_assembly StreptomycesCsp.CTLI_105C SAMN05428939 8876291 7985 0.712610404 33
GCF_900105465.1_IMG.taxon_2671180174_annotated_assembly StreptomycesCsp.CPAN_FS17C SAMN05216482 10467880 9092 0.699536426 43
GCF_900105515.1_IMG.taxon_2671180089_annotated_assembly StreptomycesCsp.C2131.1C SAMN05216483 7489175 6626 0.707695002 25
GCF_900105525.1_IMG.taxon_2687453781_annotated_assembly StreptomycesCsp.C2314.4C SAMN05428943 8345204 7024 0.702220363 44
GCF_900105605.1_IMG.taxon_2671180090_annotated_assembly StreptomycesCsp.C2231.1C SAMN05216532 9263372 8447 0.707869304 47
GCF_900105705.1_IMG.taxon_2634166340_annotated_assembly StreptomycesCgriseusC SAMN04490359 8630192 7195 0.713532344 46
GCF_900105755.1_IMG.taxon_2675902962_annotated_assembly StreptomycesCsp.CAg109_O5.10C SAMN05216533 9458099 8392 0.705895768 34
GCF_900105775.1_IMG.taxon_2684623030_annotated_assembly StreptomycesCsp.C2112.3C SAMN05428954 8080548 7090 0.701448808 41
GCF_900105915.1_IMG.taxon_2687453724_annotated_assembly StreptomycesCsp.C2224.1C SAMN05428945 8000762 7003 0.701775534 40
GCF_900187385.1_IMG.taxon_2731639226_annotated_assembly StreptomycesCsp.C2114.4C SAMN06272741 8074230 7137 0.70149657 42
GCF_900199205.1_IMG.taxon_2737472028_annotated_assembly StreptomycesCsp.C1331.2C SAMN06272789 8427392 7248 0.720014809 45
GCF_900206255.1_IMG.taxon_2739368069_annotated_assembly StreptomycesCsp.CTLI_55C SAMN06272735 10204079 9129 0.698907995 36
GCF_900215305.1_IMG.taxon_2721755846_annotated_assembly StreptomycesCsp.COK228C SAMN05442782 12153002 11032 0.693342782 41
GCF_900215565.1_IMG.taxon_2728369739_annotated_assembly StreptomycesCsp.CAg109_G2.15C SAMN06272765 10184498 8974 0.701682295 46
GCF_900215595.1_IMG.taxon_2728369725_annotated_assembly StreptomycesCsp.C1222.2C SAMN06272781 9514697 8174 0.704148342 37
GCF_900215615.1_IMG.taxon_2738541359_annotated_assembly StreptomycesCsp.CAg82_G6.1C SAMN06272727 8434102 7568 0.704380886 34
GCF_900230195.1_IMG.taxon_2718217652_annotated_assembly StreptomycesCzhaozhouensisC SAMN06297387 6532426 5503 0.724820547 33
GCF_900230275.1_IMG.taxon_2718217699_annotated_assembly StreptomycesCsp.COV198C SAMN05446589 11619287 10481 0.692885564 40
GCF_900290235.1_5143a StreptomycesCsp.CMA5143aC SAMEA104588927 9813744 8257 0.70600888 53
GCF_900460065.1_43874_D01 StreptomycesCgriseusC SAMEA3724098 8528890 7132 0.713553656 53
GCF_900460115.1_53878_B01 StreptomycesCgriseusC SAMEA101163418 6951521 5795 0.725700189 33
GCF_000156695.2_ASM15669v2 StreptomycesCfilamentosusCNRRLC11379C SAMN02595236 7851943 6950 0.702272791 37
GCF_000299175.2_ASM29917v2 StreptomycesCsp.CSM8C SAMN02471466 7145211 6412 0.720699241 24
GCF_000527195.1_ASM52719v1 StreptomycesCsp.CCNH189C SAMN02597197 7327324 6567 0.713774667 25
GCF_000612545.1_P1.1 StreptomycesCsp.CPCS3.D2C SAMN02597788 7479793 6630 0.707188489 31
GCF_000696595.1_StrepLeeu1.0 StreptomycesCleeuwenhoekiiC SAMN02808814 7854862 6782 0.715928705 41
GCF_000698945.1_LGO_A23_AS7 StreptomycesCwadayamensisC SAMN02692260 7056006 6335 0.721960833 31
GCF_000707925.1_r6_51 StreptomycesCrimosusCR6.500C SAMN02721380 8881740 7893 0.710833506 52
GCF_000707945.1_mv9.51 StreptomycesCrimosusC SAMN02730067 8197540 7137 0.711720997 45
GCF_000707965.1_rev.51 StreptomycesCrimosusC SAMN02730068 8386169 7452 0.712124178 46
GCF_000764715.1_ASM76471v1 StreptomycesCavermitilisCMA.4680C=CNBRCC14893C SAMD00041820 10426843 9118 0.696853358 58
GCF_000813365.1_ASM81336v1 StreptomycesCalbusC SAMD00023485 7594511 6380 0.717691217 30
GCF_000818175.1_ASM81817v1 StreptomycesCsp.CAcHC505C SAMN02899864 9005794 8101 0.667085966 24
GCF_000818195.1_Streptomyces_species_150FB_genome_v1 StreptomycesCsp.C150FBC SAMN03217757 9803944 8654 0.668270522 46
GCF_000829695.1_ASM82969v1 StreptomycesCsp.CNBRCC110035C SAMD00020221 7508934 6582 0.708516516 45
GCF_000829715.2_ASM82971v2 StreptomycesCsp.CNBRCC110027C SAMD00020222 8319549 7228 0.702247615 36
GCF_000972385.1_ASM97238v1 StreptomycesCsp.CWM6386C SAMN03295681 9215882 8418 0.695219544 28
GCF_000972395.1_ASM97239v1 StreptomycesCsp.CWM6391C SAMN03317180 8558285 7696 0.712621441 33
GCF_000972435.1_StrepMBT28_1.0 StreptomycesCsp.CMBT28C SAMN03444561 8003530 7075 0.715213845 37
GCF_000974485.1_ASM97448v1 StreptomycesCsp.CNBRCC109706C SAMD00020841 7736999 6307 0.708460625 46
GCF_001005295.1_ASM100529v1 StreptomycesCyangpuensisC SAMN03571527 7646853 6892 0.711359729 31
GCF_001008135.1_ASM100813v1 StreptomycesCstelliscabieiC SAMN03580356 9978344 8845 0.701329229 38
GCF_001044425.1_ASM104442v1 StreptomycesCroseusC SAMN03787768 7834742 6991 0.712523743 33
GCF_001083795.1_Nocardiopsis_sp_SBT349_SPAdes_SSPACE StreptomycesCsp.CSBT349C SAMN03468208 8064387 7094 0.718331794 46
GCF_001184025.1_ASM118402v1 StreptomycesCsp.CNBRCC110468C SAMD00035239 8723085 7654 0.707597639 34
GCF_001293595.1_ASM129359v1 StreptomycesCsp.CTP.A0875C SAMD00035869 6778367 5875 0.727166931 27
GCF_001414545.1_ASM141454v1 StreptomycesCpactumC SAMN04002534 8466361 7124 0.707446539 42
GCF_001417675.1_ASM141767v1 StreptomycesCsp.CNBRCC110030C SAMD00020839 8126267 7089 0.715250693 33
GCF_001417735.1_ASM141773v1 StreptomycesCsp.CNBRCC110028C SAMD00026622 8921218 7744 0.70614208 40
GCF_001417775.1_ASM141777v1 StreptomycesCsp.CTP.A0356C SAMD00035865 8409357 7589 0.699687275 33
GCF_001418125.1_ASM141812v1 StreptomycesCalmquistiiC SAMN04002961 7375232 6342 0.716894496 35
GCF_001418135.1_ASM141813v1 StreptomycesCaureusC SAMN04002963 7926662 7105 0.709337994 36
GCF_001418165.1_ASM141816v1 StreptomycesCprasinusC SAMN04002974 7680312 6632 0.711057355 43
GCF_001418175.1_ASM141817v1 StreptomycesChirsutusC SAMN04003009 8335451 7615 0.702257617 27
GCF_001418285.1_ASM141828v1 StreptomycesCsp.CWMMBC322C SAMN02745757 6597054 5605 0.700629026 28
GCF_001418325.1_ASM141832v1 StreptomycesCatriruberC SAMN04002960 8892875 7942 0.703959583 40
GCF_001418395.1_ASM141839v1 StreptomycesCprasinopilosusC SAMN04003992 6441003 5715 0.717028814 25
GCF_001418405.1_ASM141840v1 StreptomycesCdiastatochromogenesC SAMN04003991 9119388 8233 0.711355689 47
GCF_001418415.1_ASM141841v1 StreptomycesChirsutusC SAMN04004080 8506297 7701 0.701158341 31
GCF_001418465.1_ASM141846v1 StreptomycesCkanamyceticusC SAMN04004081 9783257 8537 0.700850179 68
GCF_001418545.1_ASM141854v1 StreptomycesCgibsoniiC SAMN04003994 6963283 6087 0.716362604 34
GCF_001418565.1_ASM141856v1 StreptomycesCgraminilatusC SAMN04003995 9608680 8475 0.69255215 57
GCF_001418625.1_ASM141862v1 StreptomycesCluridiscabieiC SAMN04004082 7921781 7044 0.704618865 40
GCF_001418645.1_ASM141864v1 StreptomycesCneyagawaensisC SAMN04004083 9132025 8184 0.702097835 36
GCF_001419685.1_ASM141968v1 StreptomycesCpuniciscabieiC SAMN04004090 8807122 8142 0.704442116 38
GCF_001419705.1_ASM141970v1 StreptomycesCprasinusC SAMN04004089 7433599 6418 0.711708121 34
GCF_001419745.1_ASM141974v1 StreptomycesCsilaceusC SAMN04004092 8744139 7676 0.711977743 63
GCF_001419765.1_ASM141976v1 StreptomycesCtorulosusC SAMN04004093 9848803 8737 0.702045527 41
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GCF_001419765.1_ASM141976v1 Streptomyces:torulosus: SAMN04004093 9848803 8737 0.702045527 41
GCF_001419795.1_ASM141979v1 Streptomyces:niveiscabiei: SAMN04004084 9549495 8771 0.702397527 56
GCF_001425805.1_Root369 Streptomyces:sp.:Root369: SAMN04155792 10741251 9706 0.694365102 29
GCF_001426325.1_Root1295 Streptomyces:sp.:Root1295: SAMN04155717 9196637 8052 0.705427431 50
GCF_001426405.1_Root1304 Streptomyces:sp.:Root1304: SAMN04155719 7584031 6697 0.715401396 24
GCF_001426425.1_Root1310 Streptomyces:sp.:Root1310: SAMN04155721 9540101 8345 0.706199874 41
GCF_001426585.1_Root431 Streptomyces:sp.:Root431: SAMN04155804 6497041 5786 0.71263506 19
GCF_001426615.1_Root1319 Streptomyces:sp.:Root1319: SAMN04155723 6744287 5787 0.703877396 29
GCF_001427245.1_Root55 Streptomyces:sp.:Root55: SAMN04155823 8054949 6978 0.701666598 39
GCF_001427565.1_Root63 Streptomyces:sp.:Root63: SAMN04155842 9213798 8069 0.706330476 51
GCF_001427745.1_Root66D1 Streptomyces:sp.:Root66D1: SAMN04155851 7586415 6710 0.715386705 25
GCF_001428885.1_Root264 Streptomyces:sp.:Root264: SAMN04155772 9015452 7931 0.706648712 42
GCF_001445655.1_ASM144565v1 Streptomyces:sp.:MBT76: SAMN04253747 8639831 7445 0.712430676 63
GCF_001469455.2_ASM146945v2 Streptomyces:sp.:AVP053U2: SAMN04158509 7759417 6680 0.709636097 51
GCF_001482415.1_ASM148241v1 Streptomyces:silvensis: SAMN04304558 9741331 8253 0.710521441 55
GCF_001485105.1_ASM148510v1 Streptomyces:acidiscabies: SAMD00034892 10725420 9439 0.697446146 58
GCF_001485125.1_ASM148512v1 Streptomyces:scabiei: SAMD00034890 10001327 8629 0.706547928 46
GCF_001531145.1_ASM153114v1 Streptomyces:sp.:IMTB:1903: SAMN04387707 7846227 7044 0.716898717 34
GCF_001553435.1_ASM155343v1 Streptomyces:hygroscopicus:subsp.:hygroscopicus: SAMD00021056 10141569 8323 0.709790356 62
GCF_001570645.1_ASM157064v1 Streptomyces:hygroscopicus:subsp.:hygroscopicus: SAMD00040622 10165415 8356 0.70990231 57
GCF_001590865.1_ASM159086v1 Streptomyces:sp.:NBRC:110611: SAMD00026621 7904619 6836 0.699420889 47
GCF_001595515.1_ASM159551v1 Streptomyces:sp.:CC71: SAMN04335756 7888579 7135 0.714540225 34
GCF_001640565.1_ASM164056v1 Streptomyces:sp.:RTd22: SAMN04901306 11185248 9507 0.703886663 55
GCF_001646665.1_ASM164666v1 Streptomyces:albulus: SAMN04621598 7642040 6717 0.722495528 41
GCF_001652895.1_ASM165289v1 Streptomyces:sp.:NBRC:109436: SAMD00020875 9888645 8043 0.709848324 57
GCF_001661615.1_ASM166161v1 Streptomyces:rangoonensis: SAMN04004091 7195882 6193 0.716514086 33
GCF_001687325.1_ASM168732v1 Streptomyces:sp.:PTY087I2: SAMN04571751 8164109 7037 0.706125135 43
GCF_001700505.1_ASM170050v1 Streptomyces:mutomycini: SAMN05326639 7070041 6089 0.697406077 45
GCF_001700515.1_ASM170051v1 Streptomyces:lushanensis: SAMN05326726 7542112 6429 0.697588841 38
GCF_001715295.1_ASM171529v1 Streptomyces:griseus: SAMN05293542 6866218 5840 0.70554291 28
GCF_001723055.1_ASM172305v1 Streptomyces:niveus: SAMN05557883 8275588 7474 0.699111015 33
GCF_001723065.1_ASM172306v1 Streptomyces:rubidus: SAMN05552974 8081483 7362 0.715860955 23
GCF_001723075.1_ASM172307v1 Streptomyces:niveus: SAMN05557884 8139255 7588 0.697406402 39
GCF_001723115.1_ASM172311v1 Streptomyces:griseus: SAMN05558833 8102089 7010 0.712236591 58
GCF_001723125.1_ASM172312v1 Streptomyces:griseus:subsp.:griseus: SAMN05558834 7958464 6967 0.711933875 52
GCF_001746285.1_ASM174628v1 Streptomyces:sp.:EN16: SAMN05567309 8570873 7691 0.706134624 39
GCF_001746295.1_ASM174629v1 Streptomyces:sp.:LUP47B: SAMN05567319 10998901 9890 0.694111283 29
GCF_001746315.1_ASM174631v1 Streptomyces:sp.:EN27: SAMN05567316 7550241 6695 0.70726198 38
GCF_001746365.1_ASM174636v1 Streptomyces:sp.:LUP30: SAMN05717681 9184130 8023 0.707441844 51
GCF_001748085.1_ASM174808v1 Streptomyces:sp.:TPSA0874: SAMD00035866 5097807 4363 0.704872018 27
GCF_001748165.1_ASM174816v1 Streptomyces:sp.:SPMA113: SAMD00052840 11596102 9264 0.701725589 77
GCF_001748305.1_ASM174830v1 Streptomyces:luteocolor: SAMD00027180 9298666 8108 0.706340676 56
GCF_001751305.1_ASM175130v1 Streptomyces:nanshensis: SAMN04026268 10271613 9065 0.676714809 47
GCF_001751345.1_ASM175134v1 Streptomyces:abyssalis: SAMN04026261 6910195 5858 0.679632833 24
GCF_001751365.1_ASM175136v1 Streptomyces:abyssalis: SAMN04026262 6610598 5662 0.699265125 26
GCF_001751375.1_ASM175137v1 Streptomyces:qinglanensis: SAMN04026264 6610624 5492 0.717756814 27
GCF_001865245.1_ASM186524v1 Streptomyces:sp.:CC53: SAMN05861226 6978886 6328 0.722421825 29
GCF_001895105.1_ASM189510v1 Streptomyces:sp.:NBRC:110465: SAMD00059478 7625844 6623 0.711529772 39
GCF_001896135.2_ASM189613v2 Streptomyces:phaeoluteigriseus: SAMN06007048 8643493 8113 0.704761997 42
GCF_001905005.1_ASM190500v1 Streptomyces:sp.:CB02923: SAMN04853037 9573831 8021 0.710213597 60
GCF_001905025.1_ASM190502v1 Streptomyces:sp.:CB03578: SAMN04857222 8401755 7434 0.714495664 40
GCF_001905045.1_ASM190504v1 Streptomyces:sp.:CB03911: SAMN04853764 9598671 8226 0.725541571 44
GCF_001905125.1_ASM190512v1 Streptomyces:sp.:TSRI0281: SAMN04857230 9627007 8487 0.697290396 51
GCF_001905365.1_ASM190536v1 Streptomyces:sp.:CB02488: SAMN03999369 8892300 7684 0.70123649 33
GCF_001905385.1_ASM190538v1 Streptomyces:sp.:CB02414: SAMN03999371 7987504 7170 0.711275302 29
GCF_001905405.1_ASM190540v1 Streptomyces:sp.:TSRI0445: SAMN03999374 7769856 6861 0.70666274 41
GCF_001905425.1_ASM190542v1 Streptomyces:sp.:MJM1172: SAMN03999375 8048201 7234 0.714969195 41
GCF_001905445.1_ASM190544v1 Streptomyces:sp.:CB00455: SAMN03999376 7561943 6708 0.71382463 34
GCF_001905485.1_ASM190548v1 Streptomyces:sp.:TSRI0261: SAMN03999380 8668234 7399 0.707060084 51
GCF_001905505.1_ASM190550v1 Streptomyces:sp.:CB02058: SAMN03999370 8308206 7177 0.703690592 40
GCF_001905525.1_ASM190552v1 Streptomyces:sp.:TSRI0395: SAMN03999372 8658545 7500 0.708441103 46
GCF_001905545.1_ASM190554v1 Streptomyces:sp.:CB02056: SAMN03999373 9543510 8074 0.727652797 71
GCF_001905575.1_ASM190557v1 Streptomyces:sp.:CB00072: SAMN03999377 8890378 7738 0.705345378 46
GCF_001905645.1_ASM190564v1 Streptomyces:sp.:CB02115: SAMN03999388 8690341 7538 0.708033104 46
GCF_001905665.1_ASM190566v1 Streptomyces:sp.:CB02261: SAMN03999389 7705652 6848 0.714054381 34
GCF_001905705.1_ASM190570v1 Streptomyces:sp.:CB02460: SAMN03999390 7412196 6542 0.709536925 31
GCF_001905725.1_ASM190572v1 Streptomyces:sp.:CB02400: SAMN03999393 8931064 7915 0.70717476 38
GCF_001905735.1_ASM190573v1 Streptomyces:sp.:CB01249: SAMN03999378 7636948 6658 0.70959823 30
GCF_001905785.1_ASM190578v1 Streptomyces:sp.:CB02130: SAMN03999383 8134270 7245 0.707069571 39
GCF_001905795.1_ASM190579v1 Streptomyces:sp.:CB01580: SAMN03999382 8492042 7294 0.703317565 36
GCF_001905825.1_ASM190582v1 Streptomyces:sp.:CB02009: SAMN03999387 9201655 8100 0.713626422 40
GCF_001905845.1_ASM190584v1 Streptomyces:sp.:TSRI0107: SAMN03999391 8740481 7605 0.712185381 37
GCF_001905855.1_ASM190585v1 Streptomyces:sp.:CB01883: SAMN03999392 8895089 7959 0.712509034 50
GCF_001905885.1_ASM190588v1 Streptomyces:sp.:CB03234: SAMN03999386 7769088 7064 0.709727048 47
GCF_001905905.1_ASM190590v1 Streptomyces:sp.:CB02366: SAMN03999384 7369245 6394 0.716305811 37
GCF_001953875.1_ASM195387v1 Streptomyces:amritsarensis: SAMN04386232 7816792 7008 0.716868498 37
GCF_001953885.1_ASM195388v1 Streptomyces:sp.:IMTB:2501: SAMN04386227 9989486 9140 0.698133375 49
GCF_001970135.1_ASM197013v1 Streptomyces:sp.:M1013: SAMN06077062 8448284 7544 0.711681977 37
GCF_001983595.1_ASM198359v1 Streptomyces:sp.:IB2014:011S1: SAMN04932664 8195763 7323 0.706212317 35
GCF_001984575.1_ASM198457v1 Streptomyces:sp.:MP131S18: SAMN05211002 7956642 7057 0.701998919 39
GCF_002078235.1_ASM207823v1 Streptomyces:viridosporus: SAMN06173285 8097217 7250 0.713957274 39
GCF_002099185.1_ASM209918v1 Streptomyces:sp.:CB03238: SAMN06642752 8518432 7728 0.70583277 45
GCF_002114215.1_ASM211421v1 Streptomyces:sp.:13S12S16: SAMN06711119 8717887 8062 0.703652354 27
GCF_002119225.1_ASM211922v1 Streptomyces:fradiae:ATCC:10745:=:DSM:40063: SAMN05722967 6716312 5800 0.735301115 29
GCF_002148965.1_ASM214896v1 Streptomyces:swartbergensis: SAMN06928588 9204779 8481 0.700950155 41
GCF_002150735.1_ASM215073v1 Streptomyces:africanus: SAMN06271532 9115570 8283 0.702695693 40
GCF_002150845.1_ASM215084v1 Streptomyces:alboverticillatus: SAMN06271534 7044380 6269 0.71055437 38
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GCF_002150845.1_ASM215084v1 Streptomyces9alboverticillatus9 SAMN06271534 7044380 6269 0.71055437 38
GCF_002154275.1_ASM215427v1 Streptomyces9castelarensis9 SAMN06277329 10807181 9602 0.698390315 65
GCF_002154345.1_ASM215434v1 Streptomyces9fimicarius9 SAMN06282270 7819863 7034 0.70851786 40
GCF_002154375.1_ASM215437v1 Streptomyces9glaucescens9 SAMN06282461 8426988 7619 0.710657415 37
GCF_002154385.1_ASM215438v1 Streptomyces9albovinaceus9 SAMN06276569 7237318 6539 0.705066666 35
GCF_002154415.1_ASM215441v1 Streptomyces9angustmyceticus9 SAMN06276655 7462466 6598 0.711530994 41
GCF_002154445.1_ASM215444v1 Streptomyces9fradiae9 SAMN06282440 6090486 5556 0.732223495 25
GCF_002154465.1_ASM215446v1 Streptomyces9vinaceus9 SAMN06277068 7034126 6457 0.707653853 15
GCF_002154505.1_ASM215450v1 Streptomyces9carpinensis9 SAMN06277327 10405645 9395 0.700475735 23
GCF_002154555.1_ASM215455v1 Streptomyces9murinus9 SAMN06282499 7954566 7043 0.707942022 50
GCF_002154575.1_ASM215457v1 Streptomyces9bobili9 SAMN06277082 8062541 7275 0.703431308 36
GCF_002154585.1_ASM215458v1 Streptomyces9pseudogriseolus9 SAMN06282523 7264127 6606 0.715425862 24
GCF_002154605.1_ASM215460v1 Streptomyces9milbemycinicus9 SAMN06282496 11617640 10147 0.697121041 81
GCF_002154615.1_ASM215461v1 Streptomyces9recifensis9 SAMN06283862 6184501 5665 0.706821182 25
GCF_002154675.1_ASM215467v1 Streptomyces9reticuliscabiei9 SAMN06283863 9962914 8841 0.691008809 39
GCF_002155725.1_ASM215572v1 Streptomyces9scabiei9 SAMN06346025 10299109 9218 0.700972408 41
GCF_002155735.1_ASM215573v1 Streptomyces9scabiei9 SAMN06346008 10073597 9092 0.69441377 33
GCF_002155765.1_ASM215576v1 Streptomyces9scabiei9 SAMN06346051 9879526 8759 0.7020329 46
GCF_002155885.1_ASM215588v1 Streptomyces9rhizosphaericus9 SAMN06291435 11558421 10021 0.700046815 83
GCF_002155905.1_ASM215590v1 Streptomyces9tricolor9 SAMN06291439 8832356 8050 0.715291671 55
GCF_002156055.1_ASM215605v1 Streptomyces9viridochromogenes9 SAMN06294989 7333324 6635 0.711990797 25
GCF_002156075.1_ASM215607v1 Streptomyces9scabiei9 SAMN06345842 10317375 9162 0.702943731 38
GCF_002156095.1_ASM215609v1 Streptomyces9sp.9NRRL9BM240859 SAMN06361599 8830681 8011 0.70367127 35
GCF_002156145.1_ASM215614v1 Streptomyces9sp.9NRRL9BM245729 SAMN06364930 8377152 7702 0.710267938 39
GCF_002217755.1_ASM221775v1 Streptomyces9hyaluromycini9 SAMD00041946 11525033 10106 0.701397586 49
GCF_002224125.1_ASM222412v1 Streptomyces9sp.9NBS914/109 SAMN06288443 12147237 10235 0.69927377 79
GCF_002242805.1_ASM224280v1 Streptomyces9diastatochromogenes9 SAMN05462163 10520052 9292 0.701480153 45
GCF_002289305.1_CMBMCS145 Streptomyces9albidoflavus9 SAMN07505021 6523997 5796 0.720414355 31
GCF_002291145.1_ASM229114v1 Streptomyces9sp.9SA159 SAMN07608010 10356278 9423 0.693965115 47
GCF_002300165.1_ASM230016v1 Streptomyces9sp.9Tue60289 SAMN05900974 7957609 6779 0.705633665 28
GCF_002742045.1_ASM274204v1 Streptomyces9sp.9HG999 SAMN06319431 8624389 7871 0.687372577 28
GCF_002761895.1_ASM276189v1 Streptomyces9sp.9JV1789 SAMN07959955 10650097 8972 0.701730147 47
GCF_002794255.1_ASM279425v1 Streptomyces9sp.9TRM9SA00549 SAMN08005496 7200897 6431 0.722485517 24
GCF_002802945.1_ASM280294v1 Streptomyces9sp.9TSRI0384M29 SAMN07346488 6937431 5834 0.725347582 36
GCF_002803065.1_ASM280306v1 Streptomyces9sp.9CB016359 SAMN07346483 10064235 9033 0.694848817 25
GCF_002803075.1_ASM280307v1 Streptomyces9sp.9CB013739 SAMN07346482 7876032 6844 0.706196951 30
GCF_002803085.1_ASM280308v1 Streptomyces9sp.9CB012019 SAMN07346481 8758226 7859 0.702719874 47
GCF_002803155.1_ASM280315v1 Streptomyces9sp.9CB029599 SAMN07346487 10358718 9240 0.709436286 52
GCF_002803175.1_ASM280317v1 Streptomyces9sp.9CB026139 SAMN07346485 7380634 6458 0.707685605 35
GCF_002803195.1_ASM280319v1 Streptomyces9sp.9CB02120M29 SAMN07346484 8451160 7474 0.714686431 39
GCF_002843305.1_ASM284330v1 Streptomyces9barkulensis9 SAMN08005599 6544873 5835 0.719480034 31
GCF_002891315.1_ASM289131v1 Streptomyces9noursei9 SAMN04075824 10123402 8844 0.70335228 55
GCF_002891865.1_ASM289186v1 Streptomyces9malaysiensis9 SAMN04038611 11608319 9303 0.700310871 65
GCF_002910755.1_ASM291075v1 Streptomyces9sp.9SM149 SAMN06828994 6344127 5279 0.714709432 35
GCF_002910795.1_ASM291079v1 Streptomyces9sp.9SM99 SAMN06828991 6450053 5810 0.717143383 26
GCF_002910815.1_ASM291081v1 Streptomyces9sp.9FM0089 SAMN06828992 6479762 5825 0.717562287 29
GCF_002910855.1_ASM291085v1 Streptomyces9sp.9SM129 SAMN06828941 6475136 5573 0.712329647 32
GCF_002910875.1_ASM291087v1 Streptomyces9sp.9SM139 SAMN06828988 8436826 7715 0.703069072 42
GCF_002910895.1_ASM291089v1 Streptomyces9sp.9SM59 SAMN06828937 7608098 6741 0.708157887 33
GCF_002910905.1_ASM291090v1 Streptomyces9sp.9SM119 SAMN06828940 8000960 7273 0.702384645 50
GCF_002910915.1_ASM291091v1 Streptomyces9sp.9SM109 SAMN06828939 7466978 6620 0.699069178 35
GCF_002910935.1_ASM291093v1 Streptomyces9sp.9B226SN1019 SAMN06828936 8273663 7309 0.707371963 44
GCF_002910985.1_ASM291098v1 Streptomyces9sp.9B188M1019 SAMN06828935 8223974 7293 0.706794827 44
GCF_002939385.1_ASM293938v1 Streptomyces9sp.9MH609 SAMN06284050 8138908 7340 0.712165394 31
GCF_002941025.1_ASM294102v1 Streptomyces9sp.9QL379 SAMN08536093 8783195 7764 0.700025683 38
GCF_002982015.1_ASM298201v1 Streptomyces9sp.9ST5x9 SAMN08629608 6414515 5688 0.727490627 36
GCF_003013745.1_ASM301374v1 Streptomyces9sp.9111WW29 SAMN06292595 8593882 7845 0.712677964 30
GCF_003046555.1_ASM304655v1 Streptomyces9sp.9VMFNMG11Ma9 SAMN08777816 8558085 7750 0.698652581 28
GCF_003112535.1_ASM311253v1 Streptomyces9rishiriensis9 SAMD00090287 9179716 7946 0.708689763 50
GCF_003112595.1_ASM311259v1 Streptomyces9rubrogriseus9 SAMD00090290 8454377 7549 0.713365444 31
GCF_003143935.1_ASM314393v1 Streptomyces9sp.9Act1439 SAMN09202778 9621493 8647 0.703831899 27
GCF_003144095.1_ASM314409v1 Streptomyces9sp.9ICBB981779 SAMN07572833 6326228 5598 0.717560315 26
GCF_003182435.1_ASM318243v1 Streptomyces9albus9 SAMN08778086 6779547 5822 0.724788402 28
GCF_003182455.1_ASM318245v1 Streptomyces9venezuelae9 SAMN08778087 8390425 7536 0.715658588 36
GCF_003205575.1_ASM320557v1 Streptomyces9tateyamensis9 SAMN08683764 7455770 6514 0.717053975 37
GCF_003253495.1_ASM325349v1 Streptomyces9sp.9ScaeMPMe1229 SAMN02745828 7360219 6445 0.709052597 28
GCF_003259275.1_ASM325927v1 Streptomyces9sp.9DpondAAME109 SAMN02745806 7393976 6511 0.709080937 27
GCF_003259355.1_ASM325935v1 Streptomyces9sp.9Amel2xB29 SAMN02745834 7011625 5895 0.710093349 31
GCF_003259365.1_ASM325936v1 Streptomyces9sp.9PsTaAHM1379 SAMN02745836 8956806 8085 0.704510264 38
GCF_003259575.1_ASM325957v1 Streptomyces9sp.9DpondAAMA509 SAMN02745807 7380346 6500 0.709032057 29
GCF_003259585.1_ASM325958v1 Streptomyces9sp.9PsTaAHM1309 SAMN02745832 8026993 7014 0.715470672 49
GCF_003259625.1_ASM325962v1 Streptomyces9sp.9KhCrAHM439 SAMN02745833 8204965 7324 0.709467067 29
GCF_003268965.1_ASM326896v1 Streptomyces9avidinii9 SAMN05421859 7653760 6743 0.702063938 34
GCF_003323715.1_ASM332371v1 Candidatus9Streptomyces9philanthi9 SAMN09508721 7661915 6503 0.713000195 31
GCF_003323735.1_ASM332373v1 Streptomyces9sp.9LHW503029 SAMN09508719 7687565 6699 0.710688321 32
GCF_003346515.1_ASM334651v1 Streptomyces9sp.9AC2309 SAMN09709326 7735729 6601 0.707759246 45
GCF_003387315.1_ASM338731v1 Streptomyces9albus9 SAMN09064994 6779356 5825 0.7248554 28
GCF_900079405.2_Streptomyces_sp_F1_v3 Streptomyces9sp.9FM19 SAMEA3925434 8142296 7259 0.70845395 41
GCF_900079415.1_Streptomyces_sp._F7 Streptomyces9sp.9FM79 SAMEA3925435 7436643 6541 0.717805349 27
GCF_900090065.1_IMGMtaxon_2513237100_annotated_assembly Streptomyces9sp.9OspMPMM459 SAMN02746034 7407922 6417 0.711882175 33
GCF_900090075.1_IMGMtaxon_2513237108_annotated_assembly Streptomyces9sp.9MnatMPMM779 SAMN02746036 8648704 7292 0.713009047 53
GCF_900090085.1_IMGMtaxon_2513237109_annotated_assembly Streptomyces9sp.9NcostMT6TM19 SAMN02746059 8099030 7061 0.705384315 44
GCF_900090095.1_IMGMtaxon_2513237115_annotated_assembly Streptomyces9sp.9SceaMPMe969 SAMN02746030 9563454 8262 0.699472656 50
GCF_900090115.1_IMGMtaxon_2518645584_annotated_assembly Streptomyces9sp.9AmelKGMA39 SAMN04487747 7135111 6137 0.712799881 32
GCF_900090125.1_IMGMtaxon_2522125136_annotated_assembly Streptomyces9sp.9WMMB97149 SAMN02745759 6594919 5547 0.708131133 32
GCF_900090135.1_IMGMtaxon_2518645622_annotated_assembly Streptomyces9sp.9LaPpAHM1999 SAMN04487750 8044205 6842 0.717096245 38







































GCF_900090145.1_IMG-taxon_2522125135_annotated_assembly Streptomyces@sp.@WMMB@322@ SAMN02745757 6597054 5607 0.700629026 28
GCF_900091905.1_IMG-taxon_2657245728_annotated_assembly Streptomyces@sp.@OspMP-M43@ SAMN04883176 8236685 7302 0.711979304 52
GCF_900092015.1_IMG-taxon_2657245727_annotated_assembly Streptomyces@sp.@MnatMP-M27@ SAMN04883145 10886035 9726 0.699345273 55
GCF_900101585.1_IMG-taxon_2663762722_annotated_assembly Streptomyces@prasinopilosus@ SAMN05216505 7125330 6150 0.720327689 29
GCF_900101975.1_IMG-taxon_2636416059_annotated_assembly Streptomyces@sp.@136MFCol5.1@ SAMN02745898 7836607 6878 0.689635581 17
GCF_900102095.1_IMG-taxon_2667527442_annotated_assembly Streptomyces@jietaisiensis@ SAMN05216260 7681257 6673 0.718330731 23
GCF_900103585.1_IMG-taxon_2615840541_annotated_assembly Streptomyces@sp.@cf386@ SAMN04487981 10622898 9328 0.696457574 44
GCF_900107965.1_IMG-taxon_2667527441_annotated_assembly Streptomyces@yanglinensis@ SAMN05216223 9592053 8041 0.716823259 34
GCF_900110755.1_IMG-taxon_2615840635_annotated_assembly Streptomyces@sp.@yr375@ SAMN04487983 9070480 7637 0.703513903 60
GCF_900112965.1_IMG-taxon_2616644814_annotated_assembly Streptomyces@mirabilis@ SAMN02787118 11555299 10460 0.692781337 34
GCF_900114215.1_IMG-taxon_2654587880_annotated_assembly Streptomyces@pini@ SAMN05192584 6338888 5643 0.721041777 32
GCF_900114955.1_IMG-taxon_2609459763_annotated_assembly Streptomyces@sp.@cf124@ SAMN04487980 9995208 8474 0.704734085 46
GCF_900116145.1_IMG-taxon_2675903139_annotated_assembly Streptomyces@harbinensis@ SAMN05444716 5802684 5206 0.720466405 24
GCF_900116325.1_IMG-taxon_2615840540_annotated_assembly Streptomyces@sp.@ok210@ SAMN04487982 8088436 7140 0.688000622 19
GCF_900119365.1_IMG-taxon_2616644941_annotated_assembly Streptomyces@atratus@ SAMN02787144 8510691 7615 0.695836811 44
GCF_900142595.1_IMG-taxon_2667527450_annotated_assembly Streptomyces@yunnanensis@ SAMN05216268 9356146 8360 0.704780564 50
GCF_900171555.1_Salb Streptomyces@albidoflavus@ SAMEA100366918 7004412 6085 0.724016855 29
GCF_900177255.1_IMG-taxon_2524614730_annotated_assembly Streptomyces@sp.@Amel2xC10@ SAMN02745830 7976204 7120 0.711159884 36
GCF_900187925.1_IMG-taxon_2524614673_annotated_assembly Streptomyces@sp.@PgraA7@ SAMN02745831 8317680 7406 0.705965144 42




Additional file 2: Table S2. List of CGCs used in Figure 3. Sequences were obtained from 
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